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ABSTRACT 
 
Macroscopic and histological characteristics of the placenta and umbilical cord are 
thought to be associated with the perinatal outcome. However, a lack of appropriate 
quantitative data on placental morphology makes it difficult to study its effects on the 
pregnancy and neonatal outcome. The umbilical cord coiling, its insertion onto the 
chorionic plate and the placental shape varies from one pregnancy to another. There 
has been very little attempt at quantifying placental and umbilical cord morphology.  
Widespread use of digital measurement techniques in biomedical science has 
superseded manual measurements. Though this technique has been applied to the 
placental measurements, no standardized methodology has been used. This study 
formally compares manually and digitally obtained placental measurements using 
proprietary software.   
This study derives indices describing the cord coiling (cord coiling index), the 
relationship of cord insertion to the placental centre (cord centrality index) and the 
shape of the placenta (eccentricity) in placentas from unselected pregnancies and 
common obstetric outcome groups. This study establishes a quantitative relationship 
of birth weight to the placental weight and circumference. It demonstrates that these 
indices in pregnancies are affected by common obstetric outcome groups such as; 
pre-eclampsia (PET), pregnancy induced hypertension (PIH), gestational diabetes 
mellitus (GDM) and delivery of a small for gestational age (SGA) baby. 
This study defines the various histological abnormalities of the placenta using strict 
criteria. It further investigates the incidence of these predefined histological 
abnormalities of the placenta in an unselected population and common obstetric 
outcome groups. 
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The guidelines published on placental examination recommend a detailed 
histopathological examination of the placenta in cases of adverse perinatal outcome. 
However, there seems to be some degree of uncertainty whether any association 
exists between histopathological findings and perinatal outcome. This study 
examines the morphological indices and histology of the placenta in infants admitted 
to the Neonatal Unit. 
This study attempts to identify the relationship between the pregnancy outcome, 
neonatal characteristics and placental pathology by examining the pregnancy and 
neonatal outcome in all cases with abnormal placental pathology.  
This study shows significant correlation between manual and digital measurements 
of the placenta. Digital measurement is a reproducible and relatively simple method 
and can be of potential importance in the future studies in this field. The quantitative 
analysis performed shows that the cord insertion is most commonly “off centre” and 
the shape of the placenta is “elliptical”, this finding is contrary to the traditional 
belief that the cord insertion is central and the placental shape is round. The study 
demonstrates that the morphological indices in common obstetric outcome groups 
are not different from the non-affected cases. It also reveals a significant positive 
correlation between birth weight to placental weight and circumference.  
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1.1 BACKGROUND OF THE STUDY 
 
 
The placenta is a neglected human organ. Pathological assessment of the placenta may 
provide considerable information which may have significant clinical impact on 
mother and the neonate. According to the guidelines of the Royal College of 
Pathologists, any sample of diagnostic value removed from the human body should  be 
histologically examined, with only a few exceptions.1 One  of the exceptions is the 
healthy human placenta, but even with valid indications the human placenta is one of 
the most under-examined specimens.2 There are no gold standards for placental 
examination for clinical indications. There is also evidence that the quality of reports  
on the investigation of the placenta is very variable.3 There is no consistency in the 
gross and histological reporting of the placenta. There is also a considerable 
discrepancy rate in the diagnosis of placental disease, and it is common for  general 
surgical pathologists not to recognise placental lesions  that may have clinical 
relevance.4 It has been suggested that the standards of placental surgical reporting can 
be improved, possibly by the use of templates and checklists for reporting of 
placentas.3 
The placental and umbilical cord measurements vary greatly from one pregnancy to 
another. There has been an increasingly growing interest in the morphometry of the 
placenta and the umbilical cord. We do not know if umbilical cord coiling, abnormal 
insertion of umbilical cord onto the chorionic plate and chorionic plate shape are 
linked with perinatal outcome. As per normal practice, morphology of the placenta 
and umbilical cord are defined qualitatively. Traditionally coiling of the cord, cord 
insertion and the placenta shape has been described qualitatively by almost all studies. 
These indices may have clinical associations with pregnancy outcome though there is 
a need to derive quantitative morphological indices, describing the above parameters 
in order to improve the accuracy of diagnosis. In recent years many researchers have 
emphasised an importance of hyper or hypo coiling of the cord.5-8  These studies have 
suggested adverse perinatal outcome with abnormal (hyper/hypo) insertion. However, 
there is still uncertainty with regards to the exact association of abnormal coiling to 
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the perinatal morbidity and mortality. It is believed that peripheral insertions of the 
umbilical cord are linked to poor pregnancy and neonatal outcome. There is confusion 
with the paracentral (eccentric) cord insertion type, as most studies conducted in the 
past have explained the paracentral insertion qualitatively. Central and paracentral 
insertions have no clinical significance; however, an extreme eccentric insertion may 
be associated with poor pregnancy and neonatal outcome.9 Shapes  of the placenta 
have been described as round, oval, irregular, star shaped, multi-lobate.10 Irregular 
chorionic plate shape may have an association with altered placental function 
resulting into adverse outcomes such as low birth weight and placenta weight ratio.10 
 
To avoid the subjective bias in placental morphological analysis, we derived 
quantitative indices describing umbilical cord insertion, as “Cord Centrality Index” 
and chorionic plate shape as “Eccentricity”. The coiling of the umbilical cord has 
been defined by an already established method as “Cord Coiling Index”.11 
 
A common practice of examination of the placenta, following an adverse perinatal 
outcome, such as pre term labour, severe intra uterine growth restriction (IUGR), still 
birth or poor neonatal outcome is to perform a manual measurement of the placenta 
and the umbilical cord. Digital imaging is being used in many sub disciplines of 
medicine including digital measurements of the placenta. 12-13  In the current study, 
digital measurements of the placenta were performed using an image processing 
programme, Image J. This java image processing software has been used in various 
studies and compared with other advanced routinely used investigative techniques 
such as CT and MRI.14  
 
There are certain potentially treatable maternal conditions, recurrent placental or 
inherited fetal conditions that can be identified by placental examination. Therefore, 
there is a need to standardise the method and reporting of placental examination. In 
order to advance and promote better understanding of placental pathology, the 
College of American Pathologists have encouraged clinicians to perform studies on 
the placenta and umbilical cord. 
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The American college of Pathologists published guidelines in 1991 to encourage 
properly designed placenta studies with appropriate outcome parameters necessary to 
draw conclusions.15  
Tragedies such as perinatal death or severe neurological impairment are increasingly 
recognised as being associated with pathological conditions of the placenta and the 
umbilical cord. These frequently develop long before labour and delivery and cannot 
be prevented by even the most attentive obstetric care. Under these circumstances, 
examination of placenta and umbilical cord in the delivery room as well as in the 
pathology laboratory can make a crucial contribution to the investigation of instances 
of pregnancy failure. 
 
The placenta is a functional unit between the mother and  the fetus. Therefore, any 
pathological event concerning the mother or the fetus may influence the normal 
function of the placenta, occasionally resulting in morphological changes. Severe 
abnormalities of the placenta may lead to adverse fetal outcome.  However, placental 
lesions are not necessarily the cause of unfavourable obstetric outcome, and some 
structural changes may be the consequences of poor fetal condition.16 
 
Placental examination can be helpful in identifying the etiology of stillbirth, preterm 
delivery, intrauterine growth restriction, and neurodevelopment impairment. It may be 
possible to determine whether the pathological condition that endangered the well 
being of the fetus was an acute or  a chronic process.17-18 Conditions with the risk of 
recurrence can be recognised, resulting in adequate treatment and preventive measures 
during subsequent pregnancies. There has been study performed to determine whether 
placental investigations assist in determining the cause of still birth and found some 
placental lesions were associated with clinical causes of still birth such as placental 
infarction, leukocyte infiltration and chorioamnionitis. Assessment of placenta can aid 
classification of still birth, even when full infant post-mortem is declined.19  
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Placental examination may have medico legal implications for example, concerning 
the aetiogy of long term neurodevelopment sequelae or the approximate timing of an 
intrauterine death.20-21  
 
The placenta is one of the important means of establishing that the fetal damage may 
cause adverse pregnancy outcome independent of clinical care. 
The entire literature is dominated by small case series of placental abnormalities 
rather than defining incidence of histological pathologies of the placenta in a general 
population. Previous studies on placental pathology have been largely confined to the 
association of particular outcomes in relation to specific abnormalities, usually in a 
small number of selected cases. The majority of studies are retrospective and notable 
also is the minimal consideration in published studies given to the combined effects of 
multiple placental lesions.  
 
Another major concern is that most studies of the placenta are based on abnormal  
placentas, which makes it difficult to differentiate between the “pathologically 
abnormal” versus “normal variant”. There are few studies that analyse normal 
placentas statistically and identify the normal variants of histological lesions  during 
the course of pregnancy.  
Recent advances such as more advanced ultrasound techniques, MRI in fetal medicine 
and placental pathology are now such that the opportunity exists to establish clearly 
which placental lesions represent the greatest threat to a healthy pregnancy and to a 
positive neonatal outcome. It is believed from that certain placental lesions are 
associated with poor neonatal outcome; conversely, there are relatively recently 
described placental lesions such as abnormal cord coiling, Villitis of unknown 
aetiology and thrombotic vasculopathy where the precise clinical implications are still 
not well understood.  
This study will unite antenatal observations and neonatal outcomes with macroscopic 
and microscopic examination of a cohort of unselected pregnancies delivered in a 
single unit. We expect through this research to propose quantitative indices and 
establish a rationale for identifying both normal and pathological appearances of 
placental histology, by linking the findings with pregnancy and neonatal outcome. 
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1.2 PLACENTA 
1.2.1 Overview of placental anatomy 
The placenta is the most important and the only organ between mother and fetus, 
serving multiple functions. It acts as an endocrine organ producing several types of 
hormones e.g. lactogen, chorionic gonadotrophins etc. It allows the exchange of 
oxygen and CO2, whereby transfer of oxygen takes place from maternal blood to the 
fetus, and carbon dioxide goes out from fetus to mother. It allows the transfer of 
carbohydrates, protein, amino acid, polypeptides, lipids, vitamins, water, electrolytes 
and pharmacological agents from the mother to the fetus.   
A placenta has a maternal surface (basal plate) and a fetal surface (chorionic plate). 
The basal plate and chorionic plate meets at the placental margin and form the smooth 
fetal membranes. The space between chorionic and basal plate is filled with the 
intervillous lakes of maternal blood. 
 
Basal plate                                 
                                                                                 
 
 
 
 
Figure1.1 Maternal surface of a normal term placenta with cotyledons (study photograph) 
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The basal plate is the placental surface, attached to the uterine wall during pregnancy, 
once separated called basal plate or maternal surface. Therefore the basal plate would 
have both fetal as well as maternal component to it, seen microscopically. The 
maternal surface is opaque, dark red in colour, consists of protuberant growths called 
cotyledons, usually 10-40 in a healthy normal term placenta, these cotyledons are 
separated by grooves, occupied by placental septa in situ (fig 1.1). These septas can 
extend even up to the fetal surface. 
Microscopic view     
            
 
 
 
Figure 1.2 shows the microscopic view of the basal plate. The basal plate has fetal 
extravillous trophoblasts and all types of maternal cells from uterine deciduas and 
deciduas basalis. The villi are surrounded by the maternal endometrium. The 
trophoblast cells, lining the endometrial side of the villi, synthesize extracellular 
matrix, fibronectin.  In microscopic examination of the basal plate, dilated maternal  
spiral arteries lined by fibrinoid matrix together with endovascular trophoblasts can be 
seen.  
 
 
Figure 1.2 Microscopic view of basal plate of the placenta (study photograph) 
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Chorionic plate 
 
 
 
 
This is the fetal surface of the placenta; a variable amount of whitish-yellow 
subchorionic fibrin can be seen under the chorion (fig 1.3). There is no clinical 
importance of subchorionic fibrin unless it is massive and extensive. Amnion is 
composed of epithelium and amniotic mesenchyme. Amniotic mesenchyme is 
attached to the chorionic mesenchyme loosely, which can be very easily separated. 
The umbilical cord is attached onto the fetal surface. Chorionic vessels run in the 
chorionic mesenchyme, which are then continuous with the vessels of the umbilical 
cord that eventually supplies the villous tree. The chorionic veins give rise to one 
single umbilical vein. Umbilical vessels give rise to multiple branches, which spread 
all over the fetal surface, up to the peripheral margin of the placental disc. 
 
 
 
 
Figure 1.3 Macroscopic view of chorionic plate of the placenta (study photograph) 
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Stem villi are composed of dense connective tissue, which are surrounded by arteries 
and vein. The arteries are thick walled compared to the veins. Peripheral extension of 
the stem villi gives rise to immature intermediate villi, which i mplant in the basal 
plate and mature intermediate villi. Immature intermediate villi are predominant form 
of villous tree in immature placentas, between 8-20 weeks of pregnancy.22 Mature 
intermediate villi develop early in third trimester and this type makes up to quarter of 
villi in a mature placenta.                                                                                                                                                                                                                                                                                                                                     
The lateral expansion of the chorionic plate of the placenta plateaus by the middle of 
third trimester.23 At 30-32 weeks gestation, growth of the placenta is mainly by 
arborisation of the villous tree, resulting into the growth of its thickness.24   
 
 
 
 
 
 
Figure 1.4 Microscopic view of the chorionic plate of the placenta (study photograph) 
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1.2.2 Placental Shape 
Normal development of a placenta is the one of the important requirements for a 
healthy pregnancy, regulating fetal growth and fetal health. The placental shape is 
evidence of a normal development of the placenta.  The placenta is normally 
considered to be a round discoid shape; however the shape has been described in 
various ways such as round, oval, irregular, star shaped, bi-lobate, multi-lobate, 
circumvallate, circummarginate and many more (figure 1.5). The placenta is the 
primary source of nutrients and oxygen to the fetus. A variable maternal utero 
placental environment affects macroscopic placental structure as a change in shape.10 
Therefore, the shape of the chorionic plate is a reflection of the function of the 
placenta and an abnormal placental shape could indicate abnormalities in utero-
placental environment.   
The clinical significance of abnormal placental shape has led to mixed opinions. One 
view is that irregular shapes are associated with lower birth weight for placental 
weight, suggesting variable shaped placentas have altered function.10  Some believe 
that abnormal shapes  (circumvallate and circummarginate) are simply variants of 
normal shape and has no clinical significance25 while one of the large studies of 7666 
cases has shown association of circumvallate placenta to the higher incidence of 
preterm labour, placental abruption and intra uterine fetal death.26 Another study 
showed higher odds of intra uterine fetal death (OR 4.7; 95% CI 1.4-15.1), preterm 
delivery at < 32 weeks (OR 4.7; 95% CI 1.6-14.1) and intrauterine growth restriction 
(OR 4.7; 95% CI 1.4-15.1) with abnormal shape of placenta than did the women with 
a normal placental shape.25 27 
A placenta with accessory lobes (succenturiate lobes) can potentially be detected 
antenatally by ultrasound; most have no clinical significance but may be associated 
with retained accessory lobe after delivery leading to either post partum haemorrhage 
or uterine sub involution. Multilobate placenta may be associated with velamentous 
insertion or blood vessels traversing in between the lobes, covering cervix, causing 
vasa previa. 
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Traditionally placental shape is described qualitatively but recently a study emerged 
with quantitative analysis of the shape of the placenta. 10 The same group related the 
variability in the chorionic plate shape to the structure of the underlying vascular 
tree. Figure 1.5 shows the different variants of placental shapes. First column shows 
the normal round to oval shape, while 2nd column with star shaped placenta and 3rd 
column has placentas with accessory lobes. 
 
Figure1.5 Shape variants of the placenta 
(Source- Yampolsky M, Salafia CM, Shlakhter O, Haas D, Eucker B, Thorp J. Modeling the variability of 
shapes of a human placenta. Placenta 2008;29(9):790-7).10 
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1.3 UMBILICAL CORD  
1.3.1 Embryology & Development of the Umbilical Cord 
The primitive umbilical ring is the junction between amnion and embryonic ectoderm. 
At the fifth week of development, structures passing through this ring are the 
connecting stalk containing allantois and umbilical vessels, yolk sac (vitelline duct) 
with vitelline vessels and the canal connecting intra and extra embryonic cavities. 
Extra-embryonic mesoderm grows towards the centre to form the chorionic cavity, a 
place which is occupied by the proper yolk sac. During the development, the yolk sac 
rotates towards the implantation site. The embryo then folds into the amniotic cavity. 
Subsequent expansion of the amniotic cavity occurs at the expense of chorionic 
cavity. Later amnion envelops the connecting stalk and yolk sac stalk together and 
that forms the primitive umbilical cord. During early development, 13-40 days post 
conception umbilical cord forms at the site of the connecting stalk, which joins the 
extra embryonic mesoderm to the embryonic disc. Proximally the primitive umbilical 
cord also contains some intestinal loops. By the end of the third month amnion has 
expanded in such a way that it comes in contact with chorion, obliterating chorionic 
cavity. The yolk sac shrinks and gets obliterated. As the development progresses, the 
connecting stalk containing allantois, vitelline duct and the umbilical vessels gets 
smaller in diameter and increases in length. Later allantois and vitelline duct are 
obliterated. Umbilical vessels remain at the end of the development, which is  
surrounded by the Wharton‟s jelly. There are two umbilical arteries, formed from two 
embryonic allantoic arteries. Initially there are two allantoic veins but as the 
development progresses, within first two months, the right allantoic vein disappears 
and only left forms the umbilical vein.  
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1.3.2 Overview of Umbilical cord anatomy 
In a typical three vessel umbilical cord there are two umbilical arteries and one 
umbilical vein, suspended in a mesodermal mucoid matrix stroma, called Wharton‟s 
jelly. There are no nerves or lymphatic vessels in the umbilical cord. Wharton‟s jelly 
consists of myofibroblasts and ground substance.28-29 This combination of loose gel 
and contractile cells gives the umbilical cord tensile strength and umbilical vessels are 
protected against any pressure or compression. The umbilical arteries do not have an 
internal elastic lamina and the media of the artery is composed of peripherally 
arranged spiral muscles. The umbilical vein does have an elastic lamina and the 
smooth muscle layer is thinner than the umbilical artery. Therefore, during the 
antenatal period, the protective elements for any umbilical cord are amniotic fluid, 
Wharton‟s jelly and the helical coiling of the umbilical vessels. 
 
 
a 
                                   b 
 
 
 
 
 
 
Figure 1.6 Macroscopic and histological view (H & E stain) of a normal 3 vessel view of the umbilical 
cord (a)study photograph (b) Websource-http://library.med.utah.edu/WebPath/PLACHTML/PLACIDX.html#5) 
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Umbilical cord length      
It is still not well understood, what factors exactly decide the length of the umbilical 
cord. However, the evidence so far available suggests fetal movement producing the 
tensile force on the umbilical cord and genetic factors play an important role in 
deciding the length of cord. Most studies on the placenta and umbilical cord to date 
have measured cord which is attached with the placenta. Ideally the measured length 
of the cord should also include the measurement of the cord attached to the baby. As 
that length can be variable depending on the condition of the baby on delivery, its 
length taken only on the part attached to the placenta will not be a true measurement 
of the cord.                                                                                  
It is believed that the tensile strength produced from the fetal movements is an 
important deciding factor for the length of the cord; conditions which affect the fetal 
movements‟ in-utero will affect the length of the cord too. Conditions restricting fetal 
movements such as skeletal dysplasia, amniotic bands, oligohydramnios, multiple 
pregnancies, uterine malformation usually have a short cord.30-32   
Boyd and Hamilton (1970)33 reported on lengths at various gestation as outlined 
below in the table. This table reflects the increasing length with increasing gestation.       
    
Table 1.1 Umbilical cord length as per gestation (Source-Boyd and Hamilton-1970)
33 
 
 
Gestation (month) Length of fetus  (mm) Average cord length (cm) Range (cm) 
Third 31-60 6 2.3 – 10.5 
Fourth 61-100 15 5 – 25 
Fifth 101-150 25 14.5 – 45 
Sixth 151-200 28 21 – 48 
Seventh to term 200-340 35 22 – 48 (or more) 
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Though the umbilical cord is extremely variable in length, an average normal length 
of umbilical cord is 55-60 cm.9 The minimum cord length which allows the normal 
vertex delivery is 32cm.34. Since this study, most authors have accepted this length as 
a minimum length, anything less than this is considered to be a short cord. 
Considering this definition of short cord, the incidence of short cord has been reported 
as 0.4-0.9% 35-37, while in one study incidence of cord less than 35 cm was 2%.38 
A short cord has been associated with intrauterine fetal distress and neonatal 
asphyxia.39 It is believed that a possible cause of fetal hypoxia with short cord is 
excessive traction on the cord during descent of the fetus, which results into occlusion 
of the cord vessels. However, this remains speculative as the pH and base deficit of 
the umbilical blood were the same for neonates with normal umbilical cord length. 38   
There is no agreed definition, as to what should be termed as excessive long cord. 
Some studies have defined cord length more than 80 cm as long cords38, while others 
have taken 100 cm as the upper limit of the cord length.36 These studies have defined 
incidence of long cords as 3.7%12 and 0.5%10 respectively. Long cords have been 
associated with increased knotting (true knots), torsion and cord prolapsed.40  
Umbilical cord diameter 
The umbilical cord diameter depends upon the number of vessels present, size of the 
umbilical vein and the fluid content of Wharton‟s jelly. By what, factors determining 
the amount of water content in Wharton‟s jelly are not clearly understood. The normal 
cord diameter is 1-2 cm and the cord can be oedematous in clinical situations such as 
maternal diabetes mellitus. Fetal outcomes are better with increased jelly in the cord, 
while cords with reduced Wharton‟s jelly are more prone to compression and 
abnormal fetal heart rate pattern, an absence of Wharton‟s jelly around umbilical 
vessels have been reported to be associated with perinatal death. 41 
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Umbilical cord coiling 
The umbilical cord is protected by Wharton‟s jelly, coiling of the umbilical vessels 
and the amniotic fluid. The umbilical cord is a coiled, helical structure but the origin 
of coiling remains unknown. Possible explanations of the origin of coiling have been 
given as torsion by active or passive movements, causing the embryo to rotate around 
its umbilical cord axis42, presence of Roach muscle, which is a small bundle of 
muscles lying just beside the umbilical artery, contributing to the coiling43, and 
hemodynamic forces of the fetus.44 
 Umbilical cord coiling is well established by 9 weeks of gestation. It is unknown 
whether there are genetic factors involved in coiling or if it is only acquired but the 
degree, tensile stress and the number of coils seems to be affected by in-utero fetal 
movements.45 Considering the fetal movements as a theory for coiling of the umbilical 
cord, hypocoiling is seen in cases of fetal anomalies affecting fetal movement such as 
amniotic bands, oligohydramnios, uterine malformations,  twins and pregnancy 
affected by chromosomal anomalies46 whereas hypercoiling is more common in 
parous women, male fetus (presumed to be more active) have longer cord than female 
fetus, maternal cocaine use and longer umbilical cords.47  The hypocoiled cord is 
more prone to kinking, compression and stasis.  
Frequency of noncoiled cord is reported as 4.3-4.9%5 48 while hypercoiling has been 
reported as high as 20% in unselected placentas.6 
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Coiling is either anti-clockwise (left) or clockwise (right). Anti clockwise coiling is 
more common. To define the direction of coils, the umbilical cord is placed vertically 
and vessels on the anterior surface of the cord are noted; if the direction is towards the 
left hand of the observer, it is noted as left sided coiling and right sided if it directed 
towards observer‟s right hand. Studies have observed the direction of coiling either 
from placental end49 or from the fetal end 50, however the direction of the coiling 
would not in fact alter whether viewed from the placental or the fetal end.51 The 
prevalence of anti-clockwise coiling varies from 65 to 76%.8 49  It is not very well 
understood why anti-clockwise pattern is more common, few researchers have 
proposed a possible explanation to this, as cranial arteries also have a spiral form, 
there may be a relationship between the direction of umbilical arteries spirals and left 
or right sided cerebral dominance. 
 
Figure 1.7 Coiling of the umbilical cord (a) Normal coiling (b) Hypercoiling (c) Hypocoiling 
(study photographs) 
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1.3.3 Umbilical Cord Coiling Index 
Umbilical cord coiling was first described in terms of the number of coils in 1954 42 
as “The index of Twist”, which was calculated by dividing the total number of coils 
by the umbilical cord length in centimetres. The coiling pattern was described as 
negative for anti-clockwise and positive for clockwise coiling. Later studies11 defined 
coiling as the term “The Umbilical coiling Index” (UCI). UCI was determined by so 
called Strong‟s formula by dividing the total number of complete umbilical vascular 
coils by the umbilical cord length (in centimetres), UCI was reported as 0.21 ± 0.07 
coils/cm, there being at least one coil in every 5 centimetres of the cord. Therefore 
hypocoiling of the umbilical cord will be defined for UCI smaller than 10 th percentile 
(i.e. less than or equal to 0.1), while hypercoiling as UCI above 90th percentile (i.e. 
equal to or more than 0.3). 
Antenatal Assessment of Cord Coiling Index 
The umbilical cord can be studied sonographically for various prenatal abnormalities 
or possible pathologies. Apart from traditional antenatal assessment of the umbilical 
cord, which includes only the number of blood vessels in the umbilical cord and 
Doppler assessment of the umbilical arteries, further detailed assessment can be done 
prenatally, such as the amount of Wharton‟s jelly, diameter of umbilical vessels7, 
coiling pattern and coiling index.49 52  
Though the reproducibility of these measurements is not yet at a level where they can 
be put to widespread use. 
UCI can be calculated for the cord either at fetal end, placental end or the central part. 
There is more coiling towards the fetal end as compared to the placental end 53, 
therefore UCI will be increasing as we move from the placental end to the fetal end. 
In studies the UCI has been measured at the placental end at the umbilical cord 
insertion, or the fetal end near the umbilical cord entrance into the fetal abdomen and 
in the middle of these two49 to obtain the true UCI. 
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To assess the UCI prenatally, in a longitudinal image of the umbilical cord, a pair of 
coils is identified and the distance between the coils is measured and UCI is 
calculated. However it is not clear as to which section of the umbilical cord should be 
chosen and how many intercoil distances should be measured to obtain the true UCI 
(postnatal UCI).  
Coiling of the umbilical cord is fully developed by end of the first trimester and it 
does not change after this except that the length of the cord keeps getting bigger in 
between the coils.42 54 In the second trimester, the entire umbilical cord can be 
visualised better in its entirety as compared to the examination in third trimester, 
where with relatively reduced liquor volume and the growing fetus, obtaining full 
view of the longitudinal section of the umbilical cord can be challenging especially of 
the fetal end of the umbilical cord. Therefore the most appropriate time to assess 
prenatal UCI should be second trimester with relatively greater amount of the 
amniotic fluid as compared to the fetal size, which allows the visualization of the most 
part of the cord. Studies have shown that sonographic evaluation of umbilical cord 
coiling in the second trimester correlates with the true UCI at birth.55 
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Postnatal Assessment of Cord Coiling Index 
The true UCI is the one which is assessed after birth. At delivery, the direction and the 
number of coiling are noted and umbilical cord coiling index is calculated by the 
standard Strong‟s formula that is defined as dividing the total number of completed 
coils by the length of the umbilical cord. 
Antenatal versus Postnatal Assessment of Cord Coiling Index 
The sensitivity of second trimester sonographic measurement for predicting 
hypocoiling or hypercoiling ranged from 9-40%49 52 as compared to the postnatal 
measurement of UCI. The distension of the umbilical vessels with the fetal blood 
resulting into tighter coiling of the vessels and therefore increased UCI could be the 
possible explanation for this low sensitivity56, or more coiling being towards the fetal 
end as compared to the placental end, or limited visualisation of the umbilical cord 
after the second trimester due to the relative fetal size and the amount of liquor 
volume, making it difficult to measure UCI.  
Most studies are not able to examine the umbilical cord which remains attached to the 
baby and the cord attached to the neonate could be of any length. Whether that makes 
any difference in the calculation of post-partum UCI, considering that umbilical cord 
is more coiled on the fetal end, is not clear. 
 
Figure 1.8 Antenatal ultrasound of cord coiling in (a) 2nd and (b) 3rd trimester of the same 
patient 
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1.3.4 Clinical significance of abnormal cord coiling                                         
Maternal risk factors for abnormal vascular coiling have been proposed as extremes of 
maternal ages, obesity, gestational diabetes mellitus and pre-eclampsia57, while others 
did not find any association between UCI and maternal age.58-59  
Hypocoiling and hypercoiling of the cord whether detected prenatally or postnatally, 
have been correlated with adverse perinatal outcome. Researchers have related 
different variables to the abnormal coiling of the umbilical cord. Hypocoiling has 
been associated with trisomies, preterm delivery, fetal death, increased intrapartum 
complications and interventional deliveries for fetal distress, Apgar score less than 7 
at 5 minutes, velamentous cord insertion and single umbilical artery, while 
hypercoiling of the umbilical cord has been linked with trisomies, small for gestation 
age, fetal asphyxia and single umbilical artery.5 8   Abnormal cord coiling is also 
associated with the thrombosis of the chorionic plate vessels, umbilical venous 
thrombosis and umbilical cord stenosis.6 
There is still controversy regarding the association of hypocoiling and adverse 
pregnancy outcome. A possible explanation for hypocoiling and adverse perinatal 
outcome has been attempted by showing a significant correlation between umbilical 
coiling index and umbilical venous blood flow7 60, which further suggest that 
quantitative analysis of umbilical venous blood flow may be a useful tool in 
conditions such as intra uterine growth restrictions.60-61 Umbilical cord is considered 
as a pumping system, the coiling of the cord is believed to contribute to the fetal 
venous return by creating a umbilical venous pressure.62 Increased coiling would 
perhaps make this pumping system more efficient and therefore increase umbilical 
blood flow while the hypocoiling of the cord  would lead to reduced blood flow and 
eventually affects the growth of the fetus causing intrauterine growth restriction.62 It is 
also thought that overcoiling makes a cord less flexible and undercoiling makes a cord 
floppy, making an undercoiled cord more prone to entanglement.63 
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Complicated pregnancies and UCI 
Studies have investigated those placentas and umbilical cord, which needed a 
histological examination of the placenta for various indications such as fetal demise, 
intrauterine growth restriction, preterm delivery, pre-eclampsia, diabetes mellitus, 
macroscopic abnormalities of placenta, fetal asphyxia, and intra uterine infection. 
Fetal death, preterm delivery, umbilical artery pH<7.05, fetal structural and 
chromosomal anomalies, fetal placental vessel thrombosis, fetal hypoxia and low birth 
weight were associated with hypercoiling while chorioamnionitis, lower Apgar score 
at 5 minutes were associated with hypocoiling. Fetal demise and structural or 
chromosomal fetal congenital anomaly cases were associated with hyper and 
hypocoiling of the cord.63                                                                                                                                                                   
As the umbilical cord coiling index can be assessed prenatally, the association of 
abnormal cord coiling index with perinatal outcome can be a predictive measure of 
adverse antenatal and perinatal outcomes. However, considering the low sensitivity of 
prenatal detection, larger studies are needed to assess the prenatal ultrasound findings 
to the perinatal outcome. 
 In summary there is still controversy and the significance of abnormal UCI 
(hypercoiling and hypocoiling), its association with adverse perinatal outcome 
remains unclear. However, it is a very simple but significant examination in assessing 
cases particularly with unexplained adverse outcome such as fetal death.  
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1.3.5 Umbilical cord insertion 
 Different ways in which the umbilical cord can be attached onto the fetal surface i.e. 
chorionic plate of the placenta have been defined qualitatively as central, eccentric, 
marginal (Battledore) and velamentous (membranous).  
a  b 
c  d 
 
 
Central and eccentric insertions account for more than 90% of cord insertions and 
have no clinical importance, while marginal insertion  may be more susceptible to 
vessel rupture and has been associated with intra uterine growth restriction, still birth 
and neonatal death.9  
 
Figure 1.9 Qualitatively described cord insertions (a) Central, (b) Eccentric, (c) Marginal, 
(d) Velamentous (study photographs)  
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The incidence of velamentous insertion  increases with maternal smoking, advanced 
age or diabetes mellitus and among multiple births, congenital malformation and in 
vitro fertilisation pregnancies.9  
Central insertion is defined as where the umbilical cord is inserted onto the centre of 
chorionic plate. The cord is inserted at the margin of the chorionic plate in marginal 
insertion and membranous insertion where the umbilical cord is not inserted into the 
placenta, but into the membranes. However, eccentric (also called paracentral) cord 
insertion has not been clearly defined. Though it is understood that the insertion 
anywhere between central and marginal insertion is eccentric insertion, eccentric 
insertion can be near to the centre or it can be near to the chorionic plate margin. It 
depends on the precision of the observer as well, an insertion exactly at the centre is 
called central, but slightly off the centre, is defined as central or eccentric. It is not 
clear whether an extreme eccentric insertion (eccentric insertions near the chorionic 
plate margin) should be defined as an eccentric insertion or marginal. Although the 
difference between extreme eccentric umbilical cord insertion and marginal cord 
insertion may be small, this differentiation is important as eccentric umbilical cord 
insertion is the most common type of umbilical cord insertion in pregnancies with 
normal outcome while some studies have shown an increased incidence of marginal 
umbilical cord insertion in pregnancies with adverse outcomes such as miscarriage, 
fetal congenital anomalies, preterm labour and intrauterine growth restriction.64-66  
 
It has been suggested that pathological variations (marginal and velamentous) result 
from disturbance of implantation or faulty implantation of fertilised ovum, which 
eventually prevent central insertion of umbilical cord from taking place.66-67 
The incidence of marginal insertion varies widely possibly due to the different 
interpretation of “extremely eccentric” and marginal insertion. Different studies have 
quoted the incidence between 2-9%.36 68-70 Researchers have different views on the 
outcomes related to marginal umbilical cord insertion.  
 
 
CHAPTER 1: INTRODUCTION 
 
Page | 25  
 
 
Studies have shown an association between marginal cord insertion and increased 
incidence of congenital malformation66, neonatal asphyxia71, and preterm labour64, 
while others did not find an increased incidence of above complications with marginal 
cord insertion.72 
  
       Placenta 
        
      cc 
                     c   
 
 Membranes               Membranes                              
 
 
 
Velamentous insertion 
Velamentous insertion is where the umbilical cord is inserted in between the fetal 
membranes, amnion and chorion and runs in the membranes unsupported by the 
placenta before the cord becomes inserted onto the placental fetal surface. Therefore 
the unprotected umbilical vessels will travel a certain distance before passing onto the 
placental surface. These membranous vessels are prone to compression, thrombosis, 
rupture, and haemorrhage especially if vessels are traversing across the cervical os 
and are ruptured with membranes during delivery, resulting into fetal morbidity and 
mortality (vasa praevia). The incidence of velamentous insertion is generally agreed 
as around 1%, with a range of 0.5-1.6%.68 73-74 
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Figure 1.10 Illustration of qualitatively described cord insertions onto the chorionic plate 
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The incidence of velamentous insertion is higher in multiple pregnancies68, in cases 
with single umbilical artery75, congenital fetal malformation and miscarriage66, while 
other researchers69 did not find the association between velamentous insertion and 
malformation. One of the largest and most detailed studies revealed higher association 
of velamentous insertion with intrauterine growth restriction, preterm delivery, 
abnormalities in the fetal heart rate patterns during labour and low Apgar score at 
birth.74 
The pathogenesis and etiology of velamentous insertion is not yet clear.66 68 One 
theory is that the yolk sac adheres to the chorion far from where it should have been 
and this causes abnormal implantation of the umbilical vessels on to the membranes. 
Another theory suggests that the body stalk does not migrate towards usual decidua 
basalis, rather umbilical cord arises from chorion which is most vascularised. With the 
progress of pregnancy vascularity of deciduas capsularis reduces while it increases for 
deciduas basalis. Therefore part of chorion closer to deciduas basalis, the one which is 
the site for the definite placenta becomes the most vascularised. That results into cord 
inserted into the membranes. Another view of velamentous insertion was due to the 
abnormal implantation. Blastocyst implanting obliquely (rather than facing) in the 
endometrium, will result into abnormal implantation of the cord. Some favour the 
theory of “trophotropism”, explaining that initially umbilical cord is inserted as 
normal but later with the growth of placental tissue more laterally leaving central part 
atrophic and that process leaves the umbilical cord in the membranes.  
Prenatal diagnosis of velamentous cord insertion has been successfully made using 
conventional ultrasound and more so by using colour Doppler ultrasound. 74 
Velamentous cord insertion has also been associated with raised maternal serum hCG 
levels during the second trimester76 though there is no explanation for this association. 
Despite all the possible complications associated with velamentous cord insertion, 
most pregnancies with velamentous cord insertion pass through antenatal period as 
well as intrapartum phase without having any complications.  
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1.4 AIMS AND OBJECTIVES OF THE STUDY 
 
 To compare manual and digital measurements of different axes of the placenta  
in unselected pregnancies. 
 
 To derive indices for placental morphology from digitally derived 
measurements. 
 
 To establish criteria and normal ranges for objective determination of 
macroscopic placental features, including shape and umbilical cord insertion 
site. 
 
 To establish the quantitative relationships of birth weight to the placental 
weight and circumference. 
 
 To define the incidence of predefined placental histopathological 
abnormalities in an unselected cohort of 1159 women with singleton 
pregnancy delivering in a single unit in relation to macroscopic features. 
 
 To determine the relationship between the predefined placental morphology 
and predefined abnormalities in relation to specific obstetric and neonatal 
outcomes of pregnancy. 
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2.1 DESIGN  
This was a prospective study of unselected mixed risk women with singleton 
pregnancy booking for delivery at the Rosie Hospital. This unit delivers both high 
and low risk care to women in Cambridge and the Eastern Region of England, and 
has approximately 6000 deliveries per annum. The study received ethical approval 
from The Peterborough and Fenland Research Ethics Committee, Cambridges hire 
(LREC Ref.no:07/Q0106/51). Recruitment was achieved over 13 months in 2007-
2008. Written maternal consent was obtained for placental examination. The study 
was undertaken in the Department of Fetal Medicine, Obstetrics and Gynaecology, 
Rosie Hospital and the Department of Pathology, Addenbrookes Hospital, 
Cambridge. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Recruitment of patients 
A total of 1159 women with a singleton pregnancy, booking at Rosie were recruited 
for the study. Study posters, explaining the study were produced to make pregnant 
women and staff involved aware of the study. Posters were displayed in the antenatal 
clinics, ultrasound Department, antenatal wards and various places in the delivery 
unit. The study aims/objectives and methodology were also discussed in 
Departmental meetings. Subjects were recruited prospectively on an ad-hoc, case-by-
case basis. All women presenting to the Rosie Hospital with a viable singleton intra-
uterine pregnancy, and booking for delivery at the Rosie during the recruitment 
period, were invited to join the study. Subjects excluded from the study were those 
who were unable to give adequate informed consent to participate in the study (for 
example language difficulty, learning disability), subject with twins or higher order 
multiple pregnancies and subjects who had a non-viable fetus on booking. 
The gestational age at which patients delivered is shown in appendix 1.  
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The patient information sheet and consent form were designed according to the 
guidance on COREC (Central Office of Research Ethics Committee). Patient 
information sheets included information explaining in a non-scientific manner, the 
purpose of the study, consenting for the study, advantages and disadvantages of 
taking part in the study, issues related to confidentiality of data, and the people 
involved in the research. (Appendix 2) 
Generally speaking, there was a separation in time between the patient information 
sheets being given to patients and consent being sought (often at the time of 
admission to the delivery unit in labour), as per the instructions of the Research 
Ethics Committee. This meant that consent was a „two stage‟ process; not all women 
given patient information sheets subsequently consented. This tended to bias 
recruitment away from severe preterm deliveries as women admitted to the delivery 
unit in this situation, and those looking after them, were less willing to consider 
discussing and consenting to this study. 
Antenatal clinic 
Antenatal clinics in the Rosie Hospital, Addenbrookes run from Monday to Thursday 
every afternoon. All women in the antenatal clinics were approached individually. 
All women had gestational age assigned from a first trimester ultrasound at 10-14 
weeks using either crown rump length (CRL) or bi-parietal diameter (BPD) 
measurement.  No selection was made based on any maternal characteristics. The 
study was explained to them and an information sheet about the study was given to 
them. They were asked to read the information sheet, encouraged to ask questions if 
unsure about anything and then to sign the written informed consent form, if they 
agreed to take part in the study. The research participants were only required to sign 
the consent form. There were no extra treatments or procedures during the 
participant's pregnancy because of this study. Women received ante-natal care as 
normal from the obstetric and community teams. This study did not affect the care 
they received, their appointments or delivery. Research participants were not 
contacted after the study and all records were anonymised.  
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A consent form was attached to the antenatal hand held notes (normally carried by 
the pregnant woman each time she attends antenatal clinic at the Hospital or to her 
midwife), to make it easier for the midwives at the delivery unit to confirm that 
woman had consented for the study.  
 
Delivery Unit 
Midwives and other delivery unit staff were informed about the study. Study posters 
were displayed. Flow charts of how to collect the placentas after the delivery were 
also displayed for the midwives. Midwives were reminded of the study especially at 
the hand over times so that it was made sure that each and every midwife in the 
delivery unit was aware of the study and the placentas were kept for the study. A 
special folder was made for the placental study which had study‟s information sheets, 
consent forms, flow charts of placental collection methods and the lab forms for the 
study. Every delivering woman was asked again if she agreed to participate in the 
study. Midwife delivering the women were asked to confirm the written consent of 
the women for the study. Placenta was examined grossly by the midwife as per 
routine and a microbiological swab was taken if required clinically. Placenta was 
placed in a double bag with the woman‟s addressograph on it, which was kept in a 
dry clean 1-2 litre bucket with a wide top air tight lid within 20 minutes of delivery. 
The placental bucket was kept in the fridge with the temperature maintained at 4-
6C.  2 fridges were procured in the delivery unit to keep the placentas before 
placentas were collected to the pathology Department. Midwives and other staff were 
regularly updated about the progress of study by regular presentations in the 
Departmental meetings. 
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2.2.2 Transportation of placenta 
A medical laboratory assistant was employed solely for the study who collected 
placentas from the delivery unit each morning Monday to Friday to the dedicated 
research section in the Department of pathology. 
Each placenta was accompanied by the dedicated pathology form with the brief 
information of the patient on it. (Pink form in appendix 6) Each placenta was 
registered on the Hospital server and assigned a pathology number, for example 
PF07 or PF08...Once the database was complete, all identifiable information of the  
patients was deleted for example name of the patient, Hospital number and the 
pathology number. A study number was given to each placenta included in the study. 
All macroscopic examinations findings were recorded on the back of the pathology 
form in a predefined section. 
 
2.2.3 Examination of Placenta 
Manual Measurements 
Placentas were examined at a dedicated perinatal lab in the pathology Department. 
Each day placentas were examined grossly, photographed and sections cut for 
microscopic examination. 
     
Figure 2.1 Instruments used for gross examination of placenta and cutting sections. 
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Instruments used were (fig 2.1)  
1. Toothed holding forceps. 
2. Fixed measuring scale (cm) 
3. Heavy cutting Mayo‟s scissors 
4. Swan Morton surgical steel sterile skin graft blade. 
5. 12 inch (300mm), disposable macro knife with a non slip integral handle with the     
double honed edge.   
6. Cassettes with covers 
7. A & D GF-3000 top-loader digital fixed weighing scale (grams) 
8. Camera- Canon Power shot G5, 5mega pixel camera. (picture not shown) 
 
For each placenta the identity was confirmed and a study number was given and it 
was anonymised so that once cut it can only be identified with the study number. A 
Pathology form was designed specifically for the study where gross and microscopic 
findings of each placenta were reported. Fresh placentas placed in labelled clean 
plastic buckets with a labelled request form were received in the Histopathology 
Department, Addenbrookes Hospital.  
The placenta was first examined grossly for the presence of any macroscopic lesions 
such as thrombosis, fibrin, infarcts and haematoma. 
The placentas were then photographed. Photographs were taken of maternal surface 
with trimmed membranes and trimmed cord, fetal surface and cross sections of the 
placenta.  
The point of insertion of the umbilical cord into the chorionic plate was noted and 
recorded as central, paracentral, marginal or velamentous. For the qualitative 
comparisons, we used the most frequently used terminology for cord insertion.33
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Central insertion is defined as any part of the umbilical cord inserting within 2cm of 
the centre of the chorionic plate; paracentral greater than 2 cm from the centre and 
within the margin of the chorionic plate; marginal at the placental margin and 
velamentous insertion as being outside the chorionic margin into the membranes.   
The cord was then excised from the point of insertion into the chorionic plate; blood 
was drained from placenta as much as possible, adherent blood clots from the 
maternal surface of placenta were removed. All membranes were trimmed off and 
the placenta was then weighed on a fixed scale. Weight was noted in grams. The 
placentas were weighed in over 90% of cases within 24 hours but in all cases within 
72 hours in accordance with published guidance for handling the placenta.17 68 
The Umbilical cord length was measured in centimetres using an accurate, non 
stretchable fixed measuring scale. The diameter of the umbilical cord was noted in 
centimetres using a fixed scale from the fetal end of the cord.  
The direction and the number of coiling of the umbilical cord were also noted. 
Direction of the cord was noted as left, if the direction of coils directed towards the 
examiners left hand, right sided coiling if directed towards right hand.   
 
Cord Coiling Index: The cord coiling index was calculated using an established 
method by dividing the number of coils by the length of the umbilical cord in 
centimetre.11 Therefore the coiling index is the total number of completed vascular 
coils per centimetre length of the cord. A complete vascular coil is defined as a 3600 
round coiling. 
Placentas were cut and sampled for histological examination. 3 standard blocks were 
taken from the cord which included maternal end, fetal end and one from the central 
area. 3 full thickness central parenchyma blocks and one full thickness peripheral 
block were taken. One block from the maternal surface was taken. Additional blocks 
were taken from the macroscopic lesion areas. 
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Small samples from few unselected placentas were also archived in “RNA later” for 
possible future molecular analysis.  
 
Digital Measurements  
The placentas were photographed using Canon Power shot G5, 5-mega pixel camera. 
Though the tripod was not used, but a uniform vertical distance and angle was kept 
for each photograph taken. Each fresh placenta was placed with the fetal surface 
uppermost, membranes were trimmed and all blood clots were removed from the 
fetal surface. A 15-centimetre ruler was placed in every placental picture for 
calibration purposes. A line was drawn between two points of known distance on the 
ruler in every picture with the placenta. The length of the line was calculated 
automatically in pixels by the software and that pixel was converted into centimetre 
by setting the scale on the software. This scale was adjusted for each picture 
separately. Each picture was uploaded on the Hospital server and identified by a 
study number; the details were entered into a secure database. Images were analysed 
using Image J software. Image J is a freely available public domain Java based image 
processing program developed by the National Institute of Health. In the current 
study, digital analysis of the placenta was performed using version 1.38e which was 
downloaded from website (http://rsb.info.nih.gov/ij) and the dimensions measured 
and shown in Figure below. 
 
a 
Figure 2.2 (a) Image J tool bar for placental measurements. 
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b 
 
 c 
Figure 2.2 (b-c) Image J scale setting for placental measurements. 
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The point of umbilical cord insertion was noted on image.  
The widest measurement of the placenta on an X-axis (A) and Y-axis (B); both 
measurements being perpendicular to each other.  
Measurements on X-axis(C) and Y-axis (D); perpendicular to each other passing 
through the umbilical cord insertion. 
Shortest distance of umbilical cord insertion to the chorionic plate margin on X-axis 
(e) and Y-axis (d) 
 
Figure 2.3 Depiction of the placental measurements. 
 
a = (½ C) – e 
b = (½ D) – d 
dc = Distance of cord insertion from centre 
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Derivation of digital parameters       
Distance of umbilical cord insertion from placental centre was calculated 
mathematically according to the Pythagorean Theory. „a‟ was calculated by 
subtracting „e‟ (shortest distance of umbilical cord insertion to the chorionic plate 
margin on X-axis) from the half of „C‟ (X-axis passing through the insertion of 
umbilical cord). „b‟ was calculated by subtracting „d‟ (shortest distance of umbilical 
cord insertion to the chorionic plate margin on Y-axis) from half of „D‟ (Y-axis 
passing through the insertion of umbilical cord). Since dc2=a2 + b2, where dc is the 
distance of umbilical cord insertion from the centre. The formula for calculating the 
distance of the cord insertion from the centre is: 
 
22   badc           
  
22 d)-(1/2D )2/1(  eCdc
 
Cord Centrality Index (CI) – a ratio that describes the distance of the umbilical 
cord insertion from the chorionic plate margin. It will range between 0 and 1 (except 
in cases of velamentous cord insertion, where the value may be greater than 1 as the 
insertion may be further from the centre than half the longest diameter).The smaller 
the CI, the closer the umbilical cord insertion to the placental centre; the greater the 
CI, the further away the cord insertion: 
placenta  theofdiameter longest   theof 
centre from insertion cord umb of istance
 
Half
D
CI   
 
Placental shape; eccentricity- Eccentricity is derived from the mathematical formula 
describing eccentricity for an ellipse/oval. This is the ratio of the distance between the 
foci to the length of the major axis 77. In this present study, this term; “eccentricity” 
therefore has been referred in a manner consistent with its common and established  
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usage in applied mathematics, engineering and astronomy, to describe the features of an 
ellipse. The term is therefore used here to describe the shape of placenta in relation to 
how circular or ovoid it is. The value of an eccentricity should fall between 0 and 1, 0 
indicates that the shape of placenta is circular while values towards 1 indicate an 
elliptical shape of the placenta. 
 
Eccentricity = 
2
axismajor 
axisminor 
1 





  
 
Circumference of the placenta was calculated by the following formula, assuming 
the placenta is an ellipse; 
Circumference = axis)minor  of half  axismajor  of (half   
 
Circumference was calculated for both digital as well as manual images. The mean 
of both circumferences (manual and digital) was calculated. The mean percentage 
difference was also calculated between the two measurements.  
Intra-observer digital measurements        
To assess the reliability and accuracy of the digital measurements, one observer (SP) 
re-measured the randomly selected 20 placentas and compared the results with the 
measurements of the same placentas performed previously by same observer. 
Inter-observer digital measurements          
Two observers (SP, CCL) performed the digital measurements on 20 randomly 
selected placentas simultaneously and the two observer‟s measurements were 
compared. 
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Fixation of placental tissues 
To preserve placental tissues, all blocks were placed in the 10% neutral buffered 
formalin solution for overnight. Tissues are fixed by cross-linkages formed in 
between the proteins, by which the antigenicity of the tissue is maintained. Buffered 
part of formalin prevents acidity that would promote autolysis. Formalin fixes the 
tissues slowly but penetrates well into the tissues. 
 
Tissue Processing 
Placental tissue processing involves the process by which tissues can be made into 
thin microscopic sections. Placental tissues samples taken in our study were 
processed in the histology laboratory in the Department of Histopathology at 
Addenbrookes Hospital, by the dedicated and trained medical laboratory assistant for 
the study, who then prepared the slides for the examination by the pathologists‟  
member of the team.  
Tissue processing involved embedding of the tissues in the paraffin first followed by 
cutting the thin sections of the tissues with the help of microtome shown in figures 
2.4 (a-d). 
Once prepared in thin sections, tissues were stained with Haematoxylin and Eosin. 
The stained tissue section was covered with the cover slip and ready to be examined 
by the pathologist team members.  
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Figure 2.4 Machines used in tissue preparation. 
 
The placental pathology findings were linked to the pregnancy and neonatal 
outcome. The histological, obstetric and neonatal variables were recorded on a 
password secured Access database using Microsoft access version 2003; the entry 
fields are outlined below. Gestation age at delivery was calculated by early dating 
ultrasound for each patient. Term pregnancy defined by completed 37 weeks of 
gestation and preterm is delivery before 37 completed weeks. 
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2.3 DEFINITIONS OF CLINICAL GROUPS  
Pre-eclampsia (PET)  
PET was defined after 24 weeks as blood pressure ≥ 140/90 on 2 or more occasions, 
at least 6 hours apart with significant proteinuria of either more than 300 mg/l in 24 
hours collection in a previously normotensive woman.78-79  Women with ≥ 2+ in a 
urine sample in absence of a demonstrable urinary tract infection were also included 
in this group.  
 
Pregnancy induced hypertension (PIH)  
PIH was defined as blood pressure ≥ 140/90 on 2 or more occasions, at least 6 hours 
apart in pregnancy after 20 weeks without any evidence of proteinuria. 
 
Gestational Diabetes Mellitus (GDM) 
According to WHO criteria, gestational diabetes is carbohydrate intolerance resulting 
in hyperglycaemia of variable severity with onset or first recognition during 
pregnancy. The definition applies irrespective of whether or not insulin is used for 
treatment or the condition persists after pregnancy. We defined the gestational 
diabetes (GDM) in our study according to the WHO criteria: fasting blood glucose 
level ≥ 7 m.mol/L or 2 hours post 75mg of oral glucose load ≥ 7.8 m.mol/L. 80  
 
Small for Gestational Age (SGA) 
Birth weight percentile less than the 10th for gestational age defined the SGA group. 
To calculate these we used the standard UK 4-in-1 charts (girls and boys), which are 
the growth charts designed principally for Hospital use for preterm and term babies and 
their follow up.81 
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2.4 OBSTETRIC FIELDS - recorded for each participant of the study are shown in 
table 2.1. 
 
General Pregnancy Ultrasound details 
Delivery/Neonata
l outcome 
Admitted to Neonatal 
Unit 
Maternal age Diabetes 
GA when uterine 
artery Doppler 
performed 
Live birth/still 
birth/neonatal 
death 
Duration of admission 
in Neonatal Unit 
Parity Pre-eclampsia Right/left uterine PI 
Birth 
weight/centile  
RDS 
Pregnancy loss PIH 
Right/left uterine 
notch 
Neonatal gender CLD 
USS EDD 
Essential 
hypertension 
GA at scan prior to 
delivery 
Neonatal 
resuscitation 
Ventilation/CPAP/  
respiratory support 
(days) 
Smoking status Thrombophelia Umbilical artery PI Neonatal outcome Post natal steroids 
Drug abuse APS Ductus venosus PI NICU admission USS 
Medications SGA≤ 10 centile  MCA PI  Seizures 
Ethnicity 
Clinical 
chorioamnionitis 
AFI  ROP 
 Abruption CTG-STV  NEC 
 GA at delivery   Inotrops 
 Onset of labour   PDA 
 Mode of delivery   Thrombocytopenia 
    Anaemia 
    Coagulopathy 
    Proven infection 
    Renal impairment 
    Survival to discharge 
    Age at death 
 
Table 2.1 Obstetric variables of the study. 
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2.5 PROTOCOL FOR EXAMINATION OF PLACENTA 
2.5.1 Macroscopic examination: A specifically designed form for the study which 
included gross and microscopic findings was used.  
2.5.2 Microscopic examination: Checklist for reporting cord and membranes are 
described in table 2.3. 
Umbilical cord and membranes Placental parenchyma 
Funisitis Chorionic plate-inflammation, infection, FTV 
Chorioamnionitis 
Stem villi-inflammation, infection, FTV, mesenchymal 
dysplasia, storage disease 
Maternal vascular disease in any 
adherent deciduas 
Distal villi-hypoplasia, Chorangiosis, villitis, infection, 
storage disease 
Meconium staining/necrosis 
Intervillous space-inflammation, infection, 
haemorrhage, fibrin (massive) 
Amnion nodosum Maternal vessels-mural fibrin deposition, atherosis 
 
Table 2.3 Checklist for histological examination of the placenta and umbilical cord. 
 
Table 2.2 Protocols for examination of the placenta and umbilical cord. 
Umbilical cord examination Placental examination Standard blocks taken 
Length (cm) 
Diameter (cm) 
Coiling index (turns/length) 
Direction of cord spiral 
Cord insertion site 
True knots 
Trimmed weight (g) 
Measurements in 3 
dimensions (cm) 
Present/absence of any 
macroscopic lesions 
including infarct (s), 
haematoma, fibrin, maternal 
surface thrombus 
 
Cord x 3 (maternal, fetal end and 
central) 
Membranes 
Central parenchyma blocks (full-
thickness) x 3 
Peripheral parenchyma block 
(full-thickness) x 1 
Maternal surface x 1 block 
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2.6 DATA ANALYSIS 
The database of the study initially was divided into two parts and was set up on two 
different servers of the Hospital, for the sake of convenience and ease for the 
research team. One database included Obstetrics and Neonatal outcome information, 
set up on the perinatal server. 
The second part of the database was set up onto the histology server, which included 
all macroscopic and microscopic findings of histopathology of placenta.  
Both databases were held on a secure server with password access to members of the 
research team only within Addenbrookes Hospital. Every placenta recruited for the 
study was given a pathology number. The pathology database had all the 
macroscopic and microscopic features of each placenta by its pathology number and 
Hospital number.  
Once all the information, Obstetrics, neonatal outcome, macroscopic and 
microscopic examinations findings of each placenta were entered onto the databases, 
the two database were merged matching with the Hospital number of the patients. 
Once merged, a study number (1, 2, 3.......) was given to each placenta. Hospital 
numbers and pathology numbers were deleted to make the database completely 
anonymised. Once anonymised, it was not possible to link the outcome data to any 
patient‟s identifiable information. 
Multivariate analyses of a range of clinical and histological parameters were done. 
Correlation of pregnancy and neonatal outcome to placental and umbilical pathology 
was performed with statistical advice from the research team with, where 
appropriate, specialist advice from the University of Cambridge and University of 
East Anglia. 
The data analysis was performed using SPSS (Statistical Package for Social Science) 
software, window version 15and 18; SPSS, Chicago IL, USA. 
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Descriptive statistics for nominal data were expressed in absolute numbers and 
percentages. Mean value and SD are presented for normally distributed continuous 
variables. For non-normally distributed variables, median and ranges are presented. 
A test of normality was performed by using frequency histograms, Q-Q plots and 
Kolmogorov-Smirnov test. Frequency histograms and Q-Q plots the observed data 
against expected data. Kolmogorov-Smirnov test quantifies the discrepancy between 
observed and expected distribution. 
To explore the association between the variables, Pearson correlation coefficient (r) 
was analysed. The value of “r” varies between -1 to +1. The sign of –ve and +ve 
shows whether there is negative or positive correlation between the variables and the 
number value signifies the strength of correlation; 1 being the strongest and 0 being 
no correlation between the variable. A linear relationship between the variables was 
plotted on a scatter plot. Coefficient of determination was calculated as r2. This 
enables us to know how much variance is shared by two variables. 
T-test was used to compare means of continuous data, if normally distributed.  If data 
did not follow a normal distribution, not even after logarithmic transformation, in 
those data to compare means, Mann-Whitney-U test was performed. Non parametric 
test was also performed if the sample size was small. A p-value of ≤ 0.05 was 
considered statistically significant.  
Z- Score 
Z-score or the standard score allows us to calculate the probability of a score 
occurring within the normal distribution and also helps to compare two scores of 
different normal distributions. 
In the current study, to establish the relationship between different continuous 
variables (birth weight, placenta weight, placenta circumference), z scores for the 
variables were calculated to normalise the data for the gestational age within the 
gestation range 33-43 weeks, using the means and SD derived from this population. 
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Bland Altman Plot82-83 
Bland Altman is a statistical method of data plotting used in analysing the agreement 
between two different methods. This plot analyses the correlation between two 
methods that are designed to measure the same variable or parameter. Bland Altman 
plot can also be used to compare a new measurements technique against an available 
standard method. 
The mean of the two measurements is plotted on the x-axis and y-axis contains the 
difference between the two values. 
The limits of agreement (95% confidence interval of the difference between the two 
methods, specified as average difference +/- 1.96 SD of the difference) were also 
computed on the Bland Altman Plot.  
In this study, Bland-Altman Plot was used to analyse the agreement between manual 
and digital measurements of the placenta.  
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 3 : A COMPARISON OF MANUAL AND DIGITAL     
PLACENTAL MEASUREMENTS 
 
 
 
Summary Points: 
 This study compared manual and digital placental dimensions in 888 
placentas. 
 The key findings were significant positive correlation between manual and 
digital measurements. 
 This chapter concludes that the digital measurement of the placenta is a 
simple and reproducible method of measurement compared to the traditional 
methods. 
 
 
 
 
This chapter is based on: 
Pathak S, Jessop F, Hook L, Sebire NJ, and Lees C. Placental weight, digitally derived 
placental dimensions at term and their relationship to birth weight. J Maternal Fetal 
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3.1 INTRODUCTION 
Placental measurements have traditionally been performed manually following 
delivery with a ruler and little is known about the correlation between the manual 
and digitally derived placental measurements following the widespread introduction 
of digital photography for recording of pathological specimens. 12 84 
Digital imaging and subsequently derived measurements are now commonplace in 
many other areas of medicine, for example in MRI organ volume estimation85 and 
for 2D distance measurements in biology, astronomy, nuclear medicine, laboratory 
medicine, immune-histochemistry and Histopathology and physics, image analysis 
using Image J software (a semi-automated web based freeware image analysis 
programme) has been widely applied. Similar imaging software has been used for 
quantification of bone metastases in prostatic cancer in which results were closely 
correlated with manual counting of lesions86 and for quantifying erythema and 
pigmentation in skin diseases.87 In hepatic CT volumetry, volumes of virtual liver 
resection specimens measured with Image J were compared with specimen weights 
and calculated volumes during pathology examination after resection; the two 
methods of measurement were closely correlated (r2 = 0.98 p<0.0001).88   
Image J has also been compared with computed tomography (CT) imaging software 
to quantify soft tissue cross-sectional areas obtained from abdominal and mid thigh 
areas with correlation coefficient (r2) of 0.99 and the two methods were comparable 
(95% confidence interval +2.5cm2 or +1.4cm2) using the Bland-Altman method.14  
Correlation coefficients have been used to compare manual and digital 
measurements, whereas a more appropriate approach would be a Bland-Altman plot 
to analyse agreement between two methods which are designed to measure the same 
parameter82 and shows the relationship between the two methods of measurements. 
This information is important to establish validity of digital measurement for future 
studies where image analysis based measurements will be increasingly used.  
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The aims of the study are to compare manually and digitally obtained long and short 
axes placental measurements and the derived placental circumference using both 
correlation coefficients and the Bland-Altman plot.  
 
3.2 METHODS 
Detail of methodology is described in chapter 2. Briefly, for the purposes of this 
chapter, 888 placentas were analysed, where the digital measurements were 
available. 
 
3.3 STATISTICAL ANALYSIS 
Details of the statistical methods are described in chapter 2. The limits of agreement 
(95% confidence interval of the difference between the two methods, specified as 
average difference +/- 1.96 SD of the difference) were also computed on the Bland 
Altman Plot. The Bland-Altman Plot was used to analyse the agreement between 
manual and digital measurements of the placenta for: 
-maximum diameter (long axis of the placenta) 
-minimum diameter (short axis of the placenta)  
-circumference.  
Pearson correlation coefficients (r) were derived using bivariate relationships for 
both manual and digital measurements; and r2 was calculated. One observer (SP) 
performed all the measurements.  
In order to determine the reliability of digital measurements, 20 randomly selected 
placentas were re-measured by same observer (SP) after 6 months. Another 
randomly selected 20 placentas were measured by 2 observers (SP, CCL) 
simultaneously.
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3.4 RESULTS 
Analysis of this study includes 888 placentas. In all placentas, all manual and digital 
measurements were obtained. Table 3.1 shows the demographics of the population 
studied.  
n=888  
Maternal age ± SD (years) 30.8 ± 5.6 
 % Caucasian (n) 89.8 (797) 
% nulliparity (n) 48.2 (428) 
% Smokers >5  cigarettes per day (n) 9.6 (85) 
Birth weight ± SD (gms) 3470 ± 496 
Mean gestation at delivery ±  SD (weeks) 39.4 ± 1.4 
Mean Placenta weight  ±  SD (gms) 478.44 ± 96.7 
  
Table 3.1 Baseline demographics of the population studied. 
Table 3.2 details the comparison of the manual and digital measurements.  
 Minimum Maximum Mean SD 
Long axis of placenta (cm) 
Manual 14.00 36.00 20.77 2.66 
Digital 12.70 30.70 18.96 2.47 
Short axis of placenta (cm) 
Manual 7.00 24.00 17.83 2.07 
Digital 8.90 22.00 15.91 1.87 
Circumference (cm) 
Manual 36.11 89.49 60.60 6.24 
Digital 38.31 77.56 54.76 5.71 
                      
Table 3.2 Manual and digital measurements of the placenta. 
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Intra-observer variability                       
In 20 randomly selected placentas; one observer (SP) re-measured the same placentas 
digitally at an interval of 6 months. The intra-observer correlation coefficient and 
coefficient of variation were 0.99 and 1.8% respectively for long axis, 0.98 and 2.1% 
for short axis measurements.  
 
Inter-observer variability                 
These measurements are based on 20 randomly selected placentas, measured by two 
observers (CCL, SP) simultaneously. The inter-observer correlation coefficient and 
coefficient of variation were 0.98 and 3.3% respectively for long axis, 0.97 and 2.6% 
for short axis measurements. 
 
Outliers 
The outliers were noted while comparing long, short axes and the circumference of 
the placenta. These numbers were re-checked on the manual as well as digital 
measurements. However these numbers of outliers were very small to have made any 
significant effect on the result. 
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Comparison of manual versus digital measurements: 
Long axis of placenta:  
Manual versus digital measurements showed a Pearson correlation coefficient (r) of 
0.74 (p<0.0001); linear correlation r2 0.54 and coefficient of variation 9.2%. The 
Bland–Altman plot mean difference between manual and digital measurements was 
1.80 cm with 95% CI (+/-1.96SD) -1.86 and 5.46 cm. 
 
Figure  3.1 Scatter plot showing correlation coefficient for manual versus digital measurements 
of long axis of the placenta 
 
Figure 3.2 Bland Altman plot for long axis of the placenta: manual versus digital measurements. 
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Short axis of placenta: 
The Pearson correlation coefficient (r) was 0.70 (p<0.0001); r2 0.49 with coefficient 
of variation of 10.3%. The Bland–Altman plot mean difference between the long 
axes measurements taken manually and digitally was 1.91 cm with 95%CI (+/-
1.96SD) -1.1 and 4.92 cm.  
 
Figure 3.3 Scatter plot showing correlation coefficient for manual versus digital measurements 
of short axis of the placenta. 
 
Figure 3.4 Bland Altman plot for short axis of the placenta: manual versus digital 
measurements.
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Circumference of placenta:  
The Pearson correlation coefficient (r) was 0.77 (p<0.0001), r2 0.59 with coefficient 
of variation 7%. The Bland–Altman plot mean difference between the measurements 
taken manually and digitally was 5.83 cm with 95% CI -2.19 and 13.85 cm. 
 
Figure 3.5 Scatter plot showing correlation coefficient for manual versus digital measurements 
of circumference of the placenta. 
 
 
Figure 3.6 Bland Altman plot for circumference of the placenta: manual versus digital 
measurements. 
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3.5 DISCUSSION 
We report manually and digitally derived measurements following delivery at 
gestation from 33-43 weeks. This data shows significant positive correlation between 
manual and digital measurements.  
Previous descriptions of manual versus digital measurements including those on the 
placenta84  have reported good correlation between the two measurements. However, the 
most appropriate method for comparing two different methods of deriving the same 
measurement is not a correlation coefficient, since one measurement technique may lead 
to systematically larger or smaller measurements than the other but still have a 
correlation coefficient close to 1. Moreover the correlation coefficient also depends on 
the way the sample is chosen, and it has meaning only for the population from which the 
study subjects can be regarded as a random sample.83 Comparison of digital 
measurements with those from previous studies using manual measurements should 
therefore be approached with caution. The problem of interpretation and comparison is 
to a large extent overcome by use of the Bland-Altman plot,82 which was used in this 
study. This plot compares two methods of measurement. For example, in the current 
study, digital measurements appear systematically shorter for both long and short axes 
of the placenta, as evidenced by the crude comparisons (Table 3.2) and Bland-Altman 
plots; the 95% limits agreements of the mean difference between the manually and 
digitally derived placental circumferences were -2.19 and 13.85 cm though the inter and 
intra observer coefficients of variation are <5% (Figure 3.6). 
The reason for this difference in measurement is not clear, and as comparative data has 
not been presented in this format before, it is not clear if the finding is unique to this 
study or others. Other studies reporting digital placental measurements did not use a 
Bland-Altman analysis for the two types of measurement, so although the correlation 
between the two types of measurement is high, it is not possible to ascertain whether 
there was a systematic over or under measurement from digital recordings.12 84 This 
finding does however sound a potential note of caution that deserves to be investigated 
in future studies. 
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The digital measurements of placenta of the current study are however comparable to 
those reported in two recent studies (Table 3.3). It must be noted that one included 
placentas from women delivering after 24 weeks; however 86% were from deliveries 
after 37 weeks.12 So with this proviso, the results can be compared accepting that the 
minimum range might be lower in that study as a result of some placentas being from 
earlier gestation deliveries. 
 Present Study Coall et al 
13
 Salafia et al 
12
 
Measurements 
(cm) 
N Mean Range n Mean Range n Mean Range 
Long axis of 
Placenta 
888 18.9 12.7-30.7 482 22 14-35 628 21 12-43 
Short axis of 
Placenta 
888 15.9 8.9-22.0 482 18 8-26 628 18 9-29 
Circumference of 
placenta 
888 54.7 38.3-77.5 482 71.8 49-111 - - - 
Distance-centre to 
cord insertion 
888 3.3 0.1-10.0 482 4.0 0.2-11.5 628 3.6 0.1-23.7 
 
Table 3.3 Digital placental measurements reported by two recent comparable studies. 
In summary, digital measurement of the placenta is reproducible and a relatively 
simple of method measurement compared to traditional manual measurement as it is 
very easy to perform, does not require much training and digital method also allows 
the measurements to be done at a later stage. Image J software is also freely available 
at no cost making it accessible to researchers in countries where financial resources 
may be limited. The measurements derived are comparable to the other studies 
though the digital measurements in our study appear to be systematically smaller 
than those derived by conventional manual measurements. Whether this is a feature 
of this study-for example Image J software- or is more likely to occur with digital 
measurements in general is not clear, neither are data available that would resolve 
this from otherwise comprehensively reported studies of this type.12 84  
 
  
CHAPTER 4 : MORPHOLOGY: UMBILICAL CORD COILING, 
UMBILICAL CORD INSERTION AND PLACENTAL SHAPE 
IN UNSELECTED PREGNANCIES
 
 
 
 
Summary Points:  
 This study derived the morphological indices for coiling of the cord (cord 
coiling index), insertion of the cord (cord centrality index), and shape of the 
placenta (eccentricity) in unselected 888 pregnancies at 33-43 weeks. 
 The key findings were suggestive that cord is inserted off the centre and 
shape of the placenta is oval or elliptical, not round.  
 
 
 
 
This chapter is based on 
Pathak S, Hook E, Hackett G, Murdoch E, Sebire NJ, Jessop F, Lees C. Cord coiling, 
umbilical cord insertion and placental shape in an unselected cohort delivering at term: 
Relationship with common obstetric outcomes. Placenta. 2010; 31: 963-8. 
Pathak S, Sebire NJ, Jessop F, Hackett G, Murdoch E, Hook E, Lees C. Morphological 
features of placenta in relation to common obstetric outcomes: Paper in progress. 
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4.1 INTRODUCTION 
It has been known for many centuries that the placental shape, size, cord insertion 
and pattern of cord coiling varies widely between pregnancies. In current obstetric   
and perinatal pathology practice, qualitative terms are generally used to describe the 
placenta, for example, “velamentous”, “central” and “marginal” cord insertions,  
“round” or “oval” placental shape, among many others.  
There has been little attempt at quantifying or describing the relationship between 
measurements, including the size of the placenta, the shape of the chorionic plate  
(fetal surface), distance of the umbilical cord insertion from the centre of the placenta 
and the deviation in placental shape from the suggested normal circular appearance.  
Little is known about these variables and their association with pregnancy and 
neonatal outcome. Though several studies on umbilical cord coiling index have 
emerged in the last few years 5-8 52, there remains uncertainty in relation to the 
significance of abnormal umbilical cord coiling detected ante or postnatally. 
Umbilical cord coiling is either anti-clockwise (left) or clockwise (right). Anti 
clockwise coiling is more common. The prevalence of anti-clockwise coiling varies 
from 65-76%. 8 49  It is not well-understood why the anti-clockwise pattern is more 
common. The umbilical cord coiling index has been defined as the number of 
completed coils per centimetre of the umbilical cord; a cord coiling index mean value 
of 0.21 (+/-0.07) is defined as normal in the delivered placenta  11.  Though some 
studies have defined „hypocoiling‟ if the cord coiling index is less than 10th centile 
and „hypercoiling‟ if more than 90th centile for gestation, the frequency of non-coiled 
cord  is reported as 4.3-4.9% 5 48 while hypercoiling has been reported as high as 
20% in unselected placentas in other studies.6 
Different types of cord insertions have been explained qualitatively in most of the 
studies in the past. An insertion anywhere between central and marginal insertion is 
generally considered to be eccentric, but none of these terms have been quantitatively 
described, making comparative studies of outcome difficult. 
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The type of cord insertion may also be described as how far the insertion point is 
located from the centre of the placenta, or alternatively, how close the umbilical cord 
insertion is to the chorionic plate margin. The distance of the umbilical cord insertion 
from the placental centre has been proposed as a clinically useful marker of placental 
insufficiency.89-90  Rath and colleagues 91 calculated a measure of relative insertion 
eccentricity by dividing the minimum distance from the umbilical cord insertion to 
the margin of the placenta by the radius of the placenta; however this is a poor 
measure of eccentricity in irregularly shaped placentas. Others  have defined the 
relative insertion eccentricity by dividing the minimum distance between the centre 
of the placenta and the insertion of the umbilical cord by the average radius of the 
placenta.13  
The placenta is normally described as either round or oval; however it can be 
described as irregular, bilobate or multilobate, among others. Irregular placental 
shapes have been associated with lower birth weight: placenta weight ratio, 
suggesting they may be associated with altered placental function.10 
The aim of this study is to derive ratios for the shape of the placenta, relationship of 
cord insertion to its centre and cord coiling in singleton pregnancy placentas from an 
unselected reference population of gestation age ranging from 33-43 weeks.  
For placental shape and cord insertion we utilized reproducible, rapidly obtained digital 
measurements in placentas to morphometrically define the cord insertion and placental 
shape10 using Image J, a freely available public domain Java based image processing 
program developed at National Institute of Health. Details have been explained in 
chapter 2 (section 2.2.3).  
Cord coiling was measured manually in the same placentas.  
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4.2 METHODS          
In this chapter, analysis is based on digital measurements of 888 placentas at 33-43 
weeks gestation without making any attempt at selection by any maternal 
characteristic.  
Details of manual, digital measurements and derivation of the morphological indices 
are described in chapter 2. Briefly cord coiling index was derived using established 
method by dividing the number of coils  by the length of the umbilical cord.11  
Digital analysis was performed using image J software and analysed the 
morphological indices; cord centrality index and eccentricity.  
 
4.3 STATISTICAL ANALYSIS 
Categorical data are presented as the number and the percentage. Continuous data is 
presented as mean with the SD. Descriptive statistics was analysed for manual and 
digital placenta and umbilical cord measurements used in this study. 
Approximate normality was checked for cord coiling Index, centrality index, and 
eccentricity index for the population, using the frequency histograms for each 
category. Q-Q plots for the same variables were also plotted between observed and 
expected distribution.   
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4.4 RESULTS 
888 placentas from singleton pregnancies, 33 to 43 weeks were examined; in all 
placentas, digital measurements were obtained. Demographics for this chapter are 
outlined in chapter 3 (Table 3.1)  
Table 3.2 outlines the manual and/or digital measurements used in the study. 
  
 
4.4.1 Umbilical cord coiling and coiling index 
For umbilical cord coiling, in 704 out of 888 cases (79.3%), the cord was left coiled 
and 145 out of 888 cases (16.3%) right coiled. There was no coiling in 19 umbilical 
cords (2.1%). Direction of coiling was bi directional in 5 (0.6%) cases. In these cases 
the number of the completed coiling were counted as explained in methods. In the 
remaining 02 cords, cord was too short to calculate the coiling index. Data were not 
available for 13 cases as the cords had been removed before the placenta reached the 
research team. Cord coiling index ranged from a minimum value of 0.00 to a 
maximum of 1.0 with a mean value of 0.20 ± 0.09.  Frequency histograms and Q-Q 
plot revealed an approximate normal distribution for coiling index. Figures below 
shows the frequency histogram and Q-Q plot of coiling index in reference 
population. 
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Figure 4.1 Frequency histogram of Coiling Index at 33-43 weeks. 
 
 
Figure 4.2 Q-Q plot for Coiling Index at gestation 33-43 weeks. 
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4.4.2 Umbilical cord insertion 
Qualitative description of the type of umbilical cord insertion in relation to previous 
standards showed that the frequency of umbilical cord insertion was „central‟ in 
245/888 (27.6%), „paracentral‟ in 567/888(63.9%), „marginal‟ in 74/888(8.3%) and 
„velamentous‟ in 2/888(0.2%).Table below shows the different types of umbilical 
cord insertion documented in previous studies and in the current study.  
 
4.4.3 Cord centrality index 
The minimum distance of the cord insertion from the centre of the placenta was 0.15 
cm and maximum distance 10.05 cm with the mean of 3.35 cm ± 1.9, irrespective of 
the direction of umbilical cord coiling.  
The Cord centrality index ranged from 0.02 to 1.0 with the mean of 0.36 ± 0.21. 
Frequency histograms and Q-Q plot of cord centrality index indicated an 
approximate normal distribution. Figure 4.3 shows the frequency histograms of cord 
centrality index in unselected population and fig 4.4 is an explanatory picture of 
placenta denoting mean centrality index as 0.36. Fig 4.5 is Q-Q plot for the cord 
centrality index in reference population. 
 
Author (Year) 
Krone 
(1961) 
Gerlach 
(1962) 
Krone 
(1965) 
Dorste 
(1971) 
Agboola 
(1978) 
Present Study      
(2010)     (n) 
Central % 25 28 14.9 22.8 26.5 27.6 (245/888) 
Paracentral % 64 62.5 65.4 62.2 62.5 63.9 ( 567/888) 
Marginal % 10 8 7.9 14.7 9.2 8.3 ( 74/888) 
Velamentous % 1 1.5 1.8 - 1.8 0.2 ( 2/888) 
Table 4.1 Qualitative description of cord insertion in different studies. 
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Figure 4.3 Frequency histogram of Cord Centrality Index at 33-43 weeks. 
 
Figure 4.4 Explanatory photograph of a placenta showing Cord Centrality Index of 0.36. 
 
Figure 4.5 Q-Q plot for Cord Centrality Index. 
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4.4.4 Eccentricity 
The placental eccentricity index ranged from 0.00 (circular shape of placenta) to 
0.91(highly elliptical shape) with a mean of 0.49 ± 0.18. The frequency histograms 
and Q-Q plot indicated a normal distribution (Fig 4.6, 4.8). Figure 4.7 shows the 
explanatory placental picture with mean eccentricity of 0.49. 
 
 
Figure 4.6 Frequency histogram of placental Eccentricity at 33-43 wks. 
 
 
.  
Figure 4.7 Explanatory photograph of a placenta showing Eccentricity of 0.49. 
 
 
          CHAPTER 4: PLACENTAL MORPHOLOGICAL INDICES IN REFERENCE POPULATION 
 
Page | 67  
 
 
 
Figure 4.8 Q-Q plot for Eccentricity at 33-43 weeks. 
 
Table 4.4 shows the 5th, 50th and 95th percentile ranges for cord centrality, 
eccentricity and cord coiling index for placentas at 33-43 weeks. Within this 
gestation range, there was no effect of gestation on any of these ratios.  
 
 
 
 
 
 
 5th 50th 95th 
Eccentricity 0.16 0.49 0.76 
Cord centrality index 0.08 0.36 0.79 
Cord coiling index 0.06 0.20 0.37 
Table 4.2 Percentile ranges of morphological indices at 33-43 weeks. 
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4.5 DISCUSSION 
Most studies done on placenta and umbilical cord are based either in high risk 
population or histology in adverse perinatal outcome. Very few studies have focused 
on the morphology of placenta in unselected reference population. Out of those few 
studies only handful studies have quantified the morphology of placenta.12-13 
Therefore there is no established baseline quantified morphological characteristics of 
placenta in an unselected population. 
Although not clearly understood, abnormal coiling of the cord (Hypo/hypercoiling) 
has been shown association with perinatal morbidity such as trisomies, preterm 
delivery, fetal death, increased intrapartum complications and interventional 
deliveries for fetal distress, low Apgar score, velamentous cord insertion and single 
umbilical artery, small for gestation age, fetal asphyxia and single umbilical artery.5 8 
56 Abnormal cord coiling has also been found with thrombosis of the chorionic plate 
vessels, umbilical venous thrombosis and umbilical cord stenosis.6  
The umbilical cord coiling index in this study was 0.20 coils/cm ± 0.09 with a 
preponderance of left sided coiling (79.3%). The cord coiling index in this study is in 
accordance with the published data.11 and so does the left sided preponderance of the 
coiling.8 45 49                                                                                                                                   
Quantitatively degree of deviations from central insertion into the chorionic plate has 
been defined as cord centrality index. In this study the data from unselected 
population of pregnancies delivering at gestation of 33-43 weeks, shows the mean 
value of cord centrality as 0.36, which signifies a markedly „off centre‟ insertion 
(Figure 4.4).   
In recent years shape of the chorionic plate has been the area of interest. Studies have 
linked the irregular and abnormal shape to the perinatal morbidities such as low birth 
weight, suggesting variably shaped placentas have altered function.10  The mean 
eccentricity index in this study is 0.49 indicating the shape of the chorionic disc more 
ellipse than round (Figure 4.7). 
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Though subjective and qualitative description of the placenta has a role 
predominantly in clinical reporting, deriving these morphological indices will allow 
entirely objective analysis of the particular index and other continuous variables in 
relation to outcomes and other placental findings.  
In summary, this study showed in the unselected reference population, mean of the 
coiling index (0.20) was similar to that shown by previous studies, centrality index as 
0.36 i.e. cord insertion off the centre and eccentricity as 0.49 i.e. chorionic disc is 
elliptical or oval, not round. 
These data are sufficiently robust to enable them to be used as a basis for future 
studies both descriptive and of outcome in pregnancy. It is, therefore, appropriate to 
dispel the widely held beliefs that the placenta is, in its natural and normal state, 
circular and that the cord normally inserts into its centre.    
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 5 : MORPHOLOGY: UMBILICAL CORD COILING, 
UMBILICAL CORD INSERTION AND PLACENTAL SHAPE 
IN PREGNANCIES WITH COMMON OBSTETRIC 
OUTCOME. 
 
 
 
 
Summary Points:  
 This study derived the morphological indices for the placenta and the 
umbilical cord in the pregnancies with common obstetric outcomes; PET, 
PIH, GDM and SGA and compared the indices with reference population.  
 Key findings: The morphological indices; cord coiling index, cord centrality 
index and eccentricity were not different in pregnancies with outcome groups. 
 
 
This chapter is based on: 
 Pathak S, Hook E, Hackett G, Murdoch E, Sebire NJ, Jessop F, Lees C. Cord coiling, 
umbilical cord insertion and placental shape in an unselected cohort delivering at term: 
Relationship with common obstetric outcomes. Placenta. 2010; 31: 963-8. 
Pathak S, Sebire NJ, Jessop F, Hackett G, Murdoch E, Hook E, Lees C. Morphological 
features of placenta in relation to common obstetric outcomes: Paper in progress.  
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5.1 INTRODUCTION 
There have been recent studies on placental shape, cord coiling and umbilical cord 
insertion.10 92 Studies have made attempts to correlate perinatal outcome with 
abnormal placenta shape, coiling and umbilical cord insertion.  Various studies have 
attempted to explain possible causes and features in respective common obstetric 
outcome group pregnancies however these have almost exclusively defined placental 
and umbilical cord features qualitatively by using descriptive terms, making direct 
comparison between groups problematic.  
Attempts at quantitative investigation have involved calculating placental shape from 
using a 3D model of placental vascular growth. This suggested that an irregular 
placental outline is an indication of sub-optimal branching structure of the vascular 
tree, accounting for the lower birth weight observed in non round/oval placentas.10 
There is also a renewed interest in the placental shape and developmental 
programming. Analysis of the relationship between placental surface area and 
hypertension in later life has been described in  subgroups defined by the mother‟s 
height and socio-economic status; the risk of developing hypertension was associated 
with reduced placental weight and area.93 Furthermore, pregnancies complicated by 
pre-eclampsia had reduced placental surface area and more oval placentas; the short 
diameter strongly associated with the severity of the pre-eclampsia.94   
Chapter 4 defines the cord coiling, insertion and shape (eccentricity) in unselected 
reference population. In this chapter, same placental indices have been investigated  
in pregnancies affected by pre-eclampsia (PET), pregnancy induced hypertension 
(PIH), gestational diabetes mellitus (GDM) and delivery of a small for gestational 
age (SGA) baby. 
The aim of this study is to derive indices describing the cord coiling,  relationship of 
cord insertion to its centre and the shape of placenta, at gestational age 33-43 weeks 
placentas from women who developed pre-eclampsia, pregnancy induced 
hypertension, gestational diabetes or small for gestational age with birth weight less 
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 than 10th centile. This study also aims to compare these morphological indices in 
women with and without pre-eclampsia, PIH, GDM or delivered SGA babies. 
Cord coiling was measured manually in the placentas. For cord insertion and 
placental shape, we utilized digital measurements in placentas to morphometrically 
define the cord insertion and placental shape using image J.  
 
5.2 METHODS  
All measurements of the placenta were derived from image J software following 
standard photography using a common protocol and scale for calibration.95  
This chapter includes the digital measurements in 888 women delivered at 33-43 
weeks. Macroscopic indices derived were coiling index, cord centrality index, 
eccentricity and the placental circumference. Frequency of these indices was noted in 
common obstetric outcome groups of PET, PIH, GDM and SGA. 
Circumference was calculated both for manual as well as digital measurements. For 
this chapter, all analysis on the circumference is taken for digital measurements only.  
Definitions of the common obstetric outcome categories are described in chapter 2.   
We compared data in a specific outcome group to the reference group excluding 
those particular cases with that outcome. We did not seek to compare data for 
common obstetric outcome groups with a normal population.  
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5.3 STATISTICAL ANALYSIS 
Descriptive statistics of manual and digital measurements were analysed.  A test of 
normality (the Kolmogorov-Smirnov test) was performed on the cord coiling Index, 
cord centrality index, and eccentricity index. Kolmogorov-Smirnov tests the 
normality of the data distribution, and quantifies the discrepancy between observed 
and expected distribution. A p value greater than 0.05 indicates normality of the 
distribution; however considering the small numbers of common obstetric outcome 
groups, the frequency histograms and Q-Q plots were also plotted for each variable 
to test the normality of the distribution.  
Considering the small number for common obstetric outcome group cases, as a 
precaution, the non parametric Mann-Whitney U test was performed to test the 
significant difference of coiling Index, cord centrality index, and eccentricity in the 
specific common obstetric outcome groups and non affected population.  
A Mann-Whitney U test 2 tailed significant values (p) was significant if value was 
≤0.05.    
     
5.4 RESULTS 
 
888 placentas from singleton pregnancies, 33 to 43 weeks were examined; in all 
placentas, digital measurements were obtained. Common obstetric outcome groups 
were; Pre-eclampsia (PET=2.3%), Pregnancy induced hypertension (PIH=2.9%), 
Gestational diabetes (GDM=4.3%) and small for gestational age of ≤ 10 th percentile 
(SGA=9.2%). Table 5.1 describes the baseline maternal demographics of the study 
population including the common obstetric outcome groups in the population.  
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N=888 Mean ± SD 
Maternal age ± SD 30.8 ± 5.6 
% Caucasian (n) 89.8 (797) 
% nulliparity (n) 48.2 (428) 
% Smokers >5  cigarettes per day (n) 9.6 (85) 
% Gestational Diabetes (n) 4.4 (39) 
% Pre-eclampsia (n) 2.3 (20) 
% Pregnancy induced hypertension (n) 2.9 (26) 
% SGA ≤ 10th birth weight percentile (n) 9.2 (82) 
Birth weight ± SD 3470 ± 496 
Mean gestation at delivery ± SD 39.4 ± 1.4 
 
 
 
Table 5.1 Baseline demographics of the reference population with common obstetric outcome 
groups. 
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Table 5.2 outlines the specific manual and digital measurements used in this chapter 
for reference population, PET, PIH, GDM, and SGA. 
 
*Reference 
Population 
(n=888) 
 
*PET (n=20) 
 
*PIH (n=26) 
 
*GDM (n=39) 
 
*SGA (n=82) 
 
Long axis 
18.9(12.7-30.7) 
 
18(15-23.2)   
± 2.2 
18.9(12.9-25.6) 
± 2.7 
19.1(12.7-25.8)  
± 2.5 
17.7(12.7-25.9) 
± 2.5 
Short axis 
15.9(8.9-22) 
1.8 
15.2(8.9-18.9)       
± 2.3 
15.9(12.1-21.3) 
±2.1 
15.9(10.6-20.4) 
±2.4 
14.4(8.9-18.2) 
±1.8 
Distance of 
cord insertion 
3.3(0.2-10.1) 
1.9 
3.6 (1.1-7.5) 
±1.9 
3.6(0.4-9.6) 
±2.4 
3.0(.2-7.7)    
±1.7 
3.5(0.2-8.3) 
±1.9 
             
41.5 (0-104)   
 14.1 
43.5 (26-71) 
±14.3 
43.5(21-103) 
±16.9 
37.7(14-77)      
± 14.2 
35.7(0-64) 
±12.4 
Cord coils 
8.4 (0-34)  
4.9 
8.4 (2-16) 
±3.9 
9.0(0-20)        
±5.8 
7.2(0-20)        
±4 
7.4(0-19)    
±4.1 
 
*All values are mean (range) ± SD 
Table 5.2  Placental measurements in reference and outcome groups. 
 
5.4.1 Umbilical cord coiling and coiling index 
Table 5.3 is the comparative table describing the directions of cord coiling in 
reference and common obstetric outcome groups. In all groups left sided coiling was 
in preponderance ranging from 70-92%. There was no coiling in 3.8% in PIH and 
1.7% in SGA. There was no non- coiling observed in the cords in the GDM and SGA 
groups. 
Table 5.4 describes the statistics of cord coiling index in all common obstetric 
outcome groups. The mean coiling index ranged from 0.19-0.22.   
Kolmogorov-Smirnov test of normality revealed a p value of 0.82, 0.71, 0.80 and 
0.18 for PET, PIH, GDM and SGA respectively indicating a normal distribution of 
data in all common obstetric outcome cases, however considering the small number 
of cases, frequency histograms Figures 5.1 (a-d) and Q-Q plots were also plotted, 
which showed normal distribution. 
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Direction of 
cord coiling   
(%) 
Left Right Bi-directional No coiling 
Missing data or cord 
too short to measure 
Reference 79.3 16.3 0.6 2.1 1.7 
PET 70 25 - - 5 
PIH 73.1 23.1 - 3.8 - 
GDM 92.1 5.3 - - 2.6 
SGA 78 18.4 - 2.4 1.2 
 
Table 5.3 Direction of cord coiling in reference and outcome groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coiling Index N Mean (range)±SD 
Reference 875 0.20 (0-1) ± 0.09 
PET 19 0.20 (0.06-0.5) ± 0.10 
PIH 26 0.20 (0-0.38) ± 0.09 
GDM 39 0.20 (0-0.43) ± 0.09 
SGA 81 0.21(0-0.55) ± 0.11 
Table 5.4 Description of Cord Coiling Index in reference and outcome groups. 
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Mann-Whitney U test was performed to test the difference in coiling index in 
common obstetric outcome groups and it was compared to the non-affected cases.  
A Mann-Whitney U test revealed no significant difference in the coiling index for 
pre-eclampsia; (n=19), U=7891, z=-0.22, p=0.82, affected cases (mean=0.20, 
median=0.15) versus non affected cases (mean=0.20, median=0.19). Results for PIH; 
(n=26), U=10778, z=-0.20, p=0.83, affected (mean=0.20, median=0.18) versus non 
affected group (mean=0.20, median=0.19). Cases of GDM (n=39), U=15475,        
z=-0.49, p=0.63, affected cases (mean=0.20, median=0.18) versus non affected cases 
(mean=0.20, median=0.19). Non parametric test showed a non significant difference 
(p=0.54) in SGA (n=81), U=30814, z=-0.62, (mean=0.21, median=0.20) versus non 
affected cases (mean=0.20, median=0.19). 
In each category above, p value was ≥ 0.05, no significant difference in the coiling 
index of the groups with or without the conditions defined. 
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           a                                                                    b 
 
 
 
   c                                d 
 
 
Figure 5.1(a-d) Frequency histograms of coiling index of obstetric outcome groups at 33-43 
weeks. 
 
 
 
 
   CHAPTER 5: PLACENTAL MORPHOLOGICAL INDICES IN OUTCOME GROUPS 
 
Page | 79  
 
 
 
 
5.4.2 Umbilical cord insertion 
 
Qualitative description of the type of umbilical cord insertion in relation to previous 
standards showed that the frequency of central and paracentral umbilical cord 
insertion remains highest even in common obstetric outcome groups. 
Table 5.5 shows the different types of umbilical cord insertion in reference and 
outcome groups. Comparing within the groups, incidence of central and paracentral 
insertion was similar to the unselected reference population. Though the incidence of 
marginal and velamentous appeared higher in pregnancy induced hypertension; 
19.3% and 3.8% respectively, but statistically it was a non significant difference 
(p≥0.05). 
 
 
 
 
 
 
 
 
 
Cord 
Insertion 
Central 
(%) 
Paracentral 
(%) 
Marginal 
(%) 
Velamentous 
(%) 
Not known 
(%) 
Reference 27.6 63.9 8.3 0.2 - 
PET 25 65 5 - 5 
PIH 23.1 53.8 19.3 3.8 - 
GDM 34.2 57.9 7.9 - - 
SGA 25.6 61 12.2 - 1.2 
Table  5.5  Qualitative description of cord insertion in reference and common obstetric outcome 
groups. 
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5.4.3 Cord centrality index 
 
The mean distance of cord insertion from the centre ranged from 2.99 -3.63 cm in all 
common obstetric outcome groups, irrespective of the direction of umbilical cord 
coiling.  
Table 5.6 describes the statistics of Centrality index in all common obstetric outcome 
groups. The mean centrality index ranged from 0.31-0.40.  Kolmogorov-Smirnov test 
of normality revealed a 2 tailed p value of 0.97, 0.52, 0.78 and 0.06 for PET, PIH, 
GDM and SGA respectively indicating a normal distribution of data in all common 
obstetric outcome cases, however considering the small number of cases, frequency 
histograms Figures 5.2 (a-d) and Q-Q plots were also calculated, showing normal 
distribution. 
 
 
 
 
 
 
 
Mann-Whitney U test revealed no significant difference in the centrality index of 
PET (n=20), U=7370, z=-1.15, p=0.24; affected (mean=0.41, median=0.38) versus 
non affected (mean=0.36, median=0.32); PIH (n=26), U=10742, z=-0.36, p=0.71, 
affected (mean=0.40, median=0.31) versus non affected (mean=0.36, median=0.32); 
GDM (n=39), U=14804, z=-1.07, p=0.28; affected (mean=0.32, median=0.31) versus 
non affected (mean=0.36, median=032); SGA (n=82), U=29627, z=-1.55, p=0.12 
affected (mean=0.40, median=0.35) versus non affected (mean=0.35, median=0.32). 
 
 
Centrality Index N Mean (range) ± SD 
Reference 888 0.35 (0.02-1.01) ± 0.21 
PET 20 0.40 (0.12-0.89) ± 0.20 
PIH 26 0.39 (0.04-0.99) ± 0.27 
GDM 39 0.31 (0.02-0.93) ± 0.18 
SGA 82 0.40 (0.02-0.99) ± 0.24 
Table 5.6  Description of Centrality index in reference and outcome groups. 
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   a                              b 
 
 
 
     c                                      d 
 
 
Figure 5.2 (a-d) Frequency histograms of Cord Centrality Index in outcome groups at 33-43 
weeks. 
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5.4.4 Eccentricity 
 
Table 5.7 describes the eccentricity in all common obstetric outcome groups. The 
mean eccentricity ranged from 0.47-0.52 in all common obstetric outcome groups.  
Kolmogorov-Smirnov test of normality revealed a 2 tailed p value of 0.98, 0.73, 0.43 
and 0.99 for PET, PIH, GDM and SGA respectively indicating a normal distribution 
of data in all common obstetric outcome cases, however considering the small 
number of cases, frequency histograms Figures 5.3 (a-d) and Q-Q plots were also 
displayed, showing a normal distribution. 
 
Eccentricity N Mean (range) ±SD 
Reference 888 0.49 (0-0.91) ± 0.18 
PET 20 0.47 (0.11-0.91) ± 0.19 
PIH 26 0.50 (0.25-0.79) ± 0.14 
GDM 39 0.49 (0-0.85) ± 0.20 
SGA 82 0.52 (0.20-0.91) ± 0.18 
 
Table 5.7 Description of Eccentricity in reference and outcome groups. 
 
Mann-Whitney U test revealed no significant difference in the eccentricity of PET 
(n=20), U=8095, z=-0.51, p=0.60; affected (mean=0.47 , median=0.50) versus non 
affected (mean=0.49, median=0.51); PIH (n=26), U=109812, z=-0.17, p=0.86, 
affected (mean=0.50 , median=0.52)versus non affected (mean=0.49, median=0.51);  
GDM (n=39), U=15718, z=-0.49, p=0.63; affected (mean=0.50 , median=0.50) 
versus non affected (mean=0.49, median=0.51); SGA (n=82), U=29920, z=-1.41, 
p=0.16, affected (mean=0.52, median=0.52) versus non affected (mean=0.48,    
median=0.51). 
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      a                                                            b 
 
 
 
 
   c                                      d 
 
 
Figure 5.3 (a-d) Frequency histograms of placental Eccentricity in obstetric outcome groups at 
33-43 weeks. 
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5.5 DISCUSSION 
 
This data highlight the morphological indices of the placenta and umbilical cord in 
common obstetric outcome pregnancies and compare these indices in the non-affected 
cases. 
The coiling index is one of the most studied umbilical cord related parameters in high 
risk pregnancies. Pre-eclampsia and gestational diabetes have been linked to the 
abnormal coiling, both non coiling as well as hyper coiling.57 96  Hypercoiling has been 
associated with SGA (OR 2.10).8 This study however showed no significant difference 
in umbilical cord coiling index with pre-eclampsia, PIH, GDM or SGA compared to that 
of population without these common obstetric outcome groups. 
Qualitatively marginal cord insertion are associated with intra uterine growth 
restriction, stillbirth and neonatal death9, and velamentous insertion with low birth 
weight, IUGR, diabetes mellitus.9 74 In the current study, there was no significant 
difference in the incidence of central, paracentral, marginal or velamentous  cord 
insertions in common obstetric outcome groups as compared to the non-affected 
groups. 
There are no studies quantitatively comparing the difference between abnormal insertion 
of the umbilical cord in common obstetric outcome groups and a reference population. 
The distance of umbilical cord insertion from the centre (or from the chorionic plate 
margin) has been considered a marker of placental insufficiency.90 97  Despite there 
being association of peripheral cord insertion with common obstetric outcome groups, 
shown in the various above studies, quantitatively defined, in the current study there was 
no significant difference in cord centrality index for pre-eclampsia, PIH, GDM and SGA 
groups compared to the reference population.  
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There are no studies describing the shape of placenta quantitatively in the common 
obstetric outcome groups of hypertensive disorders of pregnancy, GDM or SGA. 
Further, none have compared the shapes of the placenta quantitatively between common 
obstetric outcome groups and a reference population, though a recent study has shown a 
correlation between the short axis of the placenta and the severity of the pre-eclampsia.94  
This study did not find any statistically significant difference in eccentricity between the 
populations affected with the common obstetric outcome groups to that of un-affected 
rest of population. 
To summarise, coiling index, cord centrality index and eccentricity in this study was not 
different in the adverse pregnancy outcomes that has been defined previously, compared 
to the data without the disease from unselected reference population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 6 : MORPHOLOGY: PLACENTAL WEIGHT AND   
CIRCUMFERENCE-SIGNIFICANCE AND CORRELATION 
WITH BIRTH WEIGHT IN UNSELECTED PREGNANCIES 
AND COMMON OBSTETRIC OUTCOME GROUPS.
 
 
 
 
Summary points: 
 This study described the baseline data for the ratio of birth weight to the 
placental weight and placental circumference in the reference population of 
1159 at 33-43 weeks of gestation. 
 Key findings: Study analysed the relationship of birth weight to the placental 
weight and circumference and showed a strong positive correlation of birth 
weight to the placental weight and circumference.  
 This means that bigger the placenta in weight and size, heavier is the baby 
and vice versa, which may sound obvious, but has not been shown 
quantitatively before.  
 In cases with PET, these ratios were significantly smaller compared to cases 
not affected by PET.  
 
 
This chapter is based on:  
Pathak S, Jessop F, Hook L, Sebire NJ, and Lees C. Placental weight, digitally derived 
placental dimensions at term and their relationship to birth weight. J Maternal Fetal 
Neonatal Med. 2010 Oct; 23(10):1176-82 
 
 
   CHAPTER 6: PLACENTAL WEIGHT, CIRCUMFERENCE AND BIRTH WEIGHT 
 
Page | 87  
 
 
6.1 INTRODUCTION 
The weight of the placental is an important reflection of the placental function. The 
placenta weight is one of the important characteristics of the placental size. Two 
important constituents of the placenta size are chorionic plate surface area, and the 
disc thickness. The area of the uterus which is covered by the placenta is the surface 
area of the chorionic plate 98, on the other hand thickness of the chorionic disc shows 
the extent of the arborisation of the villous.33  The placenta weight can be a 'sentinel' 
indicator of nutritional and/or environmental problems. However, it is not clear, 
whether weighing the placenta reflects the “true” weight as it is extremely difficult to 
evaluate the exact amount of fetal and maternal blood present in the placenta at the 
time of weighing?  It is difficult to assess the amount of blood remained in the 
intervillous space. The amount of fetal blood trapped in the placenta will depend to 
some degree upon the timing of cord clamping after delivery of the baby.  
Moreover there are no standard techniques as to how a placenta should be weighed, 
some weigh the placenta with attached membranes and the cord and also without 
removing the adherent maternal clots, whilst other will weigh placenta with 
membranes trimmed off and with or without cutting the cord and with or without 
removing any adherent maternal clots. 
More importantly, one has to consider the fact that a placenta loses a variable but 
progressive weight while kept in the refrigerator, if not weighed soon after delivery. The 
placenta stored in the lab to be weighed later, loses weight over a period of time, one 
study showed that stored placenta loses 4% of its weight in 12 hours, 6% in 24 hours and 
10% in 48 hours.99 This problem perhaps could be avoided by keeping the placenta in 
the low temperature or fix in formalin; however it is not advisable to freeze or fix the 
placenta before examination as both these procedures can obliterate the most useful 
microscopic characteristics and make even the macroscopic examination more difficult. 
Fixation of the placenta also produces variable changes in the weight which then further 
makes difficult to weigh the placenta accurately.  
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There are different factors which may affect the placental weight for that given 
pregnancy. Placental weight varies with ethnicity 100, gestation age, maternal socio-
economic status, smoking, maternal age, sex of the infant and birth weight. 
Feto-placental weight ratio represents the balance between fetal and placenta growth. 
Any alteration in any of them will suggest disturbance in the intrauterine status and 
would warrant further investigation. Birth weights, placental weights, and birth weight 
/placental weight ratios have been correlated with perinatal morbidity and mortality. 
Less than 10th centile of the placenta weight has been associated with Intrauterine 
growth restriction, pre-eclampsia, increased intervillous fibrin deposition, villitis of 
unknown origin and trisomy whilst high placental weight has been linked with maternal 
diseases such as diabetes mellitus, anaemia, and fetal disorders such as fetal anaemia, 
hydrops, congenital syphilis and nephritic syndrome.101-102  As few studies have shown 
the importance of the weight of the placenta, it has encouraged the researchers to explore 
more about the clinical significance of placental weight. The placental weight percentile 
curves according to the gestation age and gender for that population have been 
described.103 These percentile curves are specific for that population but if one consider 
the ratio of birth weight to the placenta weight, probably that should not vary much 
between the different sets of populations and it has long been argued if this ratio is likely 
to yield useful information rather than the weight of the placenta alone. 
A positive correlation has been seen between the placental weight and the infant 
weight at birth. Birth weight of the infant is said to be directly proportional to the 
placental weight.104-105  Studies have even suggested that small for gestational age 
infants have smaller placentas than the placentas for appropriate weight for gestation 
infants, suggesting that fetal growth depends on the actual weight of the placenta.  
The placenta weight/ fetal birth weight ratio is 1:2.9 at 24 weeks which increases to 
1:6.8 at 40 weeks106, any change in this ratio will simply reflect the altered 
relationship of fetal-placental unit. In the recent literature it has been emphasised 
more onto the placental and fetal weight ratio, which was said to be more accurate 
rather than taking the weight of the placenta alone and correlating it to the neonatal  
outcome.
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Higher placental/fetal weight ratio has been correlated with high perinatal morbidity 
and mortality.107 Even in these cases one could argue, placenta gets bigger as a 
compensatory mechanism in high risk pregnancies such as pre-eclampsia, severe 
anaemia, heavy smoking in pregnancy and it won‟t be surprising to get the higher 
placental /fetal weight ratio associated with higher perinatal morbidity and mortality. 
Studies are reported showing that anaemia during pregnancy is associated with large 
placental weight and a high ratio of placental weight to birth weight. 108 109 
Placenta weight/fetal weight ratio has been well known as an predictor of developing 
disease later in adult life as intrauterine environment has an important effect on blood 
pressure and hypertension in adults.  Large British cohort studies have suggested that 
having a discordance of larger placenta with a small baby may lead to circulatory 
adaptation in the fetus, altered arterial structure in the child, and hypertension in the 
adult.110 This may have important implications for the prevention of adult 
hypertension, which appears to have its origin in fetal life. Higher placenta weight in 
the most recent pregnancy has also been correlated significantly to the reduced 
survival with the breast cancer, if diagnosed during pregnancy or within 2 years 
thereafter.111  
However placenta weight only, per se should have no clinical importance unless 
considered along with gestational age and clinical picture. 
Further, a few recent studies establish the nature of the relationship between birth 
weight and placental weight and circumference; positive correlations between 
placental and infant weight are reported105 112-113, but these data do not refer to an 
unselected population. Moreover, the available data on the birth weight/placenta 
circumference is qualitative. There is no available data on quantitative analysis on 
placental circumference and its correlation with birth weight.  
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The aims of this chapter:- 
Analysis of mean placenta weight, placenta circumference and birth weight in an 
unselected reference population.  
Analysis of mean placenta weight, placenta circumference and birth weight in 
common obstetrics outcome groups e.g. Pre-eclampsia (PET), pregnancy induced 
hypertension (PIH), gestational diabetes (GDM) and small for gestational age (SGA).  
Defining the relationship between placental weight and placental circumference 
(manual) to birth weight in the common obstetric outcome population and compare 
the ratios to the similar ratios derived for non affected cases in unselected reference 
population. 
 
6.2 METHODS 
Details of the methods are described in chapter 2. 
1159 placentas from singleton pregnancies, 33 to 43 weeks were examined. Placental 
circumference taken in this chapter is manual circumference. Definitions of the 
common obstetric outcome pregnancies have been defined in chapter 2. 
 
6.3 STATISTICAL ANALYSIS 
Descriptive analysis of birth weight, placenta weight, and placenta circumference 
was performed in reference population, pre-eclampsia (PET), pregnancy induced 
hypertension (PIH), Gestational diabetes (GDM) and Small for gestational age at 
birth (SGA). 
Normality was checked for birth weight, placenta weight and placenta circumference 
for reference population, using the frequency histograms and Q-Q plots.  
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Descriptive analysis was performed for ratio of birth weight to placenta weight and 
placental circumference in reference population, PET, PIH, GDM and SGA. 
To establish the relationship of birth weight to the placental weight and 
circumference, Z score of all the three was calculated to normalise the data for the 
gestational age within the gestation range 33-43 weeks, using the means and SDs 
derived from this population. A linear relationship was analysed on a scattered plot 
for birth weight versus placenta weight and birth weight versus placenta 
circumference. Pearson correlation coefficient (r) was derived and r2 was calculated 
for both comparisons. As multiple comparisons were made, p value of ≤ 0.01 was 
considered significant.  
T test was performed to test if there is any significant difference of ratio of birth 
weight to placenta weight and placenta circumference in the non-affected group 
compared to the group affected with PET, PIH, GDM or SGA. A T test 2 tailed 
significant values (p) was significant if value was ≤0.05. 
 
 
6.4 RESULTS   
In the study data of 1159 placentas, specific common obstetric outcome pregnancy 
categories were chosen; Pre-eclampsia, Pregnancy induced hypertension, Gestational 
diabetes and small for gestational age of ≤ 10th percentile. Table 6.1 describes the 
baseline maternal demographics of the study population including the common 
obstetric outcome groups in the population. 
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N 1159 
Maternal Age ± SD 30.9 ± 5.73 
% Nulliparity (n) 47.6 (552) 
% Smokers (n) 9.3 (108) 
% Caucasians (n) 90.7 (1051) 
% PET (n) 2.5 (29) 
% PIH (n) 2.6 (30) 
% GDM (n) 4 (46) 
% SGA <10 Centile (n) 9.4 (109) 
Mean gestation age at delivery ± SD 39.5 ± 1.49 
% Female (n) 46.7 (541) 
% Male (n) 53.3 (618) 
 
Table 6.1 Baseline demographics of the reference population. 
 
Table 6.2 describes the statistics of mean ± SD of birth weight, placenta weight and 
placenta circumference (manual) in reference population and all common obstetric 
outcome groups. Table shows the crude comparison of the means of birth weight, 
placenta weight and placenta circumference in different groups.  
 
Mean ± SD 
Gestation age 
range (Weeks) 
Birth weight (gms) Placenta weight (gms) 
Placenta circumference 
(cm) 
Reference 33-43 3480 ± 511 483 ± 100 
60.30 ± 6.28 
PET 33-41 
3076 ± 823 495 ± 117 59.42 ± 7.27 
PIH 36-42 
3451 ± 510 464 ± 102 61.81 ± 8.75 
GDM 37-41 
3511 ± 462 506 ± 92 61.26 ± 7.55 
SGA 33-42 
2671 ± 341 377 ± 68 55.95 ± 5.49 
Table 6.2  Birth weight, placental weight and circumference in reference and obstetric outcome groups. 
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Figure 6.1(a-c) represent the frequency histograms of birth weight, placenta weight 
and circumference in reference unselected population. There was data missing for 1 
birth weight, 10 placental weights and 9 placental circumferences in the reference 
population.  
     a 
     b 
  c 
Figure 6.1(a-c) Frequency histograms of birth weight, placenta weight and circumference in 
reference population.
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Table 6.3 and 6.4 describes the statistics for the ratio of birth weight to placenta 
weight and placenta circumference.  
 
Birth Wt / 
Placenta Wt 
   Coefficient of Variation 
Mean Median SD Mean centred Median centred 
Reference 7.38 7.32 1.20 16.2% 16.4% 
PET 6.60 6.49 1.03 15.6% 15.9% 
PIH 7.69 7.63 1.67 21.5% 21.7% 
GDM 7.07 6.94 1.08 15.3% 15.7% 
SGA 7.27 7.29 1.30 17.2% 17.2% 
 
Table 6.3 Birth weight and placenta weight ratio in reference and common obstetric outcome 
groups. 
 
 
Birth 
Wt/placenta 
circumference 
   Coefficient of Variation 
Mean Median SD Mean centred Median 
Reference 58.05 58.12 8.07 13.9% 13.9% 
PET 54.14 53.42 10.00 18.5% 18.8% 
PIH 56.47 55.47 8.60 15.2% 15.6% 
GDM 57.70 57.71 7.39 12.8% 12.8% 
SGA 48.27 48.66 6.14 12.7% 12.6% 
 
Table 6.4 Birth weight and placenta circumference ratio in Reference and common obstetric 
outcome groups. 
 
 
 
 
   CHAPTER 6: PLACENTAL WEIGHT, CIRCUMFERENCE AND BIRTH WEIGHT 
 
Page | 95  
 
 
Tables 6.5 (a-d) illustrates the direct comparisons of birth weight and placenta weight 
in cases with common obstetric outcome versus cases not affected by the outcome 
groups.  
a 
Birth Wt / 
Placenta Wt 
Mean Median SD 
Coefficient of Variation 
Mean Median 
No PET 7.40 7.34 1.19 16.1% 16.3% 
Present PET 6.60 6.49 1.03 15.6% 15.9% 
Overall 7.38 7.32 1.20 16.2% 16.4% 
 
b 
Birth Wt / 
Placenta Wt 
Mean Median SD 
Coefficient of Variation 
Mean Median 
No PIH 7.38 7.31 1.18 16.0% 16.2% 
Present PIH 7.68 7.63 1.66 21.5% 21.7% 
Overall 7.38 7.32 1.20 16.2% 16.4% 
 
c 
Birth Wt / 
Placenta Wt 
Mean Median SD 
Coefficient of Variation 
Mean Median 
No Diabetes 7.40 7.34 1.20 16.2% 16.4% 
GDM 7.07 6.94 1.08 15.3% 15.7% 
Overall 7.38 7.32 1.20 16.2% 16.4% 
 
d 
Birth Wt / 
Placenta Wt 
Mean Median SD 
Coefficient of Variation 
Mean Median 
NGA 7.39 7.32 1.19 16.1% 16.3% 
SGA 7.27 7.29 1.30 17.2% 17.2% 
Overall 7.38 7.32 1.20 16.2% 16.4% 
 
Table 6.5 (a-d) Birth weight and placental weight ratios in common obstetric outcome groups 
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Tables 6.6 (a-d) illustrates the direct comparison of birth weight and placental 
circumference ratio in cases with and without obstetric outcome groups. 
a 
Birth Wt / Placental   
Circumference 
Mean Median SD 
Coefficient of Variation 
Mean Median 
No PET 58.14 58.16 8.00 13.8% 13.8% 
Present PET 54.14 53.42 10.00 18.5% 18.8% 
Overall 58.05 58.12 8.07 13.9% 13.9% 
 
b 
Birth Wt /  Placental  
Circumference 
Mean Median SD 
Coefficient of Variation 
Mean Median 
No PIH 58.09 58.14 8.06 13.9% 13.9% 
Present PIH 56.47 55.47 8.60 15.2% 15.6% 
Overall 58.05 58.12 8.07 13.9% 13.9% 
 
c 
Birth Wt/ Placental 
Circumference 
Mean Median SD 
Coefficient of Variation 
Mean Median 
No Diabetes 58.08 58.16 8.10 14.0% 13.9% 
GDM 57.70 57.71 7.39 12.8% 12.8% 
Overall 58.05 58.12 8.07 13.9% 13.9% 
 
d 
Birth Wt / Placental 
Circumference 
Mean Median SD 
Coefficient of Variation 
Mean Median 
NGA 59.05 58.86 7.56 12.8% 12.8% 
SGA 48.27 48.66 6.14 12.7% 12.6% 
Overall 58.05 58.12 8.07 13.9% 13.9% 
 
Table 6.6 (a-d) Birth weight and placental circumference ratios in common obstetric outcome 
groups 
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T test was conducted to compare the birth weight ratios to placenta weight and 
circumference for all common obstetric outcome groups and the reference 
population.  
Results of test in the birth weight: placenta weight is as follows: - (affected versus 
non-affected cases) 
 PET (n=26), Mean=6.60 ± 1.03, p=0.001 (two tailed). The mean difference of the 
two means was 0.79 with 95% confidence interval of 0.34 to 1.27.  
PIH (n=30), Mean=7.68 ± 1.66, p= 0.16, GDM (n=46), Mean = 7.07 ± 1.08, p= 0.07, 
SGA (n=107), Mean=7.28 ± 1.25, p= 0.32, and unselected reference population, 
Mean = 7.39 ± 1.20.  
 
T test results for birth weight: placenta circumference is as follows: - (affected versus 
non-affected cases) 
PET (n=26), Mean=54.14 ±10, p=0.01 (two tailed), the mean difference of the means 
was 3.99 with 95% Confidence interval of 0.86 to 7.13. 
PIH (n=30), Mean =56.47 ± 8.60, p= 0.28, GDM (n=46), Mean=57.70 ± 7.39, 
p=0.76. In cases with SGA-(n=108) Mean=48.27± 6.14, p=0.00. The mean 
difference of the means was 10.79 with 95% CI of 9.53 to 12.04. Unselected 
reference population had mean value of 58.05 ± 8.07. 
 
Figures 6.2 (a-b) shows the scatter plots and the linear relationship with significant 
Pearson‟s correlation coefficient for z: birth weight to z: placenta weight and z:  birth 
weight to z: placenta circumference for reference population, r as 0.638 and 0.417 
respectively.  
For common obstetric outcome groups, z- score of birth weight and placental weight 
(figures 6.3-6.6), the Pearson‟s correlation coefficient (r) was 0.78, 0.49, 0.59, 0.45 
with p values 0.001, 0.006, 0.001 and 0.001 for PET, PIH, GDM and SGA 
respectively, showing high positive correlation.  
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Similarly significant results were obtained for z-score of birth weight and placenta 
circumference are shown in figures 6.7- 6.10, with Pearson‟s correlation coefficient 
(r) as 0.54, 0.39, 0.50 and 0.35 with p values 0.004, 0.034, 0.001 and 0.001 for PET, 
PIH, GDM and SGA respectively. These figures also compare the relationship in the 
ratios with and without the disease. 
 
 
   a 
 
  b 
Figure 6.2 (a-b) z score of birth weight versus placental weight and circumference in reference   
population. 
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       a                   b 
 
 
Figure 6.3 (a-b) z score of birth weight versus placental weight in PET. 
 
 
   a                         b 
 
 
Figure 6.4 (a-b) z score of birth weight versus placental weight in PIH. 
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           a           b 
 
Figure 6.5 (a-b) z score of birth weight versus placental weight in GDM. 
 
   a                       b 
 
 
Figure 6.6 (a-b) z score of birth weight versus placental weight in SGA. 
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   a                      b 
 
Figure 6.7 (a-b) z score of birth weight versus placental circumference in PET. 
 
   a            b 
 
 
Figure 6.8 (a-b) z score of birth weight versus placental circumference in PIH. 
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    a                  b 
 
Figure 6.9 (a-b) z score of birth weight versus placental circumference in GDM. 
 
 
   a                   b 
 
 
Figure 6.10 (a-b) z score of birth weight versus placental circumference in SGA. 
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6.5 DISCUSSION 
The normal birth: placental weight ratio has been shown to range between 6.5 to 7.1 
at term 37-42 weeks gestation114-115 Another study showed the birth weight: placental 
weight ratio ranging from 6.3 to 8.46 at 34-43 weeks study.116  The birth weight: 
placental weight ratio of 7.39 ± 1.20 in reference population from 33-43 weeks that 
was derived, is therefore within the limits of these ranges. This ratio does have 
relevance as the ratio of birth weight: placental weight has been considered to be 
more important than placental weight alone when considering adverse perinatal 
outcome such as fetal and neonatal demise.107 117  
 
In the common obstetric outcome population, birth weight: placental weight has been 
compared with non affected population. In cases with PET, this ratio has been found 
significantly (p=0.001) smaller as compared to non PET cases (6.60 versus 7.40). 
Mean difference between the groups was 0.79 with 95% confidence interval of 0.34-
1.27, Studies have shown that often infants are small for gestational age for a small 
placenta in pre-eclampsia and large for large for gestational age.118 In the current 
study, cases with PIH, GDM and SGA did not show this ratio any significantly 
different from that of non-affected groups.  
 
The other ratio, this study has looked at is birth weight: placenta circumference, 
which has not been shown before in previous studies. Whether it is a useful ratio or 
not, it is not clear yet but this can be used as a baseline for the future studies on the 
same area. 
 
This study showed significant difference in birth weight/placental circumference ratio in 
cases with PET and SGA. In cases of PET, mean difference of this ratio was 3.9 from 
non-affected population with confidence interval of 0.86-7.13 and p value was 0.01. For 
SGA, mean difference was 10.79 (48.27 versus 59.05) with 95% CI as 9.53-12.04 
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 with p value of <0.01. Though it would seem obvious that for a low birth weight, size or 
circumference of placenta should also be smaller, but the current study did not notice 
this ratio any different in cases with PIH and GDM as compared to the non-affected 
population values. 
 
This study also showed strong correlation between placental weight and 
circumference to the birth weight in all common obstetric outcome groups and 
reference group (scatter plots with positive correlation with significant Pearson‟s 
correlation coefficient‟s value; figures 6.2-6.10), which also confers that higher the 
birth weight, higher is the placental weight and the circumference and vice versa.  
Although this may sound obvious but these relationships have not been shown before 
in this manner, quantitatively.  
  
The values of placental weight and birth weight/placental weight ratio in reference 
population will provide a baseline for future studies based on the similar subjects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 7 : HISTOLOGY AND ITS RELATIONSHIP WITH 
PLACENTAL MORPHOLOGY 
 
Summary points: 
 This study has described the baseline data of predefined histological lesions 
of the placenta in common obstetric outcome groups of PET, PIH, GDM and 
SGA and in reference population and its relationship with its morphology.  
Key points: are as follows- 
 There was no significant difference in the incidence of predefined          
histological lesions in the pregnancy outcome groups. 
 Most placentas from an unselected population (72%) or common pregnancy 
outcome groups (66-80%) are histologically normal.         
 Placental morphological indices were not different in predefined          
histological lesions.  
 Macroscopic abnormalities of the placental shape and cord insertion cannot 
predict presence or absence of histological features and are of limited clinical 
significance.  
 
 
This chapter is based on: 
Pathak S, Sebire NJ, Jessop F, Hackett G, Murdoch E, Hook E, Lees C. Relationship 
between placental morphology and histological findings in an unselected population 
near term- accepted Virchows Archiv, March 2011 
Pathak S, Sebire NJ, Jessop F, Hackett G, Murdoch E, Hook E, Lees C. Placental 
histology at or near term in relationship to obstetric outcome- Virchows Archiv. 
April 2011 
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7.1 INTRODUCTION 
Though there have been some agreed standards for the placental histological 
examinations16-17, still there are no uniformly defined standards and guidelines for 
placental examinations. Not only that, there are not even agreed definitions for most 
histological pathologies. Very few Obstetricians truly understand these pathological 
lesions and their implications for the past and the future pregnancy. Frequently, 
pathologists report the placenta examination as either “NAD” or small area of 
marginal infarction, which may not have any bearing onto the clinical outcome while 
Obstetricians “blame” the only available pathology of placenta, as the possible cause 
of adverse perinatal outcome. 
Another major concern is that most of the placenta literature is based on abnormal  
placentas, which makes it difficult to differentiate for many features between the 
“pathologically abnormal” versus “normal variant”. There is a definite need for 
studies to analyse normal placentas statistically and to identify the normal variants of 
histological lesions during the course of pregnancy.  In best of my knowledge the 
pattern of histopathological abnormalities of the placenta from unselected population 
has not been described before. 
 
Complications such as pre-eclampsia, pregnancy induced hypertension, gestational 
diabetes, and small for gestational age are associated with higher perinatal morbidity 
and mortality. Since the placenta and umbilical cord is the functional unit between 
the mother and the fetus, the placenta may be expected to reflect in some way the 
health of both the baby and the mother. One might therefore hypothesize that certain 
obstetric outcomes might exhibit specific effects or histological lesions on the 
placenta.   Numerous studies have been performed on placentas in these obstetric 
outcomes, in an attempt to explain the possible effects of these on the pregnancy and 
histology of placenta. However none of the studies highlights any of the lesions as 
characteristic of any one particular obstetric outcome category, which then makes the 
whole picture very confusing. Moreover, incidence of these histological lesions 
present in obstetric outcomes has not been studied in unselected cohort.   
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PET/PIH  
Due to the incomplete invasion of trophoblast, spiral arteries remains less elastic 
leading to maternal vasospasm, this eventually causes high resistance to blood flow 
passing through these vessels and reduced utero-placental blood flow. The placenta 
in cases of pre-eclampsia and PIH may exhibit many pathological features suggestive 
of the disease but there may be completely normal placental findings 
macroscopically as well as microscopically even in cases of severe disease. 
Therefore the absence of these features should not exclude the pathology, as these 
pathological features may be characteristic but not the universal finding.  
Pathological findings of the placenta in PET and PIH depend largely on the severity 
and the duration of the disease. Pathological features described in association with 
pre-eclampsia and pregnancy induced hypertension are villous maturation, decidua 
arthropathy, retroplacental haematomas, intervillous thrombosis, fetal artery 
thrombosis, varying degree of perivillous fibrin deposition and chorioamnionitis. 
GDM 
According to the UK diabetes statistics, about 1.8 million people are diagnosed with 
the diabetes by 2004 and by 2010, this will increase to 3 million. With the increasing 
incidence of diabetes, the incidence of gestational diabetes is growing. 2-5 % of 
women delivering in England and Wales per year have diabetes during pregnancy.  
Approximately 87.5% of these have gestational diabetes.   
There are many structural and functional changes in placenta in diabetes depending 
upon the gestational period affected of the pregnancy. Microscopic features reported 
in diabetes are so varied that at times they seem to contradict each other. These 
differences could either be due to the different methodologies or may be due to the 
difference in degree of severity of diabetes and difference in gestational age at 
delivery. Histological lesions documented in diabetes are villous immaturity, 
oedema, Chorangiosis and proliferative endarteritis.  
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Small for Gestational Age 
 
Small for gestational age (SGA) infant has been defined in this study as the birth 
weight less than 10th percentile of the gestational age. SGA infants may or may not 
be growth restricted (IUGR). IUGR is associated with 6-10 times higher perinatal 
morbidity and mortality compared to normal weight neonates.  
Microscopic examination of the placenta in small for gestational age infants varies 
from case to case. Some placentas will exhibit entirely normal histology while others 
may show various histological abnormalities. Some of the common histological 
features which can be found in SGA are hypovasculariy of terminal villi, abnormal 
maternal spiral arterioles, increased fibrin deposition, villitis of unknown aetiology.  
 
 
Further, there is no data whether there is any relationship of histological lesions with 
placental morphological characteristics such as cord coiling, umbilical cord insertion 
site and placental shape. 
 
The aim of this chapter is to establish the incidence of predefined placental 
pathological abnormalities in the common obstetric outcome pregnancy outcomes 
groups of pre-eclampsia, pregnancy induced hypertension, gestational diabetes and 
small for gestational age infants compared to non-affected pregnancies and the rest 
of the unselected reference population. This chapter also aim to describe the 
relationship between morphological parameters of the placenta, as previously defined 
in chapter 4 and the common categories of histological lesions. 
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7.2 METHODS 
Details of the methods are described elsewhere (chapter 2). Briefly; analysis of this 
chapter is based on all cases with available histology analysis report. The population 
of the study was an unselected population irrespective of the risk status of the 
pregnancy.  
Histological findings of the placenta from the unselected population were compared 
with the common obstetric outcome group. Common outcome groups considered 
were pre-eclampsia (PET), pregnancy induced hypertension (PIH), gestational 
diabetes (GDM) and small for gestational age (SGA).  
Definitions of the common obstetric outcome groups of PET, PIH, GDM and SGA 
are described in Chapter 2. 
There were certain placentas where more than one histological lesion was present. 
Each placental lesion has been counted separately. Similarly, in the clinical groups, 
certain cases had more than one clinical obstetric outcome group and each group has 
been counted separately. 
Digital measurements (Cord centrality and eccentricity indices) were available on 
888 placentas. Manual measurements (Coiling index) were performed on 1141 cases, 
as in 18 cases either the umbilical cord was missing or was too short to measure.  
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MAJOR PATHOLOGICAL GROUPS          
Chorioamnionitis                    
  a  b  
Figures 7.1 Microscopic view of chorioamnionitis (a) low power (original magnification x 40)  
(b) high power (original magnification x 100)  (study   photograph). 
 
Histologic chorioamnionitis is inflammatory changes (not infective process) in 
placenta, umbilical cord, decidua, chorion and amnion. Chorioamnionitis is most of 
the time is an acute process but cases of chronic chorioamnionitis has also been 
described in literature, where placental membranes are infiltrated with chronic 
inflammatory cells.119  In one large study of chronic chorioamnionitis, it was noted to 
have lymphocytic inflammation of the fetal membranes. Villitis of unknown 
aetiology was also noted in 70% of these cases examined, though the severity of 
villitis did not seem to have any correlation with the severity of lymphocytic 
infiltration of the membranes.120  
Traditionally acute inflammation of chorion and amnion membranes and amniotic 
fluid infection has been taken together.121-122 Studies done in 1980s have shown the 
recovery of the organisms in acute inflammatory lesions of the placenta from 
subchorionic plate123-124 and chorioamniotic space.121  
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Clinical chorioamnionitis is suspected when there is presence of fever, uterine 
tenderness, and foul smelling vaginal discharge, maternal and or fetal tachycardia, 
leucocytosis, however none of these symptoms per se are not specific for 
chorioamnionitis and therefore clinical diagnosis is unreliable for the diagnosis 
histologically.    
There is a poor correlation between clinical and histological chorioamnionitis. 
However there are many important questions to consider before judging the 
relationship between clinical and histologic chorioamnionitis; such as diagnostic 
criteria for clinical chorioamnionitis in the given set up; bacterial culture of 
placenta/amniotic fluid in support of diagnosis of chorioamnionitis; and if the 
diagnoses of clinical chorioamnionitis have features suggestive of histologic 
chorioamnionitis? 
Most studies suggest that there is a poor correlation between clinical and histologic 
chorioamnionitis. In cases with confirmed histological chorioamnionitis, there may 
be no signs or symptoms suggestive of clinical chorioamnionitis at all.125  
Studies have examined cases diagnosed with clinical chorioamnionitis to confirm the 
diagnosis histologically as well and also examined the effect of chorioamnionitis on 
neonates, neonatal sepsis at less than 7 days and found poor correlation between 
clinical and histologic chorioamnionitis and neonatal sepsis.126  Another large study 
involving 6,294 singleton deliveries, there was no histological evidence of 
chorioamnionitis in 38% cases diagnosed clinically as chorioamnionitis (3%). 
Neonatal sepsis was also found only in 36% of neonates without histologic evidence 
of chorioamnionitis as compared to the 60% of neonates with confirmed histologic 
chorioamnionitis.127  
Studies have also reported positive placental bacterial culture in absence of histologic 
chorioamnionitis128 while other studies could only isolate bacteria in 70% cases of 
histologic chorioamnionitis.129  
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Therefore histologic chorioamnionitis is considered more sensitive and specific and 
is a gold standard for the diagnosis of chorioamnionitis as compared to the clinical 
diagnosis.122 130 131 
For this study, following have been grouped together as “Ascending genital tract 
infection”. 
-Neutrophils in the fetal membranes- Chorioamnionitis 
-Neutrophils at the choriodecidual junction- Choriodecidual junction syndrome 
-Inflammation of umbilical cord- Funisitis 
-Neutrophils in subchorion fibrin 
- Subacute or chronic chorioamnionitis 
 
Chronic placental underperfusion 
We defined as villous changes small, hypovascular chorionic villi with increased 
syncytial knots, placental infarction >1cm (non-peripheral) and/or atherosis. 
Presences of any or all of the features were classified in this category. 
 
Intervillous Thrombus (IVT) 
These are localised, nodular and circumscribed, old or recent thrombi within the 
intervillous space. Some authors have described these lesions as intraplacental 
haematomas as well114 but others view was to consider these as thrombi only as the 
lesions are entirely within the part of vascular system, intervillous space.117 Incidence 
of IVT varies from 3-50% in full term uncomplicated pregnancies.132, 133 
Macroscopically, intervillous thrombus can look dark red or brown, greyish or 
whitish depending upon the age of the lesion, usually round or oval lesion.  
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Thrombus could be single or multiple thrombi anywhere within placenta, varying in 
size, from few mms up to many centimetres. While histologically, erythrocytes can 
be seen with fibrin strands in fresh thrombus representing mainly red blood cells, and 
as the thrombus degenerate, depending on the size, it can displace the intervillous 
space. Infarction of the surrounding villi can also be seen. 
IVT can also be revealed on antenatal ultrasound as echo-poor placental “cavities”.134 
Small thrombi are common and have no clinical significance on the placental function. 
Presence of fetal cells in the intervillous space and therefore in the maternal circulation 
is common especially in third trimester; it is estimated around 15-30% of women will 
have some degree of slow leakage of fetal cells into the maternal circulation.135 It 
becomes significant in cases with either extremely big or multiple intervillous thrombi 
causing significant fetomaternal haemorrhage. Significant fetomaternal haemorrhage 
will have its consequences such as fetal anaemia, hydrops, end organ damage and fetal 
death. 
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Villitis of unknown aetiology (VUE) 
 a       b 
 Figures 7.2 Microscopic view of VUE (a) low power (original magnification x 40) (b) high power   
(original magnification x 100) (study photographs). 
 
Presence of morphologically increased chronic inflammatory mononuclear cells and 
fibrinoid necrosis affecting groups of chorionic villi in absence of known clinical or 
histological aetiological factor/organisms (such as TORCH group, enterovirus, 
varicella, syphilis, syphilitic spirochetosis, and other bacterial and protozoal 
infections) is called as villitis of unknown etiology. 
Incidence of chronic Villitis varies in different studies; probably due to the different 
population studied and/or different histological criteria in different units. Ethnic, 
environmental and socio-economic factors play an important role in the incidence of 
Villitis of unknown etiology. Incidence reported in United Kingdom is 13.6%136, 
while it is 7% in United States137, 14.2% in New Zealand138 and 33.8% in 
Argentina.139 
VUE could be focal or diffuse or low grade (involving less than 10 villi) or high 
grade (involvement of more than 10 villi). High and low grade classification is 
clinically helpful as it correlates more specifically to the clinical complications e.g.  
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High grade villitis is associated with adverse neurologic outcome.140      
Macroscopically there may be no obvious features. 
In cases of severe villitis, placenta is often pale in colour and also has an irregular 
consolidation of the villous parenchyma. 
Histologically features of VUE vary widely. There could be focal or multiple lesions. 
Focal or low grade patterns are usually seen in clinically asymptomatic cases while 
microscopic findings suggestive of severe villitis usually represents clinically 
significant; e.g. IUGR, fetal demise and other clinical complications. Some 
pathologists suggest that diagnosis of chronic villitis should not be made based on a 
single focus of VUE involving less than 5 villi.141 Other histological features 
associated with villitis of unknown aetiology can be fetal villous thrombosis, 
haemorrhagic endovasculopathy, villous stromal sclerosis, Chorangiosis, decidual 
plasma cells, chronic chorioamnionitis, perivillous fibrin deposition and occasional 
presence of granulomatous focus with giant cells. 
VUE may not have any clinical effects, but if severe, increase the risk of recurrent 
reproductive failure142, IUGR, 138 143-144  perinatal asphyxia145 and adverse fetal 
neurological outcomes.140 
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Fetal thrombotic vasculopathy 
 
Figure 7.3 Microscopic view of fetal thrombotic vasculopathy (original magnification x 40) 
(study photograph). 
 
Fetal thrombotic vasculopathy is a placental lesion due to the disturbances of fetal 
blood flow where there is occlusion of the chorionic or major fetal villous stem 
artery by a thrombus, which cuts the vascular supply of the area, causing avascular 
villi and resulting into the macroscopically detectable lesions.  
Macroscopic appearance depends upon the age of the lesion. New lesions will be 
evident in the chorionic plate vessels. Vessels will be engorged; at times even the 
thrombi can be seen in the large vessels of chorionic plate. Once organised, lesion 
will be firm to palpate and later gets calcified and hard to touch.  Lesions in placental 
parenchyma are discrete firm and pale patchy regions.  
 It is very easy to confuse these lesions with infarction. These pale areas are easier to 
identify on a fixed specimen as compared to a fresh placenta.  
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Microscopically appearance will depend upon the age of the lesion; early lesion will 
be represented by presence of thrombus in the chorionic vessels, reactive endothelial 
swelling in parenchyma followed by endothelial disruption with erythrocyte 
extravasations. Older lesion will be evident as intramural fibrin thrombus, fibroblast 
growth, erythrocyte fragmentation and later calcification in chorionic vessels and 
parenchyma. 
Therefore fetal thrombotic vasculopathy is a thrombotic lesion in the fetal 
circulation; associated with hypercoagulable states and if extensive, can lead to high 
perinatal morbidity such as perinatal liver disease146-147,  Neonatal thrombosis and 
neonatal neurological abnormalities leading to neonatal stroke, seizures, chronic 
neurodevelopment deficits148-150, IUGR, oligohydramnios, perinatal asphyxia, 
hydrops fetalis  as well as neonatal mortality.  
 
In this study diagnosis of this histopathological condition is made with the presence 
of –Downstream changes and no thrombus 
      Thrombus but no downstream effects  
      Abnormal vessel architecture with fibrin, recanalisation with multiple channels. 
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Massive Perivillous Fibrin Deposition  
 
Figure 7.4 Microscopic view of massive perivillous fibrin deposition (original magnification x 
40) (study photograph). 
 
Massive perivillous fibrin deposition is an important clinical entity, which is poorly 
understood but has clinically significant impact on the current pregnancy as well as 
effects onto the future pregnancy, particularly with its recurrence tendency.  
Massive perivillous fibrin deposition (MPFD) is significant  deposition of fibrin 
material in the villous parenchyma, which is present as macroscopically extensive 
lesion, extending from basal to chorionic plate with trophoblast proliferation or 
involving more than 30% of the villous parenchyma.117 Some degree of fibrin in the 
intervillous space is seen normally in nearly all term placentas as a result of turbulent 
intervillous blood flow.117  This will not have any clinical significance and therefore 
are not pathological lesions. Authors have described it as significant if; its 
macroscopically large lesion and obviously extensive, extending from basal to 
chorionic plate with trophoblast proliferation or involving more than 30% of the 
villous parenchyma.117 Others have defined it as MPFD only if the full thickness of 
the placenta is involved with the fibrin deposition with at least 50% villi involved as 
seen at least on one slide.151Another study has defined massive perivillous fibrin 
deposition in their own way that they considered significant perivillous fibrin only 
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 where at least 20-30% of villi in the central basal part of placental parenchyma were 
entrapped in fibrin.143 
It is believed that fibrin deposition entrapping up to the 30% of the villi will have no 
detrimental effects onto the overall function of the placenta i.e. fetus growth and its 
oxygenation, therefore anything affecting over 30% of villi, theoretically should be 
called massive or extensive, which will have clinical effects and that is the amount 
Pathologists and Obstetricians should take as significant and should be called as 
“massive” fibrin deposition. 
In current study, we defined MPFD as perivillous fibrin extending from basal to 
chorionic plate with trophoblast proliferation. Placental pictures of these cases were 
then analysed macroscopically to ensure that at least 30% of total volume was 
involved in order to make the diagnosis. 
On gross examination massive perivillous fibrin deposition are visible as irregular 
strands and areas of pale, greyish/yellowish coloured indurations on cut sections and 
clearly demarcated by the surrounding normal placental tissue. Mostly fibrin 
deposition is seen in the peripheral areas of the placenta. However fibrin deposition 
can be centrally located in the placenta. If the fibrin is mainly involving the maternal 
floor as in maternal floor infarct, basal plate is thick, pale and fibrin deposition will 
be localised to basal plate. 
On histology, villi are entrapped within the fibrin material with eosinophilic 
infiltration and obliterate the intervillous space. Depending upon the severity and the 
duration of the fibrin deposition, syncytiotrophoblast and capillary endothelium of 
the affected villi undergo necrosis and completely disappear. Trophoblastic basement 
membrane is thickened. With progressive lesion, fibrosis of the stroma is seen and 
ultimately obliteration of the villous vessel is seen. In the process 
syncytiotrophoblast disappears but cytotrophoblastic cells proliferates and grow into 
the surrounding fibrin and such cells sometimes detach from the parent villus and 
appear as isolated cell mass in the fibrin. 
Clinical implications of massive MPFD has been observed in cases of miscarriages152, 
recurrent miscarriages153, pre term labour, IUGR151 154-156, IUFD.154-156  
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Chorangiosis   
 
Figure 7.5 Microscopic view of Chorangiosis (original magnification x 100) (study photograph). 
Defined as a vascular lesion where there is vascular hyperplasia of the chorionic villi , 
defined as the occurrence of 10 or more villi with 10 or more capillaries in 10 or 
lower power microscopic fields. 
 
Chorangioma  
 
Figure 7.6 Microscopic view of chorangioma (original magnification x 40) (study photograph). 
Chorangioma is defined as well circumscribed, nodular lesion composed of vascular 
channels, stromal cells and surrounded by trophoblasts. 
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Features of maternal pre-eclampsia 
Included cases with fully developed atherosis only. 
Chronic histiocytic intervillousitis  
 
Figure 7.7 Microscopic view of chronic histiocytic intervillousitis (original magnification x 100) 
(study photograph). 
Marked mononuclear inflammatory cell infiltrate with associated fibrin deposition in 
the intervillous space without associated villitis or chorioamnionitis.117 
Features of acute abruption   
 
Figure 7.8 Microscopic view of retroplacental haemorrhage (original magnification x 40) (study 
photograph). 
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Features of acute abruption include the presence of significant retroplacental 
haematoma or haemorrhage or clot with signs of compression of the basal plate and 
congestion. 
Table 7.1 summarises the diagnostic criteria for all predefined histological categories 
in the study. 
 
Table 7.1 summary of the diagnostic criteria for predefined histological categories. 
Diagnosis Diagnostic criteria 
Ascending genital tract 
infection 
Any combination of: neutrophils in the fetal membranes, accumulating at the 
choriodecidual junction or umbilical cord. 
Chronic placental 
underperfusion 
Small, hypovascular chorionic villi with increased syncytial knots, placental 
infarction >1cm (non-peripheral) and/or atherosis. 
Intervillous Thrombus Localised, nodular and circumscribed old or recent thrombi within the 
intervillous space. 
Villitis of unknown 
aetiology 
 
Morphologically increased chronic inflammatory cells affecting  groups of 
chorionic villi in the absence of known clinical or histological aetiological 
factor/organisms (such as TORCH group, enterovirus, varicella, syphilis, 
syphilitic spirochetosis, and other bacterial and protozoal infections) 
Fetal thrombotic 
vasculopathy 
Lesions of the placenta due to occlusion of the chorionic or major fetal villous 
stem artery by a thrombus, causing avascular distal villi 
Chorangiosis 
10 or more villi with 10 or more capillaries / villous cross section in 10 or lower 
power microscopic fields. 
Maternal Pre-eclampsia Included cases with fully developed atherosis only 
Massive perivillous 
fibrin deposition 
Significant deposition of perivillous fibrin involving more than 50% of  the 
villous parenchyma 
Chorangioma 
A well circumscribed, nodular lesion composed of vascular channels, stromal 
cells and surrounded by trophoblasts. 
Chronic histiocytic 
intervillositis 
Marked mononuclear histiocytic inflammatory cell infiltrate with associated 
fibrin deposition in the intervillous space without associated villitis or 
chorioamnionitis 
Acute abruption 
The presence of significant retroplacental haematoma or haemorrhage or clot 
with features of compression of the overlying parenchyma. 
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7.3 STATISTICAL ANALYSIS 
Prevalence of the predefined histological abnormalities was noted in the unselected 
population.  Comparison of incidence of common histological groups was performed 
between the groups non-affected and affected with PET, PIH, GDM and SGA, using 
chi square test. A p value of ≤ 0.05 was considered significant.  
Normality of distribution was checked for cord coiling index, centrality index and 
eccentricity index for the reference population, ascending genital tract infection, 
chronic placental underperfusion, intervillous thrombus and villitis of unknown 
aetiology groups, by analysing the spread of the distribution in each frequency 
histogram. As the variables coiling index, cord centrality index and eccentricity 
showed an approximate normal distribution, a parametric test (T-test) was performed 
to compare the means of affected with non-affected cases. A p value of <0.05 was 
considered significant. 
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7.4 RESULTS 
Table 7.2 describes the baseline maternal demographics of the study population 
including the common obstetric outcome groups in the population.  
N 1159 
Maternal Age ± SD 30.9 ± 5.73 
% Nulliparity (n) 47.6 (552) 
% Smokers (n) 9.3 (108) 
% Caucasians (n) 90.7 (1051) 
% PET (n) 2.5 (29) 
% PIH (n) 2.6 (30) 
% Essential Hypertension (n) 0.4 (5) 
% GDM (n) 4 (46) 
% IDDM (n) 0.3 (3) 
% SGA <10 Centile (n) 9.4 (109) 
Mean gestation age at delivery ± SD 39.5 ± 1.49 
% Female (n) 46.7 (541) 
% Male (n) 53.3 (618) 
 
Table 7.2 Demographics of the reference population. 
The placenta and umbilical cord morphology in unselected population is described in 
chapter 4. Briefly; table 7.3 describes the statistics of the major macroscopic indices 
analysed in the study. Manual measurements were available for 1141 cases and 
digital for 888 cases. 
 N Mean (range) ± SD 
Coiling Index 1141 0.20 (0-1) ± 0.10 
Cord Centrality Index 888 0.36 (0.02-1.01) ± 0.21 
Eccentricity 888 0.49 (0-0.91) ± 0.18 
 
Table 7.3 Major morphological indices in the reference population. 
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Histology analysis was performed in 1125 cases, as in 34 placentas of the study, 
histology results were not available. Table 7.4 outlines the incidence of all 
histological lesions in different clinical outcome groups as well as in all unselected 
reference population. The majority of placentas (72.4%), as expected, did not show 
any histological abnormality in reference population.  However; almost 30% 
placental histology revealed histological abnormalities.  
 
 
 
Predefined histological features 
Reference 
Population  
% 
(n=1125) 
PET 
% 
(n=24) 
PIH 
% 
(n=27) 
GDM 
% 
(n=45) 
SGA 
% 
(n=107) 
Normal histology 72.4(814) 79.1(19) 66.6(18) 80(36) 74.8(80) 
Ascending genital tract infection 10.9(123) 8.3(2) 11.1(3) 4.4(2) 10.3(11) 
Chronic placental underperfusion 7.2(81) 4.2(1) 14.8(4) 2.2(1) 9.3(9) 
Intervillous thrombus 4.7(53) 8.3(2) 3.7(1) 6.8(3) - 
Villitis of unknown aetiology 3.7(42) - 11.1(3) - 3.7(4) 
Fetal Thrombotic Vasculopathy 1.0(11) - - 2.2(1) 0.9(1) 
Chorangiosis 0.8(9) - - 2.2(1) - 
Maternal Pre-eclampsia 0.6(7) - - 2.2(1) 0.9(1) 
Massive perivillous fibrin 
deposition 
0.4(5) 4.2(1) - - 1.9(2) 
Chorangioma 0.4(4) 4.2(1) - - 0.9(1) 
Chronic Histiocytic 
Intervillousitis 
0.3(3) - - - 0.9(1) 
Acute Abruption 0.1(1) - - - - 
 
*Total % is >100%, as some placentas had more than 1 histological lesion and each histological lesion 
has been counted separately. P >0.05 in all the groups 
Table 7.4 Incidence of predefined histological lesions in reference population and common 
obstetric outcome groups. 
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Amongst common obstetric outcome groups of PET, PIH, GDM and SGA, the 
normal histology was revealed in 79.1%, 66.6%, 80% and 74.8% respectively.  
 
Coiling index of normal histology cases (n=806) was statistically significantly lower 
compared to cases with abnormal histology (n=308, p=0.02). Coiling index of those 
with ascending genital tract infection and chronic placental underperfusion were not 
significantly different whilst cases with intervillous thrombus and villitis of unknown 
aetiology, showed more coiling compared to non-affected cases (p=0.024 and 0.009 
respectively).  
 
Cord centrality index-There was no significant difference noted in case of centrality 
index between any of the groups  
 
Eccentricity- There was no difference noted in the values of eccentricity between 
any groups. 
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Table 7.5 describes the comparative morphological indices in the reference 
population and in the most common histological lesions of the study versus non-
affected cases in each category. 
 
 
Coiling 
Index (SD) 
p value 
(comparison 
with non-
affected cases) 
Centrality 
Index (SD) 
 
p value 
(comparison 
with non-
affected cases) 
Eccentricity  
(SD) 
p value 
(comparison 
with non-
affected cases) 
Reference 
population 
0.20±0.10 
(n=1141) 
NA 
0.36±0.21 
(n=888) 
NA 
0.49±0.18 
(n=888) 
NA 
Normal histology 
0.20±0.10 
(n=806) 
NA 
0.36±0.21 
(n=615) 
NA 
0.48±0.18 
(n=615) 
NA 
Ascending genital 
tract infection 
0.20±0.09 
(n=122) 
NS 
0.37±0.23 
(n=98) 
NS 
0.52±0.17 
(n=98) 
0.07 
Chronic placental 
underperfusion 
0.21±0.11 
(n=80) 
NS 
0.32±0.21 
(n=68) 
NS 
0.48±0.19 
(n=68)) 
NS 
IVT 
0.23±0.10 
(n=53) 
0.02 
0.34±0.20 
(n=33) 
NS 
0.54± 0.16 
(n=33) 
0.08 
VUE 
0.24±0.10 
(n=39) 
0.009 
0.35±0.23 
(n=33) 
NS 
0.47±0.15 
(n=33) 
NS 
 
Table 7.5 Comparative analysis of the morphological indices of the placenta in reference 
population and abnormal histology groups.   
NA-Not applicable               NS-Non significant. 
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7.5 DISCUSSION 
This chapter has described the pattern of histology in common obstetric outcome 
groups and unselected population. Strict criteria were followed for the diagnosis of 
histological abnormalities. Incidence of various histological pathologies varies 
widely in literature; one of the reasons being lack of standard definitions for these 
lesions and every researcher has defined the lesions with their definitions and 
therefore literature lacks uniformity on the subject. 
There have always been a debate whether the detailed examination of every placenta  
by the pathologists should be a routine component of obstetric-neonatal care; group 
in favour of this option believe that this helps identifying placental pathology 
especially in cases of adverse perinatal outcome, which further helps in the 
management of the pregnancy and more so for the future pregnancy 18, however, the 
histological examination and perinatal outcome in most pregnancies is normal, for 
example in the current study, the frequency of histologically normal examination was 
observed in over 70% of cases. Therefore this decision should be left on to the 
individual unit to decide their own protocol of routine examination of each placenta 
by the pathologists, based on their manpower and financial resources. 
For the diagnosis of chorioamnionitis, clinical picture is not a reliable tool and it has 
been proven by many studies that histological diagnosis of chorioamnionitis is a gold 
standard. In the current study interestingly there were no cases of clinically 
diagnosed chorioamnionitis or any other antenatal sepsis and yet there were 
significant number (123-10.9%) of cases of ascending genital tract infection. That 
further enforces that there is very poor correlation between clinical and histological 
infection. However, the limitation of this study is that the information for clinical 
suspension of chorioamnionitis was collected only from the protos database of the 
department, not a note trawl. We don‟t have separate data on clinical markers such as 
WCC, CRP, prolonged rupture of membranes, use of antibiotics in labour. 
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Incidence of Inter villous thrombus in this study was 4.7% in unselected pregnancies, 
while literature has reported incidence varying from 3-50% in full term 
uncomplicated pregnancies.132-133 This wide variation in the incidence may well 
again be due to the lack of standard definition and protocols as well as the population 
studied. 
Villitis of unknown etiology is another major histopathological entity with high 
degree of inter-observer variation.157 As there is no standard criteria for its diagnosis, 
which makes it even more difficult to understand. It is important to understand VUE 
in a better way, as it has been associated with IUGR and with its tendency of 
recurrence in the following pregnancy and that too with increasing severity. 
Incidence of VUE in this study was much lower (3.7%), this is even lower than the 
incidence noted in one of the historic study with British population (13.6%)136  
The incidence of fetal thrombotic vasculopathy in the current study was only 1% of 
all the histology cases, which was significantly lower than reported in other series.150 
158   
Incidence of massive perivillous fibrin deposition is relatively low, quoted as low as 
0.028%155 to 0.09%.154  Incidence of MPFD was very low to draw any meaningful 
conclusion. However it is important to understand as it has important clinical effects 
and also has a recurrence rate of 10-50% in subsequent pregnancies.151 155  
It has not been clear if the histological lesions present in the placentas from obstetric 
outcome groups are any different from the rest of the unselected population. Many 
histological lesions are documented in pregnancies with these obstetric outcome 
groups but most, if not all of them, are not specific to any of the outcome group of 
the pregnancy. 
This chapter aimed to identify if the frequency and type of predefined histological 
lesions observed in placentas from the common obstetric outcome group are any 
different from unselected reference population.  
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Pre-eclampsia/Pregnancy induced hypertension 
The macroscopic and histological changes in the placenta from cases with PET and 
PIH may be characteristic but may not be there even in severely affected cases.  
Frequency of ascending genital tract infection features in PIH, were similar to that 
found in a recent study159, however the frequency of IVT (3.7% versus 18.9%) and 
Chorangiosis (0% versus 10.9%) was much less than observed in the similar study. A 
slightly higher proportion of IVT cases were observed in pre-eclampsia (8.3%).  
Features suggestive of chronic placental underperfusion were also important feature 
noted in cases of both pre-eclampsia (4.2%) as well as PIH (14.8%).  
Villitis of unknown aetiology is one of the most common histological lesions 
identified in term placentas and is associated with adverse perinatal outcome 
especially with IUGR143-144. The incidence of VUE has been reported in up to 17% in 
term cases of pre-eclampsia160, though we did not observe any cases of VUE in pre-
eclampsia subset, however VUE was noted in 11.1% cases of pregnancy induced 
hypertension. Whether it has anything to do with the pathophysiology in PIH or not, 
probably needs further exploration. This difference could either be due to the high 
degree of inter-observer variation or due to the population studied. Most studies have 
been based on the adverse outcome of the pregnancy.   
Retroplacental haematoma can be seen in up to 12-15% cases of pre-eclampsia but 
we did not notice any case in our series.  Pre-eclampsia is a hypercoagulable state, 
where there is intravascular coagulation and micro thrombosis affecting multiple 
organs. Utero-placental impairment occurs in cases of pre-eclampsia. There is 
increased antifibrinolytic activity in hypertensive disorders of pregnancy. Total effect 
of increased hypercoagulation and antifibrinolytic activity is believed to contribute 
toward the increased deposition of fibrin. Therefore one might expect to see 
significant perivillous fibrin deposition with all the cases of severe pre-eclampsia but 
that doesn‟t seems to be the case. Only a few studies have shown this association161 
while most authors did not find this finding any different from normal population.  
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In the current series, only one case of MPFD (4.2%) was found in PET but none in 
PIH. There were no cases of fetal thrombotic vasculopathy in either pre-eclampsia or 
PIH, although some studies have documented its incidence in term pre-eclampsia as 
5%.160 
 Gestational Diabetes Mellitus  
It is thought that the histological features in gestational diabetes are similar to those 
of pre existing diabetes, however less pronounced and reduced in frequency in cases 
of GDM as compared to that of overt diabetes.162 163 The pathological findings of the 
placenta do not predict the severity of the disease, neither relate to the duration of the 
disease especially with pre existing diabetes.163  Placentas from diabetic pregnancies 
show increased incidence of vascular pathological changes. Chorangiosis is an 
example of such findings, reported to be 40% in GDM. 164 This study examined the 
histological lesions specifically in placentas from known diabetic group while our 
study has quoted the incidence in an unselected population. The incidence of fetal 
thrombotic vasculopathy was noted in GDM subset as 2.2%, again indicating the  
hypercoagulable state in diabetes.  
 
Small for Gestational Age 
Histological lesions found in SGA were features of ascending genital tract infection 
(10.3%), chronic placental underperfusion (9.3%), VUE (3.7%), features of maternal 
pre-eclampsia (0.9%), MPFD (1.9%), Chorangioma (0.9%), fetal thrombotic 
vasculopathy (0.9%) and chronic histiocytic intervillousitis (0.9%).  These are the 
expected histological features secondary to the maternal vascular compromise 
leading to placental ischemia, which one would expect in cases of IUGR. A recent 
study found the most common histological lesions in IUGR (birth weight<10 th 
percentile clinically) was Chorangiosis (39%)160, however this study did not show 
any case of Chorangiosis in SGA group.  
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Comparing the histological lesions in the above obstetric outcome groups to that of 
the unselected reference group, results were as follows- 
Most placentas, as expected, showed normal histology in PET (79.1%), PIH (66.6%), 
GDM (80%) and SGA (74.8 %). These results were not different from the non-
affected cases and unselected reference population (72.4%). There was no difference 
in the frequency of ascending genital tract infection in the common obstetric 
outcome groups as compared to the unselected population.  
In the current study there were no IVT observed in SGA, while in cases with PET, 
PIH and GDM, difference was not significant.  
Reports on the frequency of villitis of unknown aetiology in cases of pre-eclampsia 
and other hypertensive disorders of pregnancy compared to the normotensive 
pregnancies have been mixed; some studies found the incidence higher 165-166, while 
others did not find any difference.167  Frequency of VUE was higher (11.1%) in cases 
with PIH but interestingly there were no cases observed in PET.  
Small for gestational age group placentas also showed similar frequency of VUE (3.7 
%) to that of unselected reference population (3.7%). 
The other abnormal histology cases were observed in very small number to perform 
any meaningful comparison to the reference population 
In summary most cases of placentas from unselected population and even common 
obstetric outcome groups are histologically normal. There was no significant 
difference in the frequency of the predefined histological lesions in obstetric outcome 
groups as compared to that of the reference population. In the common obstetric 
outcome groups, histological examination may be normal even in the presence of a 
severe disease.   
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Further, this chapter also reports a statistically significant, but small, difference in the 
cord coiling index in cases with normal compared to abnormal histology (p=0.02), in 
particular, cases with IVT and VUE show relative hypercoiling. The clinical 
significance of this finding remains uncertain and it is difficult to postulate a 
plausible mechanism whereby both of these unrelated histological features are 
related to cord coiling.          
There was no difference in cord centrality index and eccentricity between the 
common histological groups. We therefore propose that cord centrality and placental 
shape have no significant effect on these histological lesions. 
Certain common histological lesions are possibly associated with increased umbilical 
cord coiling but placental macroscopic features such as shape, and cord insertion 
have no association with histological abnormalities.  
Macroscopic abnormalities of placental shape and cord insertion cannot predict the 
presence or absence of histological features and are of limited clinical significance.  
Most histological abnormalities are either studied in uncomplicated pregnancies or in 
complicated pregnancies but in best of my knowledge, no one has presented the 
baseline histologic profile in unselected reference population. This reference range of 
histological conditions can be used as a baseline for future studies based on the same 
principals. 
 
 
 
 
 
 
 
  
CHAPTER 8 : MORPHOLOGY AND HISTOLOGY OF THE 
PLACENTA IN INFANTS ADMITTED TO THE NEONATAL 
UNIT COMPARED TO UNSELECTED PREGNANCIES. 
 
Summary Points: 
 This study described the placental morphological indices and incidence of 
predefined histological lesions in cases where infants were admitted to the 
Neonatal Unit. 
 Morphological indices were not different in the placentas from infants 
admitted to the Neonatal Unit. 
 Histological features of ascending genital tract infection were more frequent 
in the placentas from infants admitted to the Neonatal Unit.  
 There was no difference in the incidence of all other predefined histological 
lesions of the placenta in infants admitted to the Neonatal Unit. 
 
 
This chapter is based on: 
Pathak S, Sebire NJ, Jessop F, Hackett G, Murdoch E, Hook E, Lees C. Macroscopic and 
Histological Features of Placentas at 34-43 weeks‟ Gestation and their association 
with infant admission to the Neonatal Unit- submitted as short communication, 
BJOG. April 2011.  
Pathak S, Sebire NJ, Jessop F, Hackett G, Murdoch E, Hook E, Lees C. Placental 
morphological and histological features: relevance to fetal distress. Paper in 
preparation. 
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8.1 INTRODUCTON 
Examination of the placenta may be useful investigation to the clinician to determine 
the underlying mechanism which has possibly resulted in perinatal morbidity and 
even mortality. If any placental or umbilical cord lesion is found, it could guide the 
clinicians for the future pregnancy in terms of further investigations required, pre-
pregnancy counselling and care for the future pregnancy.168-169 
Despite growing interest in the morphology and histology of placentas, no large 
studies exist, which have specifically investigated placental features in infants 
particularly those admitted to the Neonatal Unit. Therefore it is not clear if the 
placenta from infants who were admitted to the Neonatal Unit is any different from 
that of the reference population.  
Guidelines suggest that placentas from pre tem deliveries and adverse perinatal 
outcome should be sent for the detailed histological examination.16-17  However, it is 
not clear whether these placental examinations can predict specific neonatal 
complications, or provides information useful for the management of the admitted 
neonates. 
This chapter aimed to define the macroscopic indices and frequency of histological 
lesions in the admitted cohort and compare those to that of the non admitted group. 
Therefore we aimed to address the question as to whether it is important to perform 
detailed macroscopic examination and histology of the placentas for all neonates 
admitted to the Neonatal intensive care unit. 
 
 
 
 
 
 
 
   CHAPTER 8: PLACENTA IN INFANTS ADMITTED TO THE NEONATAL UNIT 
 
Page | 136  
 
 
8.2 METHODS 
For this study, cohorts of neonates admitted in the Neonatal Unit from the 
prospectively recruited cohort of 1159 women (chapter 2) have been studied. 
Neonates were admitted either directly from delivery unit or from the post natal  
wards, while the women were still admitted in the unit after delivery. 71 neonates 
were admitted to the Neonatal Unit in Rosie Hospital, Cambridge during the study 
period 2007-2008. 
Placentas from those neonates admitted to the Neonatal Unit (includes 
NICU+SCBU) is referred to as “admitted cohort”, while the remainder of the 
population is referred to as “non admitted cohort”. The reference or unselected 
population included both admitted as well as non admitted groups.  
 
Manual Measurements  
Recorded variables from umbilical cord examinations included Umbilical cord 
length, number of coiling, direction of coiling, number of vessels and the insertion of 
umbilical cord onto the chorionic plate.  
Manual measurements and the indices derived from them were placental weight, 
length of axes of placenta, cord coiling index, placental circumference. 
Manual measurements were available in 68 cases of infants admitted to the Neonatal 
Unit. 
 
Digital measurements 
Digital analysis of the placenta is described in chapter 2. Measurements and indices 
derived digitally were length of axes of placenta, distance of cord insertion from the 
centre, cord centrality index, eccentricity, and placental circumference. 
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Digital measurements were available in 51 cases of neonates admitted to the 
Neonatal Unit. 
Main macroscopic indices studied in admitted cohort and compared to that of 
reference population are coiling index, cord centrality index and eccentricity. 
Derivation of these indices is described in chapter 2. 
 
Histology of the placenta 
Predefined histological lesions were examined; the criteria and definitions of these 
histological lesions are detailed in chapter 7. Briefly; the histological categories 
were, no significant histological abnormality, features of ascending genital tract 
infection, features of chronic placental underperfusion, intervillous thrombus, villitis 
of unknown aetiology, fetal thrombotic vasculopathy, Chorangiosis, features of 
maternal pre-eclampsia, massive perivillous fibrin deposition, chorangioma, chronic 
histiocytic intervillousitis, and features of acute abruption.   
Out of 71 placentas from infants admitted to the Neonatal Unit, 4 histological 
examinations findings were not available, therefore histology for 67 placentas were 
analysed and compared to the 1058 placentas from non admitted cohort. The 
frequency of each lesion was individually assessed in the admitted cohort and 
compared to the same lesion present in non admitted group.  
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8.3 STATISTICAL ANALYSIS 
Descriptive statistics of manual and digital measurements of the umbilical cord and 
placenta was performed. Frequency histograms were plotted for coiling index, cord 
centrality index and eccentricity, showing normal distribution. Normality was also 
confirmed with Q-Q plots to see the difference between observed and expected 
values of each variable. 
Though the macroscopic variables showed normal distribution, still due to the 
smaller sample size, we used a non parametric test; the Mann Whitney U test to 
compare the difference of means (medians) of coiling index, centrality index and 
eccentricity to that of rest of the non admitted population. A p value of ≤ 0.05 was 
considered significant. 
Histological lesions were defined in cases, where infants were admitted to the 
Neonatal Unit and the frequency of each histological lesion was compared to that of 
the non admitted cohort. 
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8.4 RESULTS 
Table 8.1 describes maternal and fetal characteristics for those babies admitted to the 
Neonatal Unit. The obstetric outcome groups considered were pre-eclampsia, 
pregnancy induced hypertension, gestational diabetes and small for gestational age.  
 
Mean (range) ± SD                                
or                                                             
% (n) 
Neonates admitted to 
Neonatal Unit (n=71) 
Non admitted 
(n=1088) 
Maternal age  31 ± 5.64 30.8 ± 5.74 
% Caucasian (n) 91.4 (64) 90.7 (987) 
% nulliparity (n) 54.9 (39) 47.2 (513) 
% Smokers >5  cigarettes per day (n) 12.7 (9) 9.1 (99) 
% Pre-eclampsia (n) 8.5 (6) 2.1 (23) 
% Pregnancy induced hypertension (n) 1.4 (1) 2.7 (29) 
% GDM (n) 5.6 (4) 3.9 (42) 
% SGA (n) 19.7 (14) 8.7 (95) 
% Induced onset of labour (n) 26.8 (19) 19 (207) 
% Emergency Caesarean Section (n) 21.1 (15) 10.9 (119) 
Mean gestation at delivery (Weeks) 38.3 ± 2.78 39.5 ± 1.33 
Birth weight  3192 ± 812 3498 ± 479 
% Males (n) 47.9 (34) 53.7 (584) 
% Females (n) 52.1 (37) 46.3 (504) 
% Neonates requiring immediate 
resuscitation (n) 
31 (22) 1.5 (16) 
 
Table 8.1 Demographic population of infants admitted to the Neonatal Unit. 
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22 neonates (31%) required resuscitation immediately after they were born. 4 (5.6%) 
of the neonates were resuscitated with facial oxygen and stimulus only, while 13 
(18.3%) required face mask ventilation, 4 neonates (5.6%) were intubated and 1 
needed cardiac massage. Table 9.2 describes the measurements of placenta and 
umbilical cord taken manually and digitally and the indices derived from these. 
 
Manual (n=68) Mean  ± 
SD 
 Digital (n=51) Mean ± SD 
Cord length 40.40 ± 14.19   
Cord coils 8.09 ± .59 
Distance of cord 
insertion from centre 
3.24 ± 1.87 
Coiling index 0.20 ± 0.09 Cord centrality index 0.35 ± 0.21 
Placenta weight 478 ± 116 Eccentricity 0.50 ± 0.16 
Long axis 20.37 ± 2.70 Long axis 18.91 ± 2.46 
Short axis 17.22 ± 2.63 Short axis 15.88 ±1.74 
Circumference 59.01 ± 7.38 Circumference 54.61 ± 5.84 
 
Table 8.2 Manual and digital measurements of placenta and cord and in infants admitted to the 
Neonatal Unit. 
 
Table 8.3 describes qualitatively different types of umbilical cord insertion onto the 
chorionic plate. Frequency of each type of insertion was compared to that of the non 
admitted neonatal and unselected population. Of the clinical importance: marginal 
and velamentous cord insertion were not any different in admitted cohort compared 
to that of non admitted cohort (Marginal-7 versus 6.3%, velamentous-1 versus 0.6%). 
 
 
 
 
   CHAPTER 8: PLACENTA IN INFANTS ADMITTED TO THE NEONATAL UNIT 
 
Page | 141  
 
 
 
Admitted group%  
(n=71) 
Non admitted% 
(n=1088) 
Ref Population% 
(n=1159) 
Central 23.9 22.6 22.7 
Paracentral 56.3 61 60.4 
Marginal 9.9 6.3 7.0 
Velamentous 1.4 0.6 0.6 
Missing 8.5 9.4 9.3 
 
Table 8.3 Qualitatively described cord insertions in infants admitted, non admitted to the 
Neonatal Unit and reference population. 
 
Table 8.4 compares the macroscopic indices in the Neonatal Unit admitted cohort 
versus non admitted group. 
 
Admitted to 
Neonatal Unit 
n Mean ± SD p value 
 
Coiling Index 
Yes 68 0.20 ± .09  
NS  No 1073 0.20 ± .10 
Cord Centrality Index 
Yes 51 0.35 ± .21  
NS  No 837 0.36 ± .21 
 
Eccentricity 
Yes 51 0.50 ± .16  
NS No 837 0.49 ± .18 
 
*NS-Non Significant 
Table 8.4 Morphological indices in the infants admitted versus not admitted to the Neonatal 
Unit. 
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78.9% of cords showed left coiling, similar to the reference population (77.9%). 
Cord coiling index ranged from a minimum value of 0.00 to a maximum of 0.50 with 
a mean value of 0.20 ± 0.09. Frequency histograms and Q-Q plot revealed an 
approximate normal distribution for coiling index. Figure 8.1 shows the frequency 
histogram of coiling index in admitted cohort. A Mann-Whitney U test revealed no 
significant difference in the coiling index for admitted (n=68, mean=0.20, 
median=0.18) versus non admitted group (n=1073, mean=0.20, median=0.19) with 2 
tailed p value of 0.82. 
The Cord centrality index ranged from 0.05 to 0.9 with the mean of 0.35 ± 0.21. 
Frequency histograms and Q-Q plot of cord centrality index indicated an 
approximate normal distribution. Figure 8.1 shows the frequency histograms of cord 
centrality index in the admitted group. A Mann-Whitney U test revealed no 
significant difference in the cord centrality index for admitted cohort (n= 51, 
mean=0.35, median=0.31) versus non admitted cohort (n=837, mean=0.36, 
median=0.32) with 2 tailed p value of 0.67.   
The placental eccentricity index ranged from 0.00 (circular shape) to 0.79 (Highly 
elliptical shape) with a mean value of 0.50 ± 0.16. The frequency histograms and Q-
Q plot indicated a normal distribution. Figure 8.1 shows the frequency histograms of 
eccentricity in admitted group. A Mann-Whitney U test revealed no significant 
difference in the eccentricity of admitted cohort (n=51, mean=0.50, median=0.51) 
versus non admitted group (n=837, mean=0.49, median=0.51) with p value of 0.61.  
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  a 
  b 
  c 
Figure 8.1 (a-c) Frequency histograms of morphological indices in infants admitted to the 
Neonatal Unit.
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Table 8.5 illustrates the frequency of predefined abnormal histology in placentas of 
admitted infants and compared to the non admitted population. 65.7% cases of 
placentas from admitted cohort showed normal histology of placenta, which was 
slightly less than that of non admitted population (72.8%). Features of ascending 
genital tract infection were more frequent in admitted infants (17.9%) as compared to 
the non admitted group (17.9% versus 10.5%, p=0.04) but the frequency of other 
lesions was not significantly different between the groups. There was no significant 
difference in the incidence of chronic placental underperfusion (6 vs 7.3%), 
intervillous thrombus (6% versus 4.6%), fetal thrombotic vasculopathy (1.5 versus 
0.9%) and VUE (4.5% vs 3.7%). Chorangiosis was noted only in 1 case of admitted 
group. There were no cases of MPFD, chorangioma, chronic histiocytic 
intervillousitis, and acute abruption observed in the admitted neonate‟s placentas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   CHAPTER 8: PLACENTA IN INFANTS ADMITTED TO THE NEONATAL UNIT 
 
Page | 145  
 
 
Histological features 
%Infants admitted to 
NICU (n=67)* 
%Non-admitted 
group (n=1058)* 
%Reference 
population  
(n=1125)* 
Normal histology 65.7 (44) 72.8 (770) 72.4 (814) 
Ascending genital tract 
infection 
17.9 (12) 10.5 (111) 10.9 (123) 
Chronic placental 
underperfusion 
6 (4) 7.3 (77) 7.2 (81) 
Intervillous thrombus 6 (4) 4.6 (49) 4.7 (53) 
Villitis of unknown aetiology 4.5 (3) 3.7 (39) 3.7 (42) 
Fetal thrombotic vasculopathy 1.5 (1) 0.9 (10) 1.0 (11) 
Chorangiosis 1.5 (1) 0.8 (8) 0.8 (9) 
Maternal Pre-eclampsia - 0.7 (7) 0.6 (7) 
Massive perivillous fibrin 
deposition 
- 0.5 (5) 0.4 (5) 
Chorangioma - 0.4 (4) 0.4 (4) 
Chronic histiocytic 
intervillousitis 
- 0.3 (3) 0.3 (3) 
Acute abruption - 0.1 (1) 0.1 (1) 
 
*Total number is > n (>100%), as some placentas had more than 1 histological lesion and each 
histological lesion has been counted separately. 
Table 8.5 Incidence of predefined histological categories in admitted, non-admitted and 
reference population. 
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8.5 DISCUSSSION 
The studies detailed in this chapter to evaluate whether there was any difference in 
placental morphologic and histologic characteristics in neonates admitted to the  
Neonatal Unit as compared to those where neonates were not admitted to the  
Neonatal Unit.  
Several studies have emerged in recent years on umbilical cord coiling index in 
normal as well as in complicated pregnancies and these studies have made an attempt 
to link cord coiling to the pregnancy outcome.5-8 52 However, there still remains the 
uncertainty as regards the significance of abnormal cord coiling. In this study 
umbilical cord coiling and the coiling index did not show any significant difference 
in the admitted group as opposed to that of the non-admitted group (0.20 versus 0.20, 
p=0.82). 
Abnormal cord insertion (in particular marginal and velamentous) has been linked to 
the adverse perinatal outcome. To avoid subjective bias, results of this study were 
based on quantitative analysis of cord insertion, using the index; cord centrality 
index, indicating how far the cord insertion was from the centre or the chorionic plate 
margin. In this study there was no significant different between the cord centrality 
index of admitted versus non admitted group (0.35 versus 0.36, p= 0.67) 
The placental surface area has been linked to the development of hypertension in 
later life.93 Few studies have even analysed the chorionic plate shape quantitatively. 10 
In the current study, there was no difference in the quantitatively defined placental 
shape, eccentricity index in the admitted group to that of non admitted group (0.50 
versus 0.49, p=0.61) 
 Therefore all macroscopic indices, coiling index, centrality and eccentricity index 
showed no difference in two groups. 34.3% of newborns admitted to the Neonatal 
Unit showed abnormal histology of the placentas compared to 27.6% of those not 
admitted.  
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Amongst the histological categories, the incidence of ascending genital tract 
infection was significantly greater in admitted group as compared to the non 
admitted group (17.9% versus 10.5%, p=0.04). Apart from an excess of histological 
evidence of ascending genital tract infection, there were also no significant 
differences in other placental histological findings between these groups. This is not 
entirely surprising; half of the infants admitted to the Neonatal Unit were for 
indications such as grunting/mild respiratory distress, hypoglycaemia and poor 
feeding. These clinical observations are almost always unrelated to fetal pathology, 
hence would not be expected to be associated with placental abnormalities.  
To summarise, this study did not find any major morphological or histological 
differences in the examination of the placentas of Neonates admitted to the Neonatal 
Unit. Therefore we would not support the recommendation that every placenta from 
the admitted cases should have a detailed pathological examina tion in term or near 
term cases, however medico-legal aspect of these cases cannot be ignored where it 
may well be one of the legal requirements to have thorough examination of the 
placenta.  
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 9 : CLINICAL OUTCOMES IN RELATION TO 
PLACENTAL HISTOLOGY 
 
 
 
 
Summary Points: 
 This study describes pregnancy and neonatal outcome in cases with abnormal 
placental histology. 
 Specific clinical outcomes are compared. 
 The key findings were that there was no difference in the clinical outcome 
between the histological groups. 
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9.1 INTRODUCTION 
In the previous chapter (chapter 8), gross and histological characteristics of placenta 
in infants admitted to the Neonatal unit were compared to those placenta where 
infants were not admitted to the Neonatal unit. In this chapter a different relationship 
is explored i.e. whether abnormal histology of the placenta has any bearing on the 
clinical and neonatal outcome?  This area is dominated with many controversies, 
partly due to the relatively deficit in communication between the pathologist and 
obstetricians and also due to high degree of inter-observer variability among 
pathologists in defining histological groups. 
The placental pathology has been associated with adverse neonatal outcome 
especially neurodevelopment outcome, even in normally grown term infants.140 170 
For example; chorioamnionitis has been linked to the cerebral palsy as its one of the 
major predisposing factor, only about 10% cases of cerebral palsy have been 
attributed to intra partum events, the majority of the cases thought to be linked to 
events earlier on in the pregnancy.  
Placental injury or abnormal histology may be present in the form of intra uterine 
growth restriction, abnormal fetal weight, and low birth weight placenta weight ratio 
during antenatal and neonatal period. 
The aim of the studies in this chapter was to identify specific pregnancy and neonatal 
outcome in the most common placental histological categories observed in the 
study). This compared the pregnancy and neonatal outcome in all abnormal histology 
cases to that of normal histology cases.  Clinical outcome were examined in most 
common placenta pathology categories of: ascending genital tract infection, chronic 
placental underperfusion, intervillous thrombus, villitis of unknown aetiology and 
fetal thrombotic vasculopathy.  
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9.2 METHODS 
As previously described (chapter 2 &7), of 1159 cases, histology was available in 
1125 cases. Abnormal placenta histology was noted in 313 cases while remaining 
812 cases showed normal placenta histology. Individual placenta pathology was 
noted in 313 pathology cases. How these pathological categories are defined, is 
explained in chapter 7.  
For this chapter specifically following information were observed. 
Maternal factors recorded were maternal age, parity, gestational age, incidence of 
common obstetric outcome pregnancies, onset of labour, CTG abnormalities, mode 
of delivery especially incidence of emergency caesarean sections.  
Neonatal factors recorded were neonatal outcome, birth weight, gender of the 
neonate, number of admissions to the neonatal unit, Apgar score and cord blood pH 
(arterial and venous with base excess). Neonates requiring resuscitation was also 
observed. Neonates, admitted to the neonatal unit, were observed for number of 
admission days in the neonatal and especial care unit, findings of cranial ultrasound, 
presence of hydrocephalus, seizures, retinopathy of prematurity, necrotising 
enterocolitis, patent ductus arteriosus, thrombocytopenia, anaemia, infection proven 
by laboratory findings, any evidence of renal impairment and finally if the baby was 
discharged home or transferred out to another unit for longer stay in the Hospital.  
 
9.3 STATISTICS 
Data from all abnormal placental histology cases was compared to the data from 
normal histology.  Individual placental pathology cases were also compared to that of 
the normal histology. To explore the relationship between two categorical variables, 
Chi-square test for independence was used. Means were compared of the continuous 
variables using t-test. 2 tailed significance value ≤ 0.05 was used as statistically 
significant. Numerical variables were expressed as mean ± SD.  
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9.4 RESULTS 
Out of total 1159 histology cases, data was available for 1125 cases. Normal 
histology was observed in a majority of cases 812cases (72.2%), while 313 cases 
(27.8%) showed abnormal placenta histology.  
Table 9.1 represents the predefined histologic categories in cases with abnormal 
placenta histology.  
 
Abnormal histology % (n-313)* 
Ascending genital tract infection 39.3 (123) 
Chronic placental underperfusion 25.9 (81) 
IVT 16.9 (53) 
VUE 13.4 (42) 
Fetal thrombotic vasculopathy 3.5 (11) 
Chorangiosis 2.9 (9) 
Maternal PET 2.2 (7) 
MPFD 1.6 (5) 
Chorangioma 1.3 (4) 
Chronic histiocytic intervillousitis 0.9 (3) 
Acute abruption 0.3 (1) 
 
*Total number is > 313 (>100%), as some placentas had more than 1 histological lesion and each 
histological lesion has been counted separately. 
Table 9.1 Frequency of predefined histological categories in abnormal placental histology. 
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Table 9.2 presents the maternal and neonatal characteristic data in cases with 
placental pathology versus placentas with normal histological findings.  
 
Total n=1125 Abnormal histology(n=313) Normal histology(n=812) 
Maternal age years ± SD 30.5 ± 5.6 31 ± 5.8 
Mean Gestational age ± SD 39.8 ± 1.3 39.4 ± 1.5 
% Nulliparity (n) 57.8 (181) 44.3 (359) 
% Smoker (n) 10.5 (33) 8.9 (72) 
% Maternal PET (n) 1.6 (5) 2.3 (19) 
% Maternal PIH (n) 2.9 (9) 2.2 (18) 
% Maternal GDM (n) 2.9 (9) 4.4 (36) 
% SGA≤10
th
 percentile (n) 8.6 (27) 9.8 (80) 
% Induced labour (n) 17.3 (54) 20.1 (164) 
%Emergency caesarean 
delivery (n) 
12.5 (39) 10.9 (89) 
Mean Birth Weight ± SD 3523 ± 497 3466 ± 504 
%Males (n) 53.7 (168) 52.9 (430) 
% admitted to Neonatal unit 
(n) 
7.3 (23) 5.4 (44) 
Apgar score (at 5 min) ± SD 9.85 ± 0.4 9.83 ± SD 0.6 
Cord Blood pH (Arterial) ± 
SD 
7.25 ± 0.07 7.25 ± 0.08 
BE (Arterial) ± SD -4.50 ± 2.6 -4.35 ±  2.7 
Cord Blood pH (Venous) ± SD 7.31 ± 0.07 7.31 ± 0.07 
BE (Venous) ± SD -4.22 ± 2.19 -4.17 ±  2.51 
 
Table 9.2 Maternal and neonatal characteristics in cases with normal and abnormal placental 
histology. 
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Table 9.3 compares the different resuscitation measures required immediately after 
delivery in the group with and without placental pathology. Majority of the cases, 
over 90% in both groups did not require any resuscitation. None of the neonates 
required intubation or cardiac massage in the placenta pathology group.  
 
 
Abnormal histology               
% (n=313) 
Normal histology                   
% (n=812) 
None 95.8 (300) 97.1 (788) 
Facial oxygen + Stimulus 2.3 (7) 1.5 (12) 
Face mask ventilation 1.9 (6) 1.1 (9) 
Intubation - 0.2 (2) 
Intubation + Cardiac massage - 0.1 (1) 
 
Table 9.3 Neonatal resuscitation in abnormal versus normal placental histology groups. 
 
Table 9.4 compares the neonatal outcome in the admitted neonates in abnormal 
versus normal histology group. The incidence of respiratory distress syndrome 
(RDS) was higher in the placental pathology group (26% versus 15.9%), however, 
this difference was not statistically significant (p>0.05). There was no statistically 
significant difference in the mean ventilation, CPAP, total respiratory support days in 
the group with and without placental pathology. There was no significant difference 
in the admission days to NICU, SCBU or total admission days in the unit in either of 
the group. 
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NS-Non significant 
Table 9.4 Neonatal outcome in abnormal versus normal placental histology. 
 
 
 Abnormal histology Normal histology P value 
No. of neonates admitted N=23 N=44  
% RDS (n) 26 (6) 15.9 (7) NS 
% CLD 0 0  
Ventilation days (Mean ± SD) 0.09 ± 0.4 0.10 ± 0.37 NS 
CPAP days (Mean ± SD) 0 0.30 ± 1.17 NS 
Mean total days respiratory 
support ± SD 
0.13 ± 0.46 0.33 ± 1.14 NS 
Hydrocephalus (n) 0 0  
Seizures (n) 0 0  
ROP (n) 0 0  
Feed Intolerance (n) 2 9 NS 
PDA (n) 0 1  
Thrombocytopenia n) 0 0  
Anaemia (n) 0 0  
Coagulopathy (n) 0 0  
Proven infection (n) 0 0  
NEC (n) 0 0  
Renal Impairment (n) 0 1  
NICU admission days (Mean 
± SD) 
0.17 ± 0.7 1.86 ± 4.8 NS 
SCBU admission days (Mean 
± SD) 
5.65 ± 1.7 6.53 ± 3.5 NS 
Total Hospital stay days 
(Mean ± SD) 
5.83 ± 1.9 8.21 ± 6.2 0.07 
Survival to discharge (n) 23 43 NS 
Discharged home from Rosie 
Hospital (n) 
23 40 NS 
Transferred out to different 
unit (n) 
0 3  
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Tables 9.5 (a-b) shows the pregnancy and neonatal outcomes in placentas with 
abnormal histology groups and the comparison to the normal histology data.  
 
All values in %  
(n) or Mean ± SD 
Ascending 
genital tract 
infection 
(n=123) 
Chronic 
placental 
underperfusion 
(n=81) 
IVT              
(n=53) 
VUE  (n=42) 
Fetal 
thrombotic 
vasculopathy 
(n=11) 
Normal 
histology                            
(n=812) 
Induced labour  18.7 (23) 12.3 (10) 15.1(8) 16.7(7) 27.3(3) 20.1(163) 
Emergency  
c/section 
14.6(18) 11.1(9) 17(9) 0 9.1(1) 10.9(89) 
Males 56.1(69) 58(47) 60.4(32) 31(13) 9.1(1) 52.9(429) 
Maternal PET 1.6(2) 1.2(1) 3.8(2) 0 0 2.3(19) 
Maternal PIH 2.4(3) 4.9(4) 1.9(1) 7.1(3) 0 2.2(18) 
Maternal GDM 1.6(2) 1.2(1) 5.7(3) 0 9.1(1) 4.4(36) 
SGA≤10th 
percentile 
8.9(11) 12.3(9) 0 9.5(4) 9.1(1) 9.8(80) 
Admitted to 
neonatal unit 
9.8(12) 4.9(4) 7.5(4) 7.1(3) 9.1(1) 5.4(44) 
Apgar score at 5 
min 
9.80 ± 0.4 9.83 ± 0.4 9.92 ±  0.27 9.95 ± 0.22 9.91 ± 0.30 9.85 ± 0.66 
Arterial cord 
Blood Ph 
7.24 ± 0.06 
(n=47) 
7.26 ± 0.07 
(n=23) 
7.25 ± 0.07 
(n=14) 
7.23 ± 0.07 
(n=14) 
7.32 ± 0.07 
(n=5) 
7.25 ± 0.08 
(n=254) 
BE-Arterial  
-5.0 ± 2.40 
(n=47) 
-4.5 ± 2.96 
(n=23) 
-3.99 ± 2.26 
(n=14) 
-5.00 ± 2.30 
(n=14) 
-2.34 ± 2.13 
(n=5) 
-4.35 ± 2.69 
(n=254) 
Venous cord 
blood Ph 
7.30 ± 0.07 
(n=47) 
7.32 ± 0.06 
(n=22) 
7.31 ± 0.06 
(n=14) 
7.30 ± 0.04 
(n=14) 
7.38 ± 0.10 
(n=6) 
7.31 ± 0.07 
(n=260) 
BE-Venous 
-4.63 ± 2.10 
(n=47) 
-4.02 ± 2.52 
(n=22) 
-3.99 ± 1.85 
(n=14) 
-4.51 ±  
2.24 (n=14) 
-3.15 ± 1.93 
(n=6) 
-4.17 ± 2.51 
(n=260) 
Resuscitation 
required 
9.8(12) 1.2(1) 0 0 0 3(24) 
RDS  1.6(2) 3.7(3) 1.9(1) 0 9.1(1) 15.9(129) 
 
Table 9.5 (a) Pregnancy and neonatal outcomes in cases with abnormal and normal histology. 
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Ascending 
genital tract 
infection 
(n=123) 
Chronic 
placental 
underperfusion 
(n=81) 
IVT 
(n=53) 
VUE 
(n=42) 
FTV 
(n=11) 
Normal 
histology 
(n=812) 
Mat Age 29.98 ± 5.70 30.73 ± 5.17 30.32±5.39 31.81±5.64 28.36 ± 6.28 31.00±5.78 
GA at del(wks) 40.11 ± 1.30 39.70 ± 1.21 39.74±1.00 39.74±1.15 38.82 ± 1.60 39.37±1.49 
Birth Wt (gms) 3584 ± 476 3390 ± 524 3660±426 3434±523 3382 ± 512 3466±504 
NICU admission 
(days) 
0 .25 ± 0.50 .75±1.50 0 0 1.86±4.84 
SCBU admission 
(days) 
5.58 ± 1.08 3.75 ± 2.22 4.75±2.63 7.00±2.00 8.00 ± 2.00 6.53±3.50 
Total Hospital 
admission (days) 
5.58 ± 1.08 4.00 ± 2.16 5.50±3.70 7.00±2.00 8.00 ± 2.00 8.21±6.19 
Ventilation days 0 0 .50±1 0 0 0.10±0.37 
CPAP days 0 0 0 0 0 0.30±1.17 
Total days resp 
support 
0 .25 ± 0.50 .50±1 0 0 0.33±1.14 
 
Table 9.5 (b) Pregnancy and neonatal outcomes in cases with abnormal  and normal histology. 
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9.5 DISCUSSION  
Should all placentas be sent for detailed examination of placenta if there is adverse 
perinatal outcome; it is still not clear whether the pregnancy and neonatal outcomes 
are any different in abnormal placental histology group as compared to that of 
normal histology. 
In this study, there were no differences observed in gestational age at delivery, 
prevalence of PET, PIH, GDM and SGA, rate of induction of labour or emergence 
Caesarean section in either of the group. Even there was no difference in the rate of 
admission in neonatal unit in placenta pathology versus normal cases (7.3% versus 
5.4% with p=0.26). There was no significant difference in the mean admission days 
to NICU (p=0.10), SCBU (p=0.26) or in the total spent in the neonatal unit (p=0.07).    
Cord blood gases (arterial and venous) were not any different in abnormal histology 
versus normal histology groups (Art-7.25 versus 7.25, Ven-7.31 versus 7.31). 
There was no difference observed in the incidence of respiratory distress syndrome 
in the placentas with normal versus abnormal histology, with no difference in mean 
ventilation days (p=0.92), days on CPAP (p=0.22) or in total days on respiratory 
support (p=0.42).  
None of the individual histological categories showed any increased prevalence of 
the PET, PIH, GDM or SGA. 
39.3% of all placental histology cases were of ascending genital tract infection; 
however none of these cases had any clinical signs or symptoms suggestive of 
chorioamnionitis or any other intrauterine sepsis. The result of this study is in 
accordance with the other studies showing poor correlation between clinic and 
histologic chorioamnionitis.126-127 Though the histological diagnosis of the 
chorioamnionitis is considered a gold standard, the clinical significance of this is not 
entirely clear. In this study, there were no significant differences observed in 
pregnancy and neonatal outcome of normal versus abnormal histology groups.  
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In term pregnancies, chorioamnionitis occurs in labour and clinically remains largely 
irrelevant, while in preterm deliveries, this will be of much greater clinical relevance.  
A recommendation therefore from this analysis is that every placenta does not need 
detailed pathological examination in deliveries at or close to term. However this data 
can only be represented for the population at or near term but cannot be extrapolated 
to pre term deliveries.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 10 : DISCUSSION 
 
 
Key Findings: 
 Close correlation between manual and digital placental measurements using 
software image J has been defined. 
 Morphological indices of the placenta and the umbilical cord defined for 
more objective analysis. 
 These morphological indices were not different in common obstetric outcome 
groups as compared to those of the reference population. 
 This study has shown quantitatively, strong positive correlation of birth 
weight to the placental weight and circumference.  
 For the first time, this study has described the baseline data of predefined 
histological lesions in the reference population and the pregnancies with 
common obstetric outcome. 
 Cases of IVT and VUE showed relative hypercoiling of the umbilical cord. 
Most placentas from unselected population (72%) as well as common 
obstetric outcome groups (66-80%) were histologically normal.  
 Morphological indices and predefined histological abnormalities were not 
any different in the placentas from infants admitted to the Neonatal Unit.  
 There were no differences in the pregnancy and Neonatal outcome in cases 
with abnormal predefined histological lesions. 
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10.1 OVERVIEW OF THESIS 
This study was a prospective study of an unselected reference population of women 
with singleton pregnancies, delivering in a single unit in Cambridge, Eastern region 
of England. The study received ethical approval from Cambridgeshire 3 Research 
Ethics Committee. 1159 patients were recruited for the study over a period of 13 
months in year 2007-2008. This study largely included term cases (33-43 weeks).  
The study predominantly defines the morphological and histological characteristics 
of the placenta to the pregnancy and neonatal outcomes. This study has surprisingly 
never been done before. The study derived the placental morphological indices 
quantitatively using the image analysis, and showed a strong positive correlation 
between manual and digital measurements of the placenta. Based on the derived 
indices; cord coiling, insertion and the shape of the placenta has been described 
quantitatively, avoiding the bias of qualitative method. The study has also derived 
the ratio of birth weight to placental weight and the circumference in the reference 
population. These morphological indices and the ratios will form the bases of future 
studies. 
No baseline quantitative data for placental characteristics exists. Previous studies 
have either been performed on high risk population and/or analysed placental 
characteristics qualitatively, which makes it difficult to compare the data.   
This study has defined the criteria for diagnosing the histological lesions of the 
placenta and the incidence of these predefined histological lesions in the unselected 
population. 
As most cases in any unselected population are “normal” and have a normal 
outcome, they therefore do not require further investigations of the placenta. This 
study has shown this in a more objective manner and we cannot recommend that 
there is need for routine detailed placental examination in an unselected term 
population. 
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This study was not easy to do, and many problems were encountered. It required 
involvement of great number of personnel such as dedicated laboratory assistant for 
daily transportation of placenta from delivery unit to pathology lab. Extra biomedical 
scientists were required for daily tissue sectioning and processing for further 
analysis. Procuring a fridge with greater capacity near labour ward was difficult.  
One of the most challenging tasks of this study was to keep the midwifery staff 
motivated and encouraged throughout the recruitment period so that all the placentas 
from participants were kept for the study from the patients recruited. Since a detailed 
and thorough macroscopic examination of the placenta was not possible in the 
delivery unit, a dedicated study area was required in the pathology lab. The study 
required trained perinatal pathologists, as the general pathologist may not be trained 
for the detailed placental histological examination, required by the study.  
10.2 MANUAL VERSUS DIGITAL MEASUREMENTS  
This study compared the manual measurements of placenta to the digital 
measurements of image J software. The data showed a strong positive correlation 
between manual and digital measurements using correlation coefficient a nd a more 
precise method of comparison of the two measurements; Bland Altman analysis. The 
results of digital measurements of the study were comparable to other recent studies 
(Table 3.3). 
The findings are of potential importance for future studies in this area, since with the 
widespread introduction of relatively cheap and accurate digital imaging 
technologies and low cost image analysis software, imaging based measurements are 
likely to become increasingly commonly used. The advantages of such image based 
studies includes the ability to perform measurements in a batch at a subsequent time, 
rather than delaying placental or tissue clinical examination, and the storage of the 
raw data images which can be revisited at a later date for review or further 
measurements. For most such studies examining measurements in relation to 
outcome, the precise measurements are less important since provided the same 
methodology is used for all group valid comparisons can be made.  
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There was a close correlation in manual measurements of long axis, short axis and 
circumference of the placenta to that of digital measurements, though the digital 
measurements appeared to be systematically smaller than the traditional manual 
measurements. The reason for this difference was not clear. As the comparative data 
have not been presented in this format before, it is difficult to know if this finding 
was unique to this study or whether there are other reasons. 
Digital measurement of the placenta is reproducible and a relatively simple method 
of measurement compared to traditional manual measurements. Image J software is 
also freely available making it accessible to researchers in countries where financial 
resources may be limited. 
10.3 PLACENTAL MORPHOLOGICAL INDICES 
Studies on the placenta and umbilical cord have generally investigated adverse 
outcomes where there is an indication for histological examination of the placenta, 
such as fetal demise, intrauterine growth restriction, preterm delivery, pre-eclampsia, 
diabetes mellitus, macroscopic abnormalities of placenta, fetal asphyxia, and intra 
uterine infection. Few have attempted to establish baseline characteristics in an 
unselected population delivering at term. This population studied approximates in 
maternal demographics, the incidence of pregnancy conditions and birth 
weight/gestation outcomes to a typical UK/European booking population.  
Hypocoiling and hypercoiling of the cord (whether detected in antenatal or postnatal 
period) have been reported to be associated with adverse perinatal outcome, although 
causality remains uncertain. Hypocoiling has been associated with trisomies, preterm 
delivery, fetal death, increased intrapartum complications and interventional 
deliveries for fetal distress, Apgar score less than 7 at 5 minutes; velamentous cord 
insertion and single umbilical artery. Hypercoiling has also been linked with 
trisomies, but also small for gestation age, fetal asphyxia and single umbilical artery 5 
8 56.  
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Abnormal cord coiling has also been found with thrombosis of the chorionic plate 
vessels, umbilical venous thrombosis and umbilical cord stenosis 6.  
The coiling index is probably one of the most frequently reported of umbilical cord 
related parameters in common outcome groups. Pre-eclampsia and gestational diabetes 
have been suggested as maternal risk factors for abnormal coiling 57. In gestational 
diabetes both non coiling and hyper coiling were significantly more frequent than in 
normal pregnancies96. In addition, hypercoiling has been associated with SGA (OR 
2.10) 8. The umbilical cord coiling index in this study was 0.20 coils/cm with a 
preponderance of left sided coiling (79%), according with published data which suggest 
a range of  65% to 87.5% 8 45 49.11. Our data however showed no significant difference in 
umbilical cord coiling index with pre-eclampsia, PIH, GDM or SGA compared to the 
reference population. 
Whilst central and paracentral cord insertions presumably represent variants of  normal 
and have no clinical importance, marginal insertion has been suggested as being more  
susceptible to vessel rupture and associated with intra uterine growth restriction, 
stillbirth and neonatal death 9. The incidence of velamentous insertion  increases with 
maternal smoking, advanced age or diabetes mellitus and among multiple births, 
congenital malformation and in vitro fertilisation pregnancies 9. However, in our study 
we did not observe any cases of velamentous insertion of the cord in GDM. Although 
the difference between extreme paracentral umbilical cord insertion and marginal cord 
insertion may be small, this differentiation may be important as paracentral umbilical 
cord insertion is the most common type of umbilical cord insertion in pregnancies with 
normal outcome while some studies have shown an  increased incidence of marginal 
umbilical cord insertion in pregnancies with adverse outcomes such as miscarriage, fetal 
congenital anomalies, preterm labour and intrauterine growth restriction 64-66.  
The morphological index for the degree of deviation from central insertion into the 
chorionic plate is expressed in this study as the cord centrality index (CI). The data of 
this study indicated that in unselected population of pregnancies delivering at term, the 
„normal‟ cord insertion is not in fact central. In the current study mean cord centrality 
index was 0.36, which signifies a markedly „off centre‟ insertion (Figure 4.4). 
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Transposing these results to the traditional descriptive categories, the results concur with 
historical as well as newer studies (Table 4.1). Though subjective and qualitative 
description of the placenta has a role predominantly in clinical reporting, deriving this 
index allows entirely objective analysis of this and other continuous variables in relation 
to outcomes and other placental findings. 
There are no studies comparing quantitatively the difference between abnormal 
insertion of the umbilical cord in common obstetric outcome groups and a reference 
population. The distance of umbilical cord insertion from the centre (or from the 
chorionic plate margin) has been considered a marker of placental insufficiency 90 97. 
Peripheral cord insertion is also strongly related to abnormal placental shape in severe 
IUGR with abnormal umbilical artery Doppler.171 The association of velamentous 
insertion with IUGR, low birth weight infants and pregnancies affected with diabetes 
mellitus has been reported 9. One of the largest studies of its type on 12,750 patients, 
found an increased risk of  low birth weight (OR 2.32) and small for gestational age 
infants (OR 1.54) with velamentous insertion74, and another an increased incidence of 
velamentous cord insertion in low birth weight than controls 73. Historic studies have 
reported an increased incidence of marginal cord insertion in pregnancies with IUGR 
64-66. In the current study there was no significant difference in cord centrality index for 
pre-eclampsia, PIH, GDM and SGA groups compared to the reference population.  
The shape of the placenta has been thought to closely mirror the pattern of chorionic 
vascular growth; studies modelling the placental vascular tree have suggested that 
irregular shapes of placenta are common and associated with low birth weight, 
suggesting variably shaped placentas have altered function 10. Abnormal shape has 
been associated with increased intra uterine fetal death, extreme preterm delivery and 
fetal growth restriction 172. The data of the present study indicated that the „normal‟ 
term placenta was not round. The eccentricity index in this study varied from 0 to 1 
with mean eccentricity of the chorionic disc 0.49, in other words more elliptical than 
round (fig 4.7). There are no studies describing the shape of placenta quantitatively 
in the common obstetric outcome groups of hypertensive disorders of pregnancy, 
GDM or SGA. Further few have compared the shapes of the placenta quantitatively 
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between obstetric outcome groups and a reference population, though a recent study 
has shown a correlation between the short axis of the placenta and the severity of the 
pre-eclampsia 94. The current study did not find the statistically significant difference 
in shape (eccentricity) of the placenta between the reference population and any of 
the common obstetric outcome groups. 
It is, therefore, appropriate to dispel the widely held beliefs that the placenta is, in its 
natural and normal state, circular and that the cord normally inserts into its centre.  
Further, coiling index, cord centrality index and eccentricity in this study was not any 
different in the pregnancy outcome groups compared to the data from pregnancies 
which were not affected by those outcomes. 
10.4 BIRTH WEIGHT/ PLACENTAL WEIGHT AND CIRCUMFERENCE 
The normal birth weight: placental weight ratio has been shown to range between 6.5 
to 7.1 at term 37-42 weeks gestation114-115, and 6.3 to 8.46 at 34-43 weeks.116  The 
birth weight: placental weight ratio of 7.39 ± 1.20 in the reference population from 
33-43 weeks that we derive is therefore within the limits of these gestational age 
ranges. This ratio may have relevance as the ratio of birth weight: placental weight 
has been considered to be more important than placental weight alone when 
considering adverse perinatal outcome such as fetal and neonatal demise.107 117  
This relationship between birth weight and placental weight is also important as a 
larger placental weight: birth weight ratio has been associated with chronic 
hypertension and other adverse cardiovascular outcomes in later life.110 173  
 
Confusingly, the relationship of birth weight and placental weight has been described 
differently in other studies, and gestational age strongly affects the ratio with the 
ratio being lower at earlier gestations: 2.9 at 24 weeks and 6.8 at 40 weeks.115 Some 
studies describe the feto-placental weight ratio116, others as its inverse-placental  
weight: birth weight ratio.113 One UK based study174found that the placental: birth                
weight ratio at term (39-41 weeks) ranged from 19.5 to 20.4%, which would be 
roughly be equal to birth: placental weight ratio of about 5; another measured the  
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placenta: birth weight ratio at term (>37 weeks) in a large cohort as 0.177 i.e. birth: 
placenta weight ratio as 5.6.113 These ratios are smaller than those observed in the 
current study.  
 
Ethnicity does not seem to affect this ratio, as smaller births in Asian pregnancies are 
associated with smaller placentas and greater birth weight with higher placental 
weight; therefore the ratio is thought to remain essentially the same.174 The 
population in this current study is mainly Caucasians as has been mainly the case in 
European based studies.  
 
Birth weight/placenta weight of the reference population has been compared with the 
common obstetrics outcomes in this study. This ratio is significantly smaller 
(p=0.001) in cases with PET (6.60 ± 1.03) than the cases not affected by PET (7.40 ± 
1.19).  The mean difference between the two groups was 0.79. This study did not 
show any difference in this ratio in cases with SGA, PIH and GDM compared to the 
non-affected population. 
 
Another outcome analysed in this study was the ratio of birth weight and placental 
circumference. This ratio has not been presented previously. We described it as we 
wished to establish whether a relationship existed between the birth weight and the 
placental dimensions rather than with weight or volume. Whether or not this ratio is a 
clinically useful index, describing it and deriving a relatively robust range and ratio at 
gestation between 33-43 weeks allows other researchers to compare their findings to it.  
In this study, a significant difference was observed in birth weight/placenta 
circumference ratio in cases with PET and SGA. In cases of PET and SGA, the mean 
difference of this ratio was significantly less than non-affected population. The study did 
not disclose this ratio any different in cases with PIH and GDM as compared to the non-
affected population values. 
 
The birth weight: placental weight ratio, derived in this study was consistent with the 
data from studies. The data of the birth weight ratio to the placental weight and 
circumference as robust as they were from an unselected population of women 
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delivering at gestational age of 33-43 weeks whose gestations have in all cases been 
calculated from a first trimester scan. 
 
There was a strong correlation between placenta weight and circumference to the 
birth weight in all common obstetric outcome groups and reference groups. (scatter 
plots with significant Pearson‟s correlation coefficient‟s values-figures 6.4-6.10), 
which also confers that higher the birth weight, the higher is the placenta weight and 
the circumference and vice versa.  
 
10.5 PREDEFINED HISTOLOGICAL LESIONS   
These data describe the pattern of histology in unselected population irrespective of 
the risk status of the pregnancy. To add this, the study follows strict criteria for the 
diagnosis of histological abnormalities. The incidence of various histological 
pathologies varies widely in literature; one of the reasons being lack of standard 
definitions for these lesions. Every research group has defined the lesions according 
to their definitions and therefore the literature lacks uniformity on the subject.  
Guidelines suggest that all placentas should be examined by the trained perinatal 
pathologists: Placental pathology should be a routine component of obstetric-
neonatal care, as it would provide detailed information, helpful in the post natal 
management of adverse pregnancy outcome.18 However the histological examination 
and perinatal outcome in most pregnancies is normal, for example in the current 
study, the frequency of histologically normal examination was observed in over 70% 
of cases, even in the subset of common obstetric outcome pregnancies more than 
66% placentas did not show any histological lesions. Therefore the data from this 
study do not support the recommendations for the routine examination of placenta by 
the pathologist.  
 The diagnosis of chorioamnionitis clinically is unreliable as the clinical signs and 
symptoms are non specific. These symptoms may be suggestive of some other 
pathology, not necessarily chorioamnionitis.  
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Above all most cases of chorioamnionitis (confirmed histologically) do not even 
have the clinical features of infection per se. Therefore only a histologically made 
diagnosis of chorioamnionitis should be taken as a reliable diagnosis. Interestingly, 
in the current study we had no cases of clinically diagnosed chorioamnionitis and yet  
we had significant number (123; 10.9%) of cases of histological ascending genital 
tract infection. This enforces the fact that there is a very poor correlation between a 
clinical diagnosis and histological infection. There was no difference in the 
frequency of ascending genital tract infection in the common obstetric outcome 
groups as compared to the unselected population. 
The reported incidence of IVT varies from 3-50% in full term uncomplicated 
pregnancies. 132 133   This study reported the frequency of IVT in unselected cohort of 
4.7%; comparing the incidence of IVT in uncomplicated pregnancies to small for 
gestational age (<10 centile) has shown no difference in the incidence of the 
lesion.133 In current study there were no differences in IVT observed in SGA, PET, 
PIH and GDM, compared with reference population. 
Villitis of unknown etiology is one of the most commonly found placental lesions in 
the 3rd trimester. This entity is still unknown to many clinicians and pathologists are 
still over or under diagnosing the condition. VUE is primarily seen in the term 
placenta; more than 80% cases occur after 37 weeks and all after 32 weeks of 
gestation.114  Histology findings suggestive of chronic villitis at less than 32 weeks 
should lead to a high suspicion of infectious pathology rather than making a 
diagnosis of villitis of unknown etiology.  
The diagnosis of VUE can be difficult specially when there is minor degree of 
inflammatory change. A high degree of inter-observer variation can be seen in the 
diagnosis of villitis of unknown etiology.157 There also exists different histological 
criteria for the diagnosis of villitis by different authors. Perhaps if agreed standard 
criteria for the diagnosis of VUE; this condition then can be better understood by all. 
Villitis of unknown etiology has been described to have a recurrent tendency in 
successive pregnancies and recurrent villitis tends to be more extensive and has even 
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 stronger association with intra uterine growth restriction. 175 176  The incidence of 
VUE in current study what we find was lower (3.7%) than the incidence noted in one 
of the study of the UK population (13.6%).136 The frequency of VUE was higher 
(11.1%) in cases with PIH but interestingly there were no cases observed in PET.  
We also report relatively infrequent histological lesion: fetal thrombotic 
vasculopathy, Chorangiosis, massive perivillous fibrin deposition (MPFD) in the 
study.   
In summary: these histological abnormalities are either studied in uncomplicated 
pregnancies or in complicated pregnancies but to the best of our knowledge, no study 
has presented the baseline histologic profile in unselected population. We described 
an unselected population, the prevalence of the histological abnormalities is low and 
therefore the power of the study to determine clinical significance is low. However 
the range and incidence of histological abnormalities can be used as baseline data for 
future studies. 
This study also investigated the relationship between the macroscopic placental 
indices to the placental histology. The effect of and/or association between 
histological lesions and the morphological characteristics of the placenta have not 
been previously comprehensively described in an quantitative manner, using 
objective measurements and strict histological criteria combined with completely 
blinded histological review.  
The study did not find an association between placental macroscopic features such as 
the shape (Eccentricity), and cord insertion (Cord centrality index) with the 
histological abnormalities. Placental morphology can therefore not predict the 
presence or absence of histological abnormality.  
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10.6 PLACENTA IN NEONATES ADMITTED TO THE NEONATAL UNIT 
CLINICAL AND OUTCOMES IN ABNORMAL HISTOLOGY GROUP  
Macroscopically; the cord coiling index, cord centrality index and placental 
eccentricity in infants admitted to the Neonatal Unit did not show any significant 
difference as compared to that of macroscopic indices of the cases where infants 
were not admitted.  The cord coiling index was no different in infants admitted to the 
Neonatal Unit. The cord centrality index showed no difference in Neonatal Unit 
cases, neither was eccentricity. However microscopically; 34.3% of infants admitted 
to the Neonatal Unit had histological abnormalities according to our pre defined 
histological groups.  
Clinical chorioamnionitis is associated with adverse perinatal outcomes, including 
cerebral palsy, abnormal fetal heart rate pattern, fetal hypoxia, chronic lung disease, 
broncho-pulmonary dysplasia, IUGR, fetal sepsis, fetal and neonatal death. These 
will obviously increase the rate of neonatal admission. However, it is difficult to 
determine whether the increased incidence of ascending genital tract infection is a 
true reflection of the Neonatal Unit admitted cohort or is due to any particular 
clinical outcome group. 
The incidence of chronic placental underperfusion, IVT, VUE, fetal thrombotic 
vasculopathy and Chorangiosis was very small number to draw any meaningful 
conclusions. No cases of MPFD, chorangioma, chronic histiocytic intervillousitis, 
and acute abruption were observed in the placentas where infants were admitted to 
the Neonatal Unit. 
Comparing all cases of abnormal placental histology to normal histology, there was 
no significant difference in maternal age, gestational age, prevalence of PET, PIH, 
GDM and SGA, rate of induction of labour or emergency caesarean section. There 
was no difference in the rate of admission to the Neonatal Unit based on the 
histology of the placenta. There was no difference in cord blood gases (arterial and 
venous) in both groups. In both groups over 95% of neonates did not require any 
resuscitation.  
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The incidence of respiratory distress syndrome was not different in the two groups. 
Similarly, there was no significant difference in mean ventilation days, days on 
CPAP, total days on respiratory support, mean admission days to NICU, SCBU or in 
the total spent in the Neonatal Unit.    
Individually comparing with the most common histological categories, there was no 
significant difference between the cases with abnormal and normal histology and the 
incidence of maternal pre-eclampsia, PIH, GDA and SGA was not increased in the 
abnormal histology group. 
Out of 313 cases with abnormal placenta histology, the most common histological 
category was ascending genital tract infection, which constituted 39.3% of all 
placental pathology cases. In this study there were neither cases of clinical suspected 
chorioamnionitis nor any obvious cases of antenatal sepsis. Clinical signs and 
symptoms which may be suggestive of chorioamnionitis are non specific; there is a 
poor correlation between clinical and histologic chorioamnionitis.126-127  We included 
funisitis (umbilical cord inflammation) and the inflammation at the choriodecidual 
junction within the ascending genital tract infection group.  Intrauterine infection due 
to any cause is well known to be linked with preterm deliveries.177-180 Intrauterine 
infection and subsequent resulting fetal infection has been implicated in neonatal and 
fetal injury181-182, cerebral palsy183 and chronic lung disease.184  The end state is 
infection is fetal infection and increased neonatal mortality due to neonatal sepsis; 
Chorioamnionitis results in increased perinatal morbidity and mortality.  
Diagnosis of chorioamnionitis clinically is an unreliable tool as the clinical signs and 
symptoms suggestive of chorioamnionitis are non specific. However its clinical 
significance is not clear as most term cases would have no clinical concerns. 
In summary, this study showed no obvious utility to examining the placenta routinely 
or in the case of neonatal and fetal pathology. However in such cases, the 
significance of detailed placental examination by the pathologist would still remain 
from medico-legal purposes.  
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We recommend that the strict criteria for the definitions for all common histological 
categories and standard protocols should be developed for better understanding of the 
disease. 
10.7 REFLECTIONS ON PROBLEMS IN THESIS 
Ethics committee/ R&D /Consent 
Patients were provided the consent form with the study information in the antenatal 
clinics. They were asked to sign the consent forms if agreed to participate in the 
study. Consent forms were kept in the patients notes. At the time of delivery, the 
evidence of consent was confirmed by the delivery unit staff and placenta was sent to 
the study attached with a study pathology form with a confirmation of the consent. 
During the study, there were problems with regard to the consent for the placental 
study. The research team identified some shortcomings in filing the written consent 
form, in the patients‟ notes, as per the study protocol. In the interest of research 
governance, the team agreed to review all case notes when a concern was raised.  
Where there was no evidence of signed consent form in the patients‟ notes, the cases  
were not included in the study and the patient information was removed from the 
study database.  
There were some cases where there was no evidence of the written consent form in 
the case notes, but the completed and signed study pathology form by the attending 
doctor or midwife was present with the placenta stating explicitly that the consent 
has been taken. These cases also have not been included in the current study, as they 
are pending ethics committee decision.  
We very much regret that we do not include these cases but feel we have no 
alternative in absence of any response from the ethical committee. (Reference letter 
in appendix) 
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10.8 LIMITATIONS OF STUDY 
All pregnant women with singleton pregnancy were approached for the study 
irrespective of their gestational age at the time of recruitment. Therefore we perhaps 
did not recruit patients who either had pre term delivery or developed for example 
early onset pregnancy complications for example early onset pre eclampsia, IUGR 
etc. Because of the laborious consenting process, women in whom there were clinical 
difficulties at preterm gestations are less likely to have consented to take part in this 
study. However the incidence of term complications of pre eclampsia, PIH, GDM 
and SGA are broadly similar to those reported in other studies from unselected 
population. We do plan to extend this study including specific cases of early onset 
PET, IUGR, clinical abruption cases, diabetes and IUFD. 
We also could not recruit those placentas where placenta those were delivered 
manually, making it difficult to perform measurements. 
We did not have control on the length of the umbilical cord left on the neonates. We 
only relied on the cord which was received with the placenta. This problem is 
encountered in most studies performed on the umbilical cord. Therefore fetal end o f 
the cord is not truly “fetal” end. The method we have used to derive the placental 
circumference worked well for regularly shaped placentas, however was more 
approximate where a placenta was a very abnormal shape. There is no geometrical 
way of reliably defining the axes of the placenta and its centre where a placenta has a 
grossly irregular shape. This is an invariable limitation of this type of study, however 
we did not exclude any placentas on the basis of very irregular shape. Furthermore 
for consistency rather than deriving placental circumference through direct tracing, 
we derived this in all cases from the major and minor axes which form the basis of 
the eccentricity and the cord centrality indices. 
In the reference population, 123 cases (out of 1125) showed signs suggestive of 
histological ascending genital tract infection; none of these cases had a record made 
of clinical chorioamnionitis. However we relied on the obstetric database “protos” 
for the clinical diagnosis. We did not consider individual clinical markers such as 
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 WCC, CRP, history of rupture of membranes or use of antibiotics in labour as 
diagnostic in themselves as clinical chorioamnionitis. 
 
10.9 FUTURE WORK   
Following demonstration of quantitative morphology of the placenta in unselected 
population, this work now allows the future studies to perform further analysis based 
on the morphology of the placenta. 
This data will serve as baseline dataset for all future studies on placental morphology 
in unselected as well as common obstetric outcome pregnancies. 
During the period of the study, placental tissues in some cases were stored in RNA 
later for possible future molecular based studies. 
Future work which could follow this study are: 
Study on increased number of abnormal cases now that we have a large reference 
population to compare with nested cases control studies. 
Analysis on cases of preterm pre-eclampsia, SGA, placental abruption, IUD, diabetes 
including IDDM and clinical chorioamnionitis. 
To define incidence of rare histological findings in abnormal outcome groups. 
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Gestational age (Weeks) n (%) 
24-28 0 
29 1 (0.1) 
30 0 
31 1 (0.1) 
32 0 
33 4 (0.3) 
34 4 (0.3) 
35 8 (0.7) 
36 19 (1.6) 
37 62 (5.3) 
38 143 (12.3) 
39 295 (25.5) 
40 319 (27.5) 
41 269 (23.2) 
42 31 (2.7) 
43 3 (0.3) 
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